{
  "nodes": [
    "%",
    "(0.13–0.65)",
    "(0.16–0.76)",
    "(0.19–0.90)",
    "(0.20–0.91)",
    "(0.21–0.97)",
    "(0.23–0.85)",
    "(0.24–0.87)",
    "(0.24–1.25)",
    "(0.29–1.13)",
    "(0.34–1.48)",
    "(0.43–1.51)",
    "(0.43–1.55)",
    "(10.6)",
    "(10.7)",
    "(2021) 12:36",
    "(26.3)",
    "(A)",
    "(A2106)",
    "(B)",
    "(ESB)",
    "(SD)",
    "(Table 4)",
    "(a)",
    "(a)–(c)",
    "(at least 13 years old)",
    "(b)",
    "(c)",
    "(d)",
    "(e)",
    "(f)",
    "(g)",
    "(log) odds ratios (ORs) of preference for treatment attributes",
    "(n=19)",
    "(n=19*)",
    "(n=7)",
    "(ongoing wave)",
    "(phenotypic) association",
    "(ref.: Lowest tertile)",
    "(self reported) impulsivity",
    "(three-item) tailored TS-OCB scale",
    "***p",
    "***p,0.001",
    "**p",
    "**p,0.01",
    "*p",
    "*p,0.05",
    "-",
    "-0.007",
    "-0.020",
    "-0.025",
    "-0.028",
    "-0.035",
    "-0.037",
    "-0.042",
    "-0.056",
    "-0.064",
    "-0.066",
    "-0.068",
    "-0.071",
    "-0.073",
    "-0.075",
    "-0.091",
    "-0.1 (9.01)",
    "-0.104",
    "-0.136",
    "-0.142",
    "-0.144",
    "-0.157",
    "-0.175",
    "-0.180",
    "-0.182",
    "-0.189",
    "-0.260",
    "-0.289*",
    "-0.343*",
    "-0.355*",
    "-0.451***",
    "-1.3 (14.92)",
    "-12.2 (12.89)",
    "-13.4 (11.69)",
    "-14.7 (10.90)",
    "-17.6",
    "-24.0 (12.56)",
    "-29.65",
    "-5.49",
    "...",
    ".001",
    ".01",
    ".05",
    ".05 level.",
    ".05 significance level.",
    ".70",
    "0",
    "0 (never)",
    "0 = not true",
    "0.001",
    "0.002",
    "0.004",
    "0.006",
    "0.008",
    "0.009",
    "0.01",
    "0.011",
    "0.012",
    "0.016",
    "0.02",
    "0.021",
    "0.023",
    "0.029",
    "0.03",
    "0.033",
    "0.038",
    "0.03–3.78",
    "0.04",
    "0.040",
    "0.05",
    "0.06–4.17",
    "0.07",
    "0.080",
    "0.088",
    "0.09",
    "0.092",
    "0.100",
    "0.11",
    "0.113",
    "0.125",
    "0.128",
    "0.134",
    "0.135",
    "0.139",
    "0.145",
    "0.15",
    "0.156",
    "0.16",
    "0.162",
    "0.164",
    "0.176",
    "0.177",
    "0.178",
    "0.188",
    "0.19",
    "0.201",
    "0.205",
    "0.21",
    "0.21%",
    "0.219",
    "0.220",
    "0.23",
    "0.231",
    "0.237",
    "0.24",
    "0.25 mg/kg body weight",
    "0.266",
    "0.27",
    "0.270",
    "0.273*",
    "0.28",
    "0.29",
    "0.297*",
    "0.2–13.02",
    "0.3 (1.20)",
    "0.31",
    "0.33",
    "0.35",
    "0.350**",
    "0.36",
    "0.38",
    "0.4 (1.08)",
    "0.4 (11.25)",
    "0.4%",
    "0.41",
    "0.420**",
    "0.43",
    "0.44",
    "0.45",
    "0.46",
    "0.47",
    "0.48",
    "0.51",
    "0.52",
    "0.53",
    "0.530",
    "0.535",
    "0.549",
    "0.55",
    "0.57",
    "0.6 (0.93)",
    "0.61",
    "0.63",
    "0.64",
    "0.644",
    "0.663",
    "0.67",
    "0.69",
    "0.70",
    "0.71",
    "0.72",
    "0.73",
    "0.74",
    "0.75",
    "0.76",
    "0.79",
    "0.8%",
    "0.80",
    "0.82",
    "0.840",
    "0.86",
    "0.87",
    "0.89",
    "0.92",
    "0.93",
    "0.94",
    "0.95-3.64",
    "0.96%",
    "032",
    "0–5.39",
    "1",
    "1 % increase in potential of treatment abuse",
    "1 % increase in risk of loss of appetite",
    "1 % increase in risk of sleep disturbance",
    "1 % increase in risk of vomiting",
    "1 094",
    "1 346",
    "1 437",
    "1 497",
    "1 584",
    "1 609",
    "1 689",
    "1 724",
    "1 776",
    "1 881",
    "1 = sometimes true",
    "1 in 10 (10 %)",
    "1 in 100 (1 %)",
    "1 in 5 (20 %)",
    "1 to 10 seconds",
    "1 year",
    "1)",
    "1, 74",
    "1,352 participating students",
    "1,567 trials",
    "1-back",
    "1.00",
    "1.01",
    "1.02",
    "1.05",
    "1.09",
    "1.21",
    "1.22",
    "1.26",
    "1.2–8.84",
    "1.34",
    "1.51",
    "1.51–15.85",
    "1.57",
    "1.58",
    "1.60",
    "1.62",
    "1.63",
    "1.66–4371.8",
    "1.8 (1.51, 2.22)",
    "1.84",
    "1.93",
    "10",
    "10 January 2013",
    "10 November 2017",
    "10 daily seizures",
    "10 participants",
    "10 patients",
    "10 sessions",
    "10 subjects",
    "10% of the population",
    "10-20 International System",
    "10.07",
    "10.4 (OL)",
    "100",
    "100 card selections",
    "100 ms",
    "100%",
    "102",
    "10repeat",
    "10th revision",
    "11",
    "11 635",
    "11 June 2013",
    "11 November 2017",
    "11 patients",
    "11 previously identified",
    "11 subjects",
    "11, 12, 16",
    "11.1",
    "11.3 (P1)",
    "11.42",
    "11.7% life-time prevalence rate",
    "11.8",
    "11.90",
    "11/26 (42.3%)",
    "115",
    "119",
    "12",
    "12 (63.2%)",
    "12 articles",
    "12 h",
    "12 months",
    "12 weeks",
    "12%",
    "12,16",
    "12.22%",
    "12.53%",
    "12.9",
    "12.91%",
    "1217",
    "123",
    "124",
    "125",
    "1255",
    "128",
    "13",
    "13 347",
    "13 691",
    "13 subjects",
    "13, 14",
    "13.21%",
    "13.38%",
    "13.58",
    "13.71±2.69 years old",
    "133",
    "138 mixed undergraduate and community participants",
    "13–14 h",
    "13–17 years",
    "14",
    "14 mothers",
    "14 patients",
    "14 weeks",
    "14 years",
    "14.3",
    "14.63",
    "14.7",
    "14.90 ± 2.79",
    "141",
    "143",
    "1455",
    "14–17 Group",
    "15",
    "15 (78.9%)",
    "15 individuals",
    "15 of 19 patients",
    "15 subjects",
    "15, 16",
    "15,025 participants",
    "15-item questionnaire",
    "15.59",
    "15.64",
    "15.77",
    "15.88",
    "15/26 (57.7%)",
    "1500 children",
    "155 (OL)",
    "16",
    "16 arrows",
    "16 participants",
    "16.00 ± 6.86",
    "16.48",
    "16.52",
    "16.9 (G1)",
    "161",
    "163",
    "165",
    "169 (79.3%)",
    "169 LDX clinical responders",
    "17",
    "17 items",
    "17,19",
    "17.13",
    "17.2 years",
    "17.80 ± 11.96",
    "170 (6 months)",
    "178",
    "18",
    "18 items",
    "18 pairs of hypothetical treatment choices",
    "18 patients",
    "18-item ADHD assessment scale",
    "18-item Adult ADHD Self-Report Scale (ASRS)",
    "18.5",
    "18.6",
    "18/525",
    "184",
    "18–40 years",
    "18–55",
    "18–60",
    "18–63",
    "18–65",
    "19",
    "19 (73.1%)",
    "19 of 25 patients",
    "19 weeks",
    "19,24–27,29",
    "19.2",
    "19.5",
    "19.7",
    "196/290 (68%)",
    "1965",
    "1967",
    "1969",
    "1973–1990",
    "1973–1991",
    "1973–1992",
    "1973–1994",
    "1973–1997",
    "1973–2008",
    "1980–2001",
    "1982",
    "1983",
    "199 COM",
    "1990",
    "1992",
    "1994",
    "1995",
    "1996",
    "1997",
    "1998",
    "1999",
    "1st WAVE",
    "1–2 h/day",
    "2",
    "2 / 13",
    "2 032",
    "2 044 992",
    "2 125",
    "2 279",
    "2 308 032",
    "2 = often true",
    "2 March 2021",
    "2 months to 6.35 years",
    "2 months to 6.6 years",
    "2 separate crossover studies",
    "2 subjects",
    "2 teaching hospitals",
    "2 years",
    "2)",
    "2,024 studies",
    "2-back condition",
    "2.0 (1.21, 6.63)",
    "2.1 (1.74, 2.72)",
    "2.11",
    "2.19",
    "2.20",
    "2.28",
    "2.3 (0.91)",
    "2.4",
    "2.4 years",
    "2.48",
    "2.6",
    "2.6 (1.05)",
    "2.68",
    "2.70",
    "2.82",
    "2/525",
    "20",
    "20 J Compensation",
    "20 males",
    "20 patients",
    "20%",
    "20.7 (G2)",
    "2000",
    "2000 to 2012",
    "2000–2011",
    "2001",
    "2002",
    "20025266",
    "2003",
    "2004",
    "2005",
    "2006",
    "2007",
    "2008",
    "2009",
    "2010",
    "2010 or earlier",
    "20100020353",
    "2011",
    "2011 and 2015",
    "2011a",
    "2011a,b",
    "2011b",
    "2012",
    "2012 Alberta REAL Kids survey",
    "2012 REAL Kids Alberta survey",
    "2012 REAL Kids survey",
    "2013",
    "2014",
    "2015",
    "2016",
    "2016.00455",
    "2021",
    "2021:14",
    "21",
    "21 months",
    "21,465 individuals",
    "21-ii",
    "21/290 (7.2%)",
    "212",
    "218 (5 weeks)",
    "2191 participants",
    "21:226",
    "22",
    "22 626",
    "22-ii",
    "22.3 months‒3.5 years",
    "22.98, SD = 4.71",
    "220 parents of adolescents",
    "2220 participants",
    "23",
    "23.54 (SD = 4.62; 17–40 years)",
    "23.6",
    "23.69",
    "24",
    "24-item Yawning (YWN) scale",
    "24.1",
    "24.5% life-time prevalence rate",
    "24.74",
    "241 ASD",
    "246",
    "24–27",
    "25",
    "25 Children",
    "25 participants",
    "25.4",
    "250",
    "2500g",
    "25th and 75th percentiles",
    "25–54",
    "26",
    "26 nonremitters on prior MPH at screening",
    "26,31",
    "26.5",
    "26.6",
    "26.9",
    "261 families",
    "2637",
    "27",
    "27.12",
    "27.3%",
    "2783",
    "279",
    "28",
    "28 patients",
    "28 teachers",
    "28.0",
    "28.23",
    "28.4",
    "28.6",
    "28.80",
    "28.98",
    "283",
    "2831",
    "285",
    "289",
    "29",
    "29,30",
    "29.2",
    "290",
    "290 randomized participants",
    "29319347",
    "29319675",
    "294 participants",
    "297 children",
    "2marker haplotypes",
    "2nd WAVE",
    "2–50",
    "3",
    "3 291 773 offspring",
    "3 567",
    "3 728",
    "3 patients",
    "3)",
    "3-dimensional environments",
    "3-session intervention",
    "3.25",
    "3.3%",
    "3.37",
    "3.4%",
    "3.48-6.33",
    "3.77%",
    "3.78%",
    "3.8 (P2)",
    "3.87%",
    "30",
    "30 days",
    "30 mg/d LDX",
    "30%",
    "30.09",
    "30.58",
    "300 1–3500 (n = 1 075 447)",
    "30–33",
    "31",
    "31 cases",
    "31.1±10.9",
    "31.5±22.4 months",
    "317 participants",
    "318 participants",
    "3196",
    "32",
    "32.55",
    "32.79",
    "321 participants",
    "33",
    "33.8 months",
    "3382",
    "33–79",
    "34",
    "34 females",
    "340",
    "35",
    "35 962",
    "350 1–4000 (n = 1 152 337)",
    "3566",
    "36",
    "36.1",
    "36.6",
    "37",
    "37 weeks",
    "37.3",
    "3757",
    "38",
    "38.5%",
    "380 parents of children with ADHD",
    "384-well SpectroChip",
    "39",
    "39.13%",
    "396 participants",
    "3rd WAVE",
    "3–5%",
    "4 (seven times a week)",
    "4 153",
    "4 293",
    "4 cases",
    "4 decks",
    "4 novel variants",
    "4 patients",
    "4 weeks",
    "4-year follow-up",
    "4.1 (1.17)",
    "4.2",
    "4.26",
    "4.3, 5 (OL)",
    "4.58–40.28",
    "4.78",
    "4.78 times",
    "4.79-10.91",
    "4.90",
    "4.90 times",
    "4/525",
    "40",
    "40 study sites in the United States",
    "40%",
    "401, 370 (OL)",
    "41",
    "41 female healthy controls",
    "41%",
    "41.3/58.7",
    "418 participants",
    "42",
    "42 out-patient women with BPD",
    "42.4",
    "42.6",
    "42.9",
    "42500 (n = 114 580)",
    "43.1%",
    "43.2",
    "43.5%",
    "43.9",
    "430",
    "44",
    "44 133",
    "44 studies",
    "4411 randomized participants",
    "4436 participants",
    "45",
    "45 (Wd)",
    "45 (only 33 items for scoring)",
    "45.87 ± 16.40",
    "454",
    "46 patients",
    "46.2%",
    "47",
    "47 participants",
    "475",
    "48",
    "48 males",
    "48.7",
    "487",
    "488",
    "489",
    "490",
    "496 participants",
    "4th WAVE",
    "5",
    "5 (P3)",
    "5 130",
    "5 698",
    "5 Blombergstrasse",
    "5 June 2013",
    "5 point likert scale",
    "5 subjects",
    "5 weeks + 6 months",
    "5-HTT",
    "5-HTT gene",
    "5-HTT genotype",
    "5-point Likert scale",
    "5.04-8.27",
    "5.13",
    "5.35%",
    "5.41%",
    "5.42%",
    "5.45",
    "5.67",
    "50",
    "50 mg/d LDX",
    "50 min/session",
    "50.001",
    "5005",
    "501",
    "502",
    "5029 participants",
    "51",
    "515",
    "52",
    "521 303",
    "525",
    "53",
    "53 subjects",
    "53-60",
    "53.8%",
    "535",
    "54",
    "54%",
    "54000 (n = 583 909)",
    "55",
    "550",
    "56",
    "56 weeks",
    "56.9%",
    "5638 probes",
    "57",
    "57 (29.9%)",
    "57 subjects",
    "57.19",
    "58",
    "58.7%",
    "59.7 %",
    "593 individuals",
    "594",
    "5:35",
    "6",
    "6 ADSA Impulsivity Subscales",
    "6 March 2016",
    "6 and 18",
    "6 subjects",
    "6 to 7 years",
    "6 weeks",
    "6.48%",
    "60",
    "60 arrows",
    "60 mm2 dish",
    "60 mm2 dishes",
    "60%",
    "60% of the cohort",
    "600 participants",
    "60‒70%",
    "60–73% of left-handers",
    "61",
    "61.5%",
    "61.8 %",
    "611",
    "62-64",
    "63 ODD (−) cases",
    "63-66",
    "63.2",
    "631",
    "64",
    "64 arrows",
    "646",
    "6525 GC Nijmegen",
    "656 of the assessed patients",
    "656 patients",
    "66 weeks",
    "6604",
    "67",
    "67%",
    "67.1",
    "6737",
    "6751",
    "68",
    "68 subjects",
    "69.70 ± 16.87",
    "6–12 months",
    "6–12 weeks",
    "6–18 years old",
    "7",
    "7 November 2017",
    "7 children",
    "7 patients",
    "7 subjects",
    "7 weeks",
    "7-repeat allele of the DRD4 exon 3 variable number of tandem repeat",
    "7.07",
    "7.49",
    "7.57",
    "7.7%",
    "70",
    "70 mg/d LDX",
    "70 subjects",
    "70.22*",
    "714",
    "72 391",
    "72 subjects",
    "725",
    "73 qualitative trials",
    "73%",
    "730",
    "75",
    "76",
    "778 participants",
    "78.50 ± 15.31",
    "78.9",
    "79",
    "79.2",
    "79.3",
    "8",
    "8 272",
    "8 810",
    "8 November 2017",
    "8 patients",
    "8 subjects",
    "8 to 10 years of age",
    "8 to 12 years of age",
    "8-session Intervention",
    "8.1%",
    "8.13 ± 5.08",
    "8.4%",
    "8.87 times",
    "80",
    "80 days",
    "80%",
    "803",
    "82",
    "822",
    "83",
    "838 participants",
    "84%",
    "85.2",
    "86",
    "86%",
    "860 patients",
    "87",
    "87.5",
    "87–96% of the population",
    "88",
    "89",
    "89 712",
    "89 subjects",
    "8–14 years",
    "9",
    "9 138",
    "9 ODD (+) cases",
    "9 patients",
    "9 subjects",
    "9 years",
    "9,14,16,25,31,32",
    "9- or 10-repeat",
    "9-repeat",
    "9-repeat allele of the variable number of tandem repeat in the 3′-untranslated region (3′-UTR) of the dopamine transporter gene (SLC6A3/ DAT1)",
    "9-repeat carriers",
    "9.61±14.05 months",
    "90",
    "90 females",
    "90% of the population",
    "900 ms",
    "91",
    "91 071",
    "92",
    "925",
    "93%",
    "934 primary students",
    "94",
    "942",
    "95",
    "95 % CI",
    "95% CI",
    "95% CIs",
    "95% confidence interval",
    "95% credible interval",
    "95%CI",
    "95.8",
    "953",
    "956",
    "97%",
    "98",
    "9–17 years",
    "< 1 h/day",
    "< 2500",
    "< 35",
    "<0.001",
    "> 18 at screening",
    ">18 on Prior MPH",
    ">18 on Prior MPH Treatment",
    "A Difference Between the Existing Studies",
    "A chi-squared test",
    "A common approach",
    "A component",
    "A cutoff of 26 points",
    "A relatively similar pattern",
    "A response of “usually”",
    "A, C/D and E components",
    "A.",
    "A22287",
    "A31570",
    "A31571",
    "A31572",
    "AB-G",
    "ABCD computerized version of the IGT",
    "ABG",
    "ACE or ADE models",
    "ADHA",
    "ADHD",
    "ADHD (+) cases of first wave",
    "ADHD Group",
    "ADHD Outpatient Service",
    "ADHD R+",
    "ADHD R2",
    "ADHD Rating Scale (ADHD-RS)",
    "ADHD Rating Scale IV",
    "ADHD Rating scale-IV",
    "ADHD Symptom Severity",
    "ADHD Symptoms",
    "ADHD and ASD symptom persistence",
    "ADHD and ED",
    "ADHD and TS",
    "ADHD and controls",
    "ADHD and impulsivity",
    "ADHD and the ODD group",
    "ADHD as children",
    "ADHD associated deficits",
    "ADHD boys/ADHD girls",
    "ADHD cases",
    "ADHD children",
    "ADHD co-morbidity",
    "ADHD cohorts",
    "ADHD combined type",
    "ADHD comorbidity",
    "ADHD consultation service",
    "ADHD current symptoms",
    "ADHD diagnose",
    "ADHD diagnosed cases",
    "ADHD diagnoses",
    "ADHD diagnosis",
    "ADHD diagnosis and psychiatric symptoms",
    "ADHD diagnostic group",
    "ADHD expert",
    "ADHD group",
    "ADHD groups",
    "ADHD has presented a rising trend",
    "ADHD impulsivity",
    "ADHD in general",
    "ADHD individuals",
    "ADHD literature",
    "ADHD measures",
    "ADHD medication",
    "ADHD medication-treated and medication-naive patients",
    "ADHD might be",
    "ADHD non-symptomatic group",
    "ADHD outpatient service",
    "ADHD patients",
    "ADHD patients and controls",
    "ADHD prevalence",
    "ADHD prevalence among primary pupils",
    "ADHD prospective study",
    "ADHD rate",
    "ADHD rehabilitation",
    "ADHD severity",
    "ADHD status",
    "ADHD stimulant medications",
    "ADHD study",
    "ADHD subjects",
    "ADHD subjects in the reward condition",
    "ADHD subtypes",
    "ADHD symptom control",
    "ADHD symptom count",
    "ADHD symptom counts",
    "ADHD symptom severity",
    "ADHD symptom types",
    "ADHD symptomatic and non-symptomatic groups",
    "ADHD symptomatic group",
    "ADHD symptomatology",
    "ADHD symptoms",
    "ADHD syndromes",
    "ADHD tendency",
    "ADHD traits",
    "ADHD treatment",
    "ADHD treatments",
    "ADHD with Comorbid CD",
    "ADHD with MPH",
    "ADHD without MPH",
    "ADHD, attention-deficit hyperactivity disorder",
    "ADHD, combined type",
    "ADHD- and TS-like behaviors",
    "ADHD-C",
    "ADHD-C type",
    "ADHD-H",
    "ADHD-HI",
    "ADHD-HI type",
    "ADHD-I",
    "ADHD-I type",
    "ADHD-RS",
    "ADHD-RS-IV",
    "ADHD-RS-IV Total Score",
    "ADHD-RS-IV total score",
    "ADHD-RS-IV total scores",
    "ADHD-like behaviors",
    "ADHD-like symptoms",
    "ADHD-related behaviors",
    "ADHD-related difficulties",
    "ADHD-related problems",
    "ADHD-specific characteristics",
    "ADHDC type",
    "ADHDRS-IV",
    "ADHDa",
    "ADHDs",
    "ADHD–ASD",
    "ADHS-SB",
    "ADHS-SB subscales",
    "ADI",
    "ADI Regres‑ sion supplement",
    "ADI regression supplement",
    "ADI-R",
    "ADI-R Autism Diagnostic Observation Schedule",
    "ADI-R subscales",
    "ADI-R total",
    "ADNP syndrome",
    "ADOS",
    "ADOS total",
    "ADOS-2",
    "ADOS-G",
    "ADP ribosylation factors (ARFs)",
    "ADSA",
    "ADSA Items",
    "ADSA Total",
    "ADSA Total scores",
    "ADSA impulsivity subscales",
    "ADSA ratings",
    "ADSA subscale scores",
    "AE",
    "AED therapy at the time of diagnosis",
    "AED, antiepileptic drug.",
    "AEDs",
    "AF",
    "AF/RN",
    "AGU",
    "AHS",
    "AMOS 23",
    "AMPA receptor-mediated synaptic transmission",
    "ANCOVA",
    "ANOVA analyses",
    "ANOVAs",
    "ANX",
    "APA",
    "APA 2013",
    "AQ",
    "AQ scores",
    "AQs",
    "ARC",
    "ARF protein superfamily",
    "ARF proteins",
    "ARF6",
    "ARFGEF",
    "ARHGEF6",
    "ARVCF",
    "ARVCF gene",
    "ASD",
    "ASD Diagnosis",
    "ASD Symptomatology",
    "ASD and ADHD factors",
    "ASD factor",
    "ASD individuals",
    "ASD measures",
    "ASD symptom indicators",
    "ASD symptoms",
    "ASD traits",
    "ASD, autism spectrum disorder",
    "ASD/ADHD30",
    "ASDa",
    "ASP",
    "ASRS",
    "ASRS in Brazil",
    "ASRS scales",
    "ASRS score",
    "ASRS v1.1",
    "ASRS v1.1 guidelines",
    "ASRS-hyper/imp.",
    "ASRS-hyper/impulsivity",
    "ASRS-hyperactivity/impulsivity",
    "ASRS-inattent.",
    "ASRS-inattention",
    "ASRS-overall",
    "ASRSinattention",
    "ASW",
    "ATX",
    "AUC",
    "Aagaard and Hansen",
    "Abbott",
    "Abbreviations",
    "Abcam AB107853",
    "Aberrant Behavior Checklist",
    "Abnormal dendritic spine characteristics",
    "Abnormal in ADHD",
    "Abnormally High Opioid Levels",
    "Abnormally Reduced Pain Perception",
    "Above average age at first stimulant use",
    "Abraham",
    "Abramovitch and Schweiger",
    "Abramovitch et al.",
    "Abstinence",
    "Academic",
    "Academic failure",
    "Accepted: 25 March 2021",
    "Accident before onset or Posttraumatic stress disorder",
    "Achenbach Child Behavior Checklist",
    "Achievement",
    "Acknowledgments",
    "Actb gene",
    "Acute declines in cognitive performance",
    "Adams et al. (2009)",
    "Adams et al.35",
    "Adaptations Coping style SumV SumT Food W: M Non-adaptations Χ2 Test Extratensive 4 6 0.12 Introversive 4 3 0.31 Ambitent 10 19 0.29 1<V 5 19 0.02 1>V 13 9 0.53 T>1 4 16 0.02 T=1 4 4 0.32 T=0 10 8 0.24 Food = 0 12 10 0.31 All cases 17 Χ2Test 0.01 29 Food > 1 6 18 0.01 Positive 14 21 0.31 22 Negative 4 7 0.29 6 0.01",
    "Adding ED severity to the concept of ADHD",
    "Additional Reward",
    "Additional file 1",
    "Additional file 1: Table S1",
    "Additional file 1: Table S5",
    "Additional file 2: Table S6",
    "Additionally",
    "Adelaide",
    "Adelaide School of Medicine",
    "Adjusted OR",
    "Adjusted model 1",
    "Adjusted model 2",
    "Adjustment disorder",
    "Adjustment failure",
    "Adler et al",
    "Adler et al51",
    "Adolescents",
    "Adult ADHD Investigator Symptom Rating Scale (AISRS)",
    "Adult ADHD Sample",
    "Adult ADHD Self-Report Scale (ASRS)",
    "Adult ADHD Self-Report Scale-V",
    "Adult ADHD Self-report Scale",
    "Adult ADHD SelfReport Scale",
    "Adult Psychiatrists' Experiences of DD",
    "Adult Self Rating Scale (ASRS)",
    "Adults",
    "Adults with ADHD",
    "Adults with Impulsiveness Behaviors",
    "Advanced Test of Attention",
    "Adverse Events",
    "Advokat",
    "After a mean follow-up",
    "After treatment",
    "Afternoon",
    "Afzali",
    "Age",
    "Age (increase in 10 years)",
    "Age (yrs)",
    "Age at MRI",
    "Age at diagnosis",
    "Age at first",
    "Age at first stimulant use",
    "Age of Symptom Onset",
    "Age of onset",
    "Age range",
    "Age, years",
    "Age-adjusted cumulative dosage",
    "Age-adjusted duration",
    "Aharon-Peretz",
    "Ahn",
    "Aiman Al Najjar",
    "Ainsworth et al.",
    "Akaike information criterion (AIC)",
    "Akili Interactive Labs",
    "Alberta",
    "Alberta Health and Wellness",
    "Alberta ambulatory care database",
    "Alberta health insurance number",
    "Alberta, Canada",
    "Alcobra",
    "Alcohol",
    "Alcohol Use Disorder Identification Test (AUDIT)",
    "Alcohol Use Disorders Identification Test (AUDIT)",
    "Aldenkamp",
    "AlexaFluor Phalloidin-647",
    "All Participants",
    "All participants together",
    "All patients",
    "All these above-mentioned elements",
    "All three",
    "All three clinical groups",
    "Allen Hauser",
    "Alprazolam",
    "Alterations",
    "Alzheimer’s disease",
    "Aman et al.",
    "Amaxa Mouse Neuron Nucleofector Kit",
    "American College of Medical Genetics and Genomics",
    "American Psychiatric Association",
    "American families with autistic children",
    "American football",
    "Amiri et al,23",
    "Amiri et al23",
    "Among 13 patients",
    "Amphetamine",
    "Amsalem",
    "Amsterdam",
    "An alternative hypothesis",
    "Anagnostou",
    "Analysis of the Yawning scale",
    "Analyzed the Data",
    "Analyzed the data",
    "Anckarsater et al. 2007",
    "Anderson",
    "Anderson and Gerbing (1988)",
    "Animal Ethics committee",
    "Animal studies",
    "Animated triangle",
    "Anita Burns",
    "Anker",
    "Anker et al.",
    "Anna Maria Werling",
    "Annabelle P. Groenman",
    "Annett Handedness Questionnaire",
    "Annual household income",
    "Anthony Conciatore",
    "Antidepressants",
    "Antipsychotics",
    "Antisocial Behaviour",
    "Anton et al. (2009)",
    "Anxiety",
    "Anxiety Disorders",
    "Anxiety disorder",
    "Anxiety/depression",
    "Anxiety/depression symptoms",
    "Applied Biosystems",
    "Applied Diagnostic Systems",
    "Applied Methods of Our Study",
    "Applied Tasks",
    "April 2018",
    "April 7",
    "April 7, 2021",
    "April in 2012",
    "Arabgol et al,22",
    "Arabgol et al22",
    "Arch Pediatr Adolesc Med",
    "Arf activation",
    "Arf6",
    "ArfGEFs",
    "Arg326Cys variant",
    "Arg326His variant",
    "Armonk, NY, USA",
    "Article",
    "Article 229",
    "Article 229 Luan et al",
    "Article 229 Luan et al.",
    "Article 455",
    "Article 632207",
    "Article 638259",
    "Article 946",
    "Articles",
    "Arzneimittel-Richtline",
    "As Expected",
    "Asare",
    "Asbridge",
    "Asconapé",
    "Asherson",
    "Asherson et al. 2005",
    "Asherson et al. 2012",
    "Asherson, 2004",
    "Asperger’s syndrome",
    "Assault",
    "Assay Design 3.0 software",
    "Assertion",
    "Assessment tools",
    "Associate Professor C Shoubridge",
    "Association for Molecular Pathology Guidelines",
    "Association with Higher Opioid Levels",
    "Asthma",
    "Astra-Zeneca",
    "Astrocyte activation",
    "At present",
    "Athletes with ADHD",
    "Atilla Turgay",
    "Atonic feature with unresponsiveness",
    "Attent/Conc",
    "Attention",
    "Attention Deficit Hyperactivity Disorder",
    "Attention Deficit Hyperactivity Disorder (ADHD)",
    "Attention Deficit Scale for Adults (ADSA)",
    "Attention Enhancement System",
    "Attention deficit hyperactivity disorder",
    "Attention deficit hyperactivity disorder (ADHD)",
    "Attention deficit/Hyperactivity disorder",
    "Attention-Deficit Hyperactivity Disorder",
    "Attention-Deficit/Hyperactivity Disorder",
    "Attention-Deficit/Hyperactivity Self-Report Scale",
    "Attention-deficit hyperactivity disorder",
    "Attention-deficit hyperactivity disorder symptom count",
    "Attention-deficit/ hyperactivity disorder",
    "Attention-deficit/hyperactivity disorder",
    "Attention/Concentration",
    "Attention/concentration",
    "Attitudes",
    "Attitudes Toward DD",
    "Attribute identification",
    "Australia",
    "Australian National Health and Medical Research Council",
    "Australian Research Council",
    "Author Contributions",
    "Authors",
    "Authors’ assertion",
    "Autism Diagnostic Interview-Revised",
    "Autism Diagnostic Interview-Revised (ADI-R)",
    "Autism Diagnostic Observation Schedule module 4",
    "Autism Diagnostic Observation ScheduleGeneric (ADOS-G)",
    "Autism Interventions (AIMS) project",
    "Autism Project",
    "Autism Spectrum Disorder (ASD)",
    "Autism-Spectrum Quotient",
    "Avoidance of DD",
    "Avoidant",
    "Aware of abuse potential",
    "Axio Vs40",
    "Axiocam Mrm camera",
    "Axiovision",
    "B",
    "B vitamins",
    "B27",
    "B6",
    "B9",
    "B9 levels",
    "BAI",
    "BCD",
    "BCD MJW",
    "BD Biosciences",
    "BDI",
    "BDI ratings",
    "BICF2G630798942",
    "BICF2S23712114",
    "BICF2S23712115",
    "BIS-10",
    "BLOCK-iT RNA designer",
    "BMC Psychiatry",
    "BMC Psychiatry (2018) 18:298 Page 5 of 12",
    "BMC Psychiatry (2018) 18:298 Page 6 of 12",
    "BMC Psychiatry (2018) 18:298 Page 7 of 12",
    "BMC Psychiatry (2021)",
    "BMI",
    "BP",
    "BPD",
    "BPD diagnosis",
    "BPD subjects",
    "BPD women",
    "BRAG1",
    "BRIEF authors",
    "BRIEF-P",
    "BRIEF-P Figure 1 Profiles",
    "BRIEF-P Inhibit",
    "BRIEF-P items",
    "BRIEF-P parent form",
    "BRIEF-P subscale scores",
    "BRIEF-P’s five clinical scales",
    "BUP",
    "Baio",
    "Baker",
    "Barbara Franke",
    "Barbaresi et al,18",
    "Barbaresi et al.",
    "Barbaresi et al18",
    "Barkley",
    "Barkley Interview",
    "Barkley et al",
    "Barkley et al. (1993)",
    "Barkley et al46",
    "Baron-Cohen et al.",
    "Barratt Impulsiveness Scale",
    "Barratt Impulsivity Scale",
    "Barrowclough",
    "Barry et al.",
    "Basagaña",
    "Basel",
    "Baseline Endpoint",
    "Bashiri A",
    "Bashiri A, et al.",
    "Basic Science Research Program",
    "Baslet",
    "Bastiaansen et al.",
    "Bayerl and colleagues [54]",
    "Bayesian information criterion (BIC)",
    "Bcriticism",
    "Because",
    "Bechara et al.",
    "Beck Anxiety Inventory (BAI)",
    "Becker et al.",
    "Bedtime activities Diet behaviors",
    "Beery-Buktenica Developmental Test of Visual-Motor Integration",
    "Behav/Disorg",
    "Behavior Modification Efforts",
    "Behavior changes",
    "Behavioral Comorbidities",
    "Behavioral and Brain Functions",
    "Behavioral change",
    "Behavioral changes",
    "Behavioral effects",
    "Behavioral side effects",
    "Behavioral symptoms",
    "Behaviors displayed by adult rats",
    "Behaviour/Disorganized",
    "Behavioural Model of TS",
    "Behcet’s disease",
    "Being from East Asia (versus Central Europe)",
    "Being involved in bullying (as a bully)",
    "Belcher",
    "Belgian",
    "Belgium",
    "Below average age at first stimulant use",
    "Benbadis",
    "Berk",
    "Besides",
    "Better Concentration Abilities and Reduced Impulsivity",
    "Between-Subjects Effects",
    "Betäubungsmittelgesetz",
    "Bevital AS",
    "Bhui",
    "Biddle",
    "Biederman",
    "Biederman and Faraone",
    "Biederman et al,21",
    "Biederman et al21",
    "Biederman et al46",
    "Biele",
    "Bins",
    "Biocoat poly-L-lysine coverslips",
    "Biographical Data",
    "Biomarkers for Childhood Neuropsychiatric Disorders (BioNed) project",
    "Bioulac et al.",
    "Bioulac et al. (2012)",
    "Bipolar disorder",
    "Birth weight category, g",
    "Birth year",
    "Bishop and Seltzer",
    "Bishop et al.",
    "Bishop’s card reaching task",
    "Bivariate",
    "Bivariate and Multivariate Logistic Regression Models",
    "Bivariate correlations",
    "Black et al. 2004",
    "Black et al. 2010",
    "Bloch and Leckman",
    "Blood Oxygen Level Dependent signal",
    "Blood Pressure",
    "Blood biomarker levels",
    "Blood biomarkers",
    "Blum",
    "Bnon-reward",
    "Bobo et al.",
    "Bobo et al. 2020",
    "Bodde",
    "Bodde, et al.",
    "Boers",
    "Bolaños et al",
    "Bold response reward anticipation VS vmPFC",
    "Bold response reward receipt VS vmPFC",
    "Bonar",
    "Bonferroni correction",
    "Bonferroni corrections",
    "Bonferroni p",
    "Bonferroni threshold for significance",
    "Boon",
    "Borkan",
    "Bornova",
    "Borzekowski",
    "Both",
    "Both Contingencies",
    "Both Datasets Together",
    "Both Responses",
    "Both moderators and independent variables",
    "Bowman",
    "Box-Cox transformations",
    "Boy",
    "Brain MRI",
    "Brain MRI scans",
    "Brain MRIs",
    "Brain Regions Implicated in Motivational Impulsiveness",
    "Brain injury",
    "Brain volume",
    "Brain-derived blood biomarkers",
    "Bramham et al. 2009",
    "Brand et al.",
    "Brand-Gothelf",
    "Brand-Gothelf et al.",
    "Brazil",
    "Brazilian",
    "Brennan",
    "Breward",
    "Brian M. D’Onofrio",
    "Brief Scale for Psychiatric Problems in Orthopedic Patient",
    "Brincks",
    "Bristol-Myers Squibb",
    "British parents",
    "Britton",
    "Brogan",
    "Bron et al,15",
    "Brookes et al20",
    "Brooks",
    "Browes",
    "Brown et al.",
    "Bryden et al.",
    "Brümmer et al.",
    "Bullying",
    "Burns (2015)",
    "Burström",
    "Bush",
    "Bussing et al.",
    "Bánsági",
    "C",
    "C allele",
    "C terminus of IQSEC2",
    "C-G and T-G haplotypes",
    "CA",
    "CA1 neurons",
    "CAARS-S:L",
    "CAARS-S:L Diagnostic Group",
    "CAARS-S:L subscales",
    "CADDRA",
    "CAPA",
    "CAVE",
    "CB",
    "CBCL",
    "CBT",
    "CBT intervention",
    "CBT skills",
    "CC",
    "CD",
    "CD diagnosis",
    "CDKL5-related disease",
    "CEU",
    "CGI-ADHD",
    "CGI-I",
    "CGI-Improvement",
    "CGI-S",
    "CGI-Severity",
    "CH",
    "CHB",
    "CHIP-CE",
    "CHIP-CE scores",
    "CI",
    "CI ratio",
    "CI task",
    "CLON",
    "CNKI",
    "COM",
    "COMT",
    "COMT-polymorphism",
    "CON",
    "CON R+",
    "CON R2",
    "CONSORT",
    "CONSORT EHEALTH checklist",
    "CONSORT EHEALTH group",
    "CONSORT subitem 23",
    "CONSORT subitem 24",
    "CONSORT subitem 25",
    "COREQ guidelines",
    "COVID-19",
    "COVID‑19 lockdown",
    "CPRS",
    "CPRS-R",
    "CPRS-R ADHD index scores",
    "CPRS-R:L",
    "CPT",
    "CPT (VC)",
    "CPT Performance",
    "CPT performance",
    "CPT test",
    "CRISIS 3.2 questionnaire",
    "CS",
    "CSHQ",
    "CSI-4",
    "CSI-4 cut-off points",
    "CSI-4 scores",
    "CST",
    "CT",
    "CTRS-R:L",
    "Cahill",
    "Cahill et al. 2012",
    "California State University, Fullerton",
    "Calvert and Bishop",
    "Cambridge Gamble Task",
    "Cambridge University Press",
    "CanFam 3.1",
    "Canada",
    "Canadian ADHD Resource Alliance",
    "Canadian Institute for Health Information Discharge Abstract Database",
    "Canadian Psychiatric Association",
    "Canadian nutrient files",
    "CanineHD BeadChip genotyping",
    "Cannabis Use Disorder Identification Test (CUDIT-R)",
    "Capital Institute of Pediatrics",
    "Capital Institute of Pediatrics at Beijing, China",
    "Card sort task",
    "Career",
    "Caregivers",
    "Carli et al.",
    "Carli et al. 2013",
    "Cartei",
    "Carter et al.",
    "Casas et al",
    "Catharina A. Hartman",
    "Cavanna et al.",
    "CdxA transcription factor",
    "Cedrus RB-730 response pad",
    "Ceiling Effect",
    "Ceiling Effects",
    "CellTracker CM-DiI",
    "Celltech",
    "Center for Disease Control and Prevention",
    "Central Europe",
    "Centre for Addiction Disorders",
    "Cephalon",
    "Ceranoglu",
    "Cessation Efforts",
    "Chabot and Serfontein",
    "Chan et al.",
    "Chang",
    "Change from baseline",
    "Change in CHIP-CE five domains",
    "Change in clinical severity",
    "Changes in behavior",
    "Channel 7 Children’s Research Foundation",
    "Channon et al.",
    "Charach et al",
    "Characteristics",
    "Chen et al.",
    "Cherland and Fitzpatrick",
    "Cherland and Fitzpatrick63",
    "Cheryl Shoubridge",
    "Chi square tests",
    "Chi-square test",
    "Chi-square tests",
    "Chiba University Ethics Committee",
    "Chicago",
    "Chicago, Il, USA",
    "Child Adolesc Psychiatry Ment Health",
    "Child Behavior Checklist",
    "Child Health and Illness Profile-Child Edition",
    "Child Psychiatric Division",
    "Child Psychiatrists",
    "Child Psychiatry",
    "Child Symptom Inventory-4 Parent Checklist",
    "Child Symptom Inventory-4 Parent Checklist (CSI-4)",
    "Child and Adolescent Psychiatry and Mental Health",
    "Child sample",
    "Childhood",
    "Childhood ADHD",
    "Children",
    "Children aged 10 years and younger",
    "Children and Adolescents with ADHD",
    "Children and Adolescents with ADHD and MPH",
    "Children and Adolescents with ADHD without MPH",
    "Children and adolescents",
    "Children with ADHD",
    "Children’s Depression Inventory",
    "Children’s Sleep Habits Questionnaire",
    "Children’s Sleep Habits Questionnaire (CSHQ)",
    "Child’s Pain",
    "Child’s age",
    "China",
    "Chinese",
    "Chinese Han population",
    "Chinese subjects",
    "Chiu",
    "Cho",
    "Cho et al. (2002)",
    "Cho et al. (2002)57",
    "Choi",
    "Choi H",
    "Chorea",
    "Chou",
    "Chr",
    "Christakis et al.",
    "Christensen",
    "Chronicity",
    "Cigarettes",
    "Clancy et al. (2006)",
    "Cláudia Drummond",
    "Cleland",
    "Clin Neurol Neurosurg",
    "ClinicaVR",
    "ClinicaVR: Classroom-",
    "Clinical Characteristics",
    "Clinical Global Impressions",
    "Clinical Global Impressions of Severity (CGI-S)",
    "Clinical Global Impressions-ADHD-Severity",
    "Clinical Global Impressions-ADHD-Severity (CGI-ADHD)",
    "Clinical Global Impressions-Improvement",
    "Clinical Global ImpressionsSeverity",
    "Clinical Laboratory Improvement Amendments",
    "Clinical Outcomes of PNES",
    "Clinical characteristics",
    "Clinical outcomes in adults",
    "Clinical trial",
    "ClinicalTrials.gov",
    "ClinicalTrials.gov identifier: NCT03844321",
    "Clinically Recruited Adults",
    "Clinically Referred Adults",
    "Clustering",
    "Cochrane Handbook",
    "Cochrane library",
    "Cochrane review",
    "Cochran’s Q test",
    "CogCubed",
    "Coghill and Sonuga-Barke",
    "Cognition",
    "Cognitive Control",
    "Cognitive Deficits",
    "Cognitive Demands",
    "Cognitive Domains",
    "Cognitive Performance",
    "Cognitive Strategies",
    "Cognitive and Motivational Factors",
    "Cognitive inputs",
    "Cohen et al.",
    "Cohen’s d effect sizes",
    "Colins et al. 2012",
    "Collection site (Amsterdam)",
    "College athletes",
    "College-aged soccer players",
    "Collins and Lapp",
    "Combined subtype",
    "Comfort",
    "Commentaries",
    "Common and Distinct Effects of Frequent Comorbidities in ADHD",
    "Communication Skills",
    "Como",
    "Comorbid Disorders like ASD",
    "Comorbid Psychiatric Diagnosis",
    "Comorbid psychogenic disorders",
    "Comorbidities like ASD",
    "Comparability of studies",
    "Comparing parents’ ratings of EF",
    "Comparison group",
    "Comprehensive Approach",
    "Conceived and Designed the Experiments",
    "Concentration",
    "Concentric Circle plugin",
    "Conceptualization",
    "Conclusions",
    "Conclusions were based on pooled data from 3-5-year old children",
    "Concussion",
    "Concussive",
    "Condition under study",
    "Conduct disorder",
    "Conner et al. [14]",
    "Conners ADHD rating scales",
    "Conners ADHD subscales (L, M and N)",
    "Conners' Parent Rating Scale (CPRS)",
    "Conners’ Adult ADHD Rating Scales",
    "Conners’ Parent Rating Scale-Revised",
    "Conner’s Rating Scale",
    "Conrod",
    "Consalvo",
    "Consequences of non-adherence/adherence",
    "Considering These Effects of Psychostimulants on the Opioid System",
    "Consistency/LT",
    "Consistency/Long Term",
    "Contact/collision-prone sports",
    "Contacts on SNS",
    "Contains Supplementary Appendix A",
    "Content Analytical Rules",
    "Continued",
    "Continuous Performance Task",
    "Contributed reagents/materials/analysis tools",
    "Control Group",
    "Control group",
    "Controls",
    "Conversely",
    "Conversion Disorder",
    "Coolidge et al. 2009",
    "Coordination",
    "Copa D’Or Hospital",
    "Copyright and usage",
    "Corina U. Greven",
    "Cornuz et al.",
    "Corona",
    "Corona crisis",
    "Correlation",
    "Correlations",
    "Correspondence",
    "Cortese et al.",
    "Cortical thickness",
    "Covariates",
    "Cox",
    "Cox proportional hazard models",
    "Cox proportional hazard regression",
    "Crabbe et al.",
    "Crane et al.",
    "Crawford et al.",
    "Creative Commons Attribution (CC BY) licence",
    "Creative Commons Attribution 4.0 International License",
    "Creative Commons Attribution License",
    "Creative Commons Attribution License (CC BY)",
    "Creative Commons Attribution NonCommercial License",
    "Creative Commons Attribution – Non Commercial (unported, v3.0) License",
    "Creative Commons licence",
    "Criminal Activity",
    "Criminal Behaviour",
    "Criminal Conviction",
    "Criminal Conviction (CC)",
    "Criminal conviction (CC)",
    "Criminalityb",
    "Cronbach’ s alpha of the ADHDRS-IV",
    "Cronbach’s α",
    "Cubillo et al.",
    "Cummins",
    "Current Study",
    "Current consensus",
    "Current medication",
    "Current or previous alcohol abuse",
    "Current stimulant age use",
    "Current stimulant use",
    "D",
    "D and I",
    "D.M.",
    "D1-/D2-type receptor activity ratio",
    "D1-type DA receptors",
    "D2-type DA receptors",
    "DA",
    "DAD",
    "DADD",
    "DAKO",
    "DAS-II",
    "DASII",
    "DAT1",
    "DAT1 10-repeat homozygotes",
    "DAT1 10/10 genotype",
    "DAT1 10/10 homozygotes",
    "DAT1 9-repeat carriers",
    "DAT1 and warmth",
    "DB",
    "DCDQ",
    "DCE",
    "DCE survey",
    "DD",
    "DD Experience",
    "DD Process",
    "DD in Psychiatry",
    "DD in an ambiguous way",
    "DD in psychiatry",
    "DD is practiced",
    "DD of ASD",
    "DD of conditions",
    "DD of psychiatric disorders",
    "DD of schizophrenia",
    "DD of severe psychiatric disorders",
    "DD of three diagnoses",
    "DD should be shared",
    "DDX3X syndrome",
    "DDX3X variants",
    "DDX3X variants in the cohort",
    "DESR questionnaire",
    "DG",
    "DISCUSSION 22",
    "DIV8",
    "DIVA 2.0",
    "DLD",
    "DLG1",
    "DLG2",
    "DLG3",
    "DLG4",
    "DM",
    "DMN",
    "DMN and FPCN",
    "DMN deactivation",
    "DMN interactions that underlie SITUT",
    "DMN-FPCN and within-DMN functional connectivity",
    "DMN-FPCN coupling",
    "DMN-FPCN functional connectivity",
    "DMN-FPCN interaction",
    "DMN-FPCN interactions during SITUT",
    "DMN-FPCNA interactions",
    "DMN-SMNA antagonism",
    "DNA",
    "DNase I",
    "DOI",
    "DOI:10.1371/journal.pone.0146271",
    "DQ",
    "DQI",
    "DQI-I measure",
    "DQII",
    "DRD4",
    "DRD4 7-repeat",
    "DRD4 7-repeat carriers",
    "DRD4 7-repeat polymorphism",
    "DRD4 7repeat carriers",
    "DRD4 gene",
    "DRD4 genotypes",
    "DSM",
    "DSM - IV criteria for ADHD",
    "DSM -IV criteria for co-morbid adult ADHD",
    "DSM IV",
    "DSM IV and DSM V",
    "DSM IV-TR criteria",
    "DSM-",
    "DSM- IV-TR",
    "DSM-5",
    "DSM-5 classification",
    "DSM-5 criteria",
    "DSM-5 criterion",
    "DSM-5 diagnoses of ASD",
    "DSM-5 diagnosis of ID",
    "DSM-III",
    "DSM-IV",
    "DSM-IV ADHD symptoms",
    "DSM-IV Hyperactive-Impulsive Symptoms",
    "DSM-IV Hyperactivity/Impulsivity",
    "DSM-IV Inattention",
    "DSM-IV Inattentive Symptoms",
    "DSM-IV ODD criteria",
    "DSM-IV TR",
    "DSM-IV Total ADHD Symptoms",
    "DSM-IV anxiety subtypes",
    "DSM-IV criteria",
    "DSM-IV diagnostic criteria for ADHD",
    "DSM-IV-TR",
    "DSM-IV-TR criteria",
    "DSM-IV-defined substance use disorder diagnoses",
    "DSM-IV24 symptoms of ADHD",
    "DSM5",
    "DSMIV criteria",
    "DZ",
    "DZ covariance",
    "Daily Stress Inventory (DSI)",
    "Dalsgaard et al.",
    "Damasio’s Somatic Marker Hypothesis",
    "Dangerous",
    "Daniel Park",
    "Daniels",
    "Danish birth cohort",
    "Data",
    "Data Analyses",
    "Data Collection",
    "Data analysis",
    "Data curation",
    "Data on DD in Child Psychiatry",
    "Datastar PsycINFO",
    "Davand",
    "David Butler",
    "David Smyth",
    "Davidson (2008)",
    "Davis",
    "Days",
    "De La Cerda",
    "De la Marche et al.",
    "De novo mutations",
    "Declaration of Helsinki",
    "Declaration of interest",
    "Decreased NPC",
    "Default Mode Network",
    "Deficiencies in basic self-regulatory processes",
    "Degree of symptom control",
    "Delay Aversion",
    "Delay Aversion Task",
    "Delay in PNES diagnosis",
    "Delay-Associated Demands",
    "Delay-Rich Settings",
    "Demographic factors",
    "Denmark",
    "Department of Child and Adolescent Psychiatry",
    "Department of Clinical Neuropsychology",
    "Department of Cognitive Neuroscience",
    "Department of Human Genetics",
    "Department of Neurological Medicine of Capital Institute of Pediatrics",
    "Department of Paediatrics",
    "Department of Pharmacology",
    "Department of Psychiatry",
    "Department of Psychiatry and Psychotherapy",
    "Department of child and adolescent psychiatry (CAPP)",
    "Departments of Psychiatry and of Neuroscience and Physiology",
    "Depression",
    "Depression Case–Control (DeCC) study",
    "Depressive disorder",
    "Despite the high rate of comorbid psychological problems",
    "Deters and Mehl",
    "Developing",
    "Developmental Coordination Disorder Questionnaire",
    "Developmental quotient",
    "Devinsky",
    "Diagnosis",
    "Diagnosis (n)",
    "Diagnosis (n) Screening (+) (−) Total (n)",
    "Diagnosis 6 Reward",
    "Diagnosis Delivery",
    "Diagnosis Delivery (DD)",
    "Diagnosis Delivery by Child Psychiatrists",
    "Diagnosis Delivery by Child Psychiatrists sample",
    "Diagnostic Group",
    "Diagnostic Group X Reward",
    "Diagnostic Interview Schedule for Children (DISC-IV-P)",
    "Diagnostic Interview for Adult ADHD",
    "Diagnostic and Statistical Manual of Mental Disorder",
    "Diagnostic and Statistical Manual of Mental Disorders",
    "Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5)",
    "Diagnostic and Statistical Manual of Mental Disorders, 4th Edition",
    "Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV)",
    "Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)",
    "Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision",
    "Diagnostic and Statistical Manual of Mental Disorders-4th edition (DSMIV)",
    "Diagnostic and Statistical Manual of Mental Disorders-IV",
    "Diagnostic assessment for ADHD",
    "Diagnostic exome sequencing",
    "Diego Novick",
    "Diet Quality Index",
    "Differences in Age and Diagnosis Systems",
    "Differences in Findings",
    "Differences in Reported Results",
    "Differences in methodology",
    "Differential Abilities Scales",
    "Diffusion Tensor Imaging",
    "Dinner",
    "Diplopia",
    "Discipline of Paediatrics",
    "Disclosure",
    "Discriminability Score",
    "Discussion",
    "Disorder",
    "Disorders",
    "Dissociative symptom",
    "Distress",
    "Distress accompanying DD",
    "Distribution",
    "Distribution of the vitamin levels",
    "Distributions",
    "Diverse Length of Abstinence",
    "Doberman pinchers40",
    "Domains",
    "Donders Centre for Cognitive Neuroimaging Nijmegen",
    "Donders Institute for Brain, Cognition and Behaviour",
    "Dopamine Agonists such as Amphetamines",
    "Dopaminergic neural pathways",
    "Dove Medical Press Limited",
    "DovePress",
    "Dovepress",
    "Dovepress Konrad-Bindl et al",
    "Dovepress Powered by TCPDF (www.tcpdf.org)",
    "Dowson",
    "Dr JS Richards",
    "Dr Randall Walikonis",
    "Dr S. Young",
    "Dr. Ercan",
    "Dr. Rohde",
    "Driving Risks",
    "Drug Abuse Screening Test-20 (DAST)",
    "Drug-based treatment",
    "Dual-Pathway-Model of ADHD",
    "Dullur et al. 2021",
    "Duration Human Proximity",
    "Duration Physical Contact",
    "During practice",
    "Durkee et al.",
    "Dutch",
    "Dutch and German parents",
    "Dutch parents",
    "Dutch part",
    "Dutch version of the AQ",
    "Dutch version of the IRI",
    "Dx interview",
    "Dysregulation",
    "Dystonia after hyperventilation",
    "Díaz-Orueta et al.36",
    "Döpfner et al",
    "Döpfner et al56",
    "D’Alessio",
    "E-Prime (Psychology Software Tools Inc.)",
    "E-mail",
    "EB",
    "ECG",
    "ED",
    "ED in adults",
    "ED is a common feature of ADHD",
    "EDTA",
    "EE",
    "EE measurement",
    "EEG",
    "EF",
    "EF ability",
    "EF and ADHD in preschool age children",
    "EF and ToM",
    "EF and ToM latent factors",
    "EF as measured by the BRIEF-P",
    "EF difficulties",
    "EF impairment",
    "EF indicators",
    "EF measures",
    "EF profile",
    "EFA",
    "EFA and SEM modeling",
    "EFA6A",
    "EGFP",
    "EMBASE",
    "EMBASE.com",
    "EQ-5D-Y",
    "EQ-5D-Y descriptive system",
    "ER",
    "ER MPH",
    "Each item",
    "Early withdrawal",
    "Earmuffs",
    "East Asia",
    "East Asian patients",
    "Eberhardt",
    "Ebrahimian",
    "Eddy et al.",
    "Edinburgh Handedness Inventory",
    "Education",
    "Education under 10 yearsb",
    "Edwards",
    "Effect Size of Reward",
    "Effective Reinforcers",
    "Efficient strategy",
    "Efron et al",
    "Efron et al47",
    "Ege University",
    "Eidelman",
    "Eight Attempts",
    "Eight of 25 patients",
    "Eight patients",
    "Eighty-seven individuals",
    "Einat & Einat, 2008",
    "Eisenberger",
    "Eisenberger et al.",
    "Ekwaru",
    "El Asam et al.",
    "Elaborated Intrusion (EI) theory of desire",
    "Electrocardiograms",
    "Elefix z-401ce",
    "Elevated Pain Perception",
    "Elevated Rate of Accident Proneness",
    "Eli Lilly",
    "Eli Lilly and Company",
    "Eli Lilly and Company Limited",
    "Eli-Lilly",
    "Elif Ercan",
    "Ellison",
    "Embase",
    "Emergency Settings",
    "Emotional Control",
    "Emotional Control scale",
    "Emotional Dysregulation",
    "Emotional dysregulation",
    "Emotive",
    "Empirical Studies on DD",
    "Empirical and Methodological Qualitative Analysis",
    "Employment status",
    "Enagandula et al.",
    "Encephalitis",
    "Encopresis",
    "Ensembl 81, ENSCAFG00000014232",
    "Ensemble 81, ENSCAFG00000011694.3",
    "Enuresis",
    "Environmental correlation estimates",
    "Environmental correlations",
    "Epidemiological Sample",
    "Epilepsia",
    "Epilepsy",
    "Epilepsy Behav",
    "Epilepsy diagnosis in 8 patients",
    "Epilepsy surgery",
    "Epileptic Seizures",
    "Episode semiology",
    "Ercan",
    "Ercan et al.",
    "Esbensen et al.",
    "Estimated IQ",
    "Ethics Committee of Copa D’Or Hospital",
    "Ettinger",
    "Eunice Kennedy Shriver National Institute of Child Health and Human Development",
    "Euphoria",
    "Eur Child Adolesc Psychiatry",
    "Eur Child Adolesc Psychiatry (2014) 23:1189–1200",
    "Europe",
    "European Medicines Agency",
    "European descent",
    "European population",
    "Evening Time of Day",
    "Examples of individual graphs",
    "Examples of networks graphs.",
    "Executive Circuit",
    "Existing Performance Deficits",
    "Experimental Paradigm",
    "Expired Air Carbon Monoxide Level",
    "Expressive Vocabulary Test",
    "Expressive and Receptive Language",
    "External Ratings",
    "Externalizing Behaviour",
    "Eye movement",
    "F",
    "F (1,113)",
    "F (1,132)",
    "F ADHD",
    "F P Contrasts",
    "F(1, 71)",
    "F(1, 74)",
    "F-Values",
    "F-values",
    "F7, F8, FZ, CZ, T3, T4, PZ, and OZ",
    "FDA-approved package inserts/labels (US)",
    "FGD1",
    "FGD1 gene",
    "FIDD",
    "FIGURE 7",
    "FIGURE 8",
    "FIGURE S1",
    "FIGURE S2",
    "FLAG (IQSEC2)",
    "FLAG-tag",
    "FOXP2 gene",
    "FP",
    "FPCN",
    "FPCNA",
    "FPCNB",
    "FSIQ",
    "FTND",
    "FY",
    "FaCE questionnaire",
    "FaCE scale",
    "FaCE score",
    "FaCE-F-imagery",
    "FaCE-F-intensity",
    "FaCE-F-intrusion",
    "FaCE-S-imagery",
    "FaCE-S-intrusion",
    "FaCE-Sintensity",
    "Facebook",
    "Facebook Craving Experience (FaCE)",
    "Facebook addiction",
    "Facebook use habit",
    "Facebook-ing",
    "Faculty of Health Sciences",
    "Faculty of Medicine",
    "Fagerstrom Test for Nicotine Dependence",
    "Fagerström Test for Nicotine Dependence (FTND)",
    "Failing gradesb",
    "Fallowfield",
    "False belief",
    "False-Belief story",
    "False-Belief tasks",
    "Familial distress",
    "Families",
    "Family History",
    "Family Members",
    "Family history of ADHD",
    "Faraone et al. 2006",
    "Faught",
    "Fauth-Bühler et al.",
    "Fayyad",
    "Fayyad et al. (2007)",
    "Febrile convulsions/epilepsy",
    "Federal Ministry of Health",
    "Federal Office for the Protection of the Data",
    "Federal University of Rio Grande do Sul",
    "Feels or complains that no",
    "Felipe Kenji Sudo",
    "Female",
    "Female Group",
    "Female adults",
    "Female and male youth",
    "Female gender",
    "Fetal growth and psychiatric problems Table 1",
    "Ficker",
    "Fifth Edition",
    "Fig 3",
    "Fig. - 1",
    "Fig. - 2",
    "Fig. 1",
    "Fig. 1(a)",
    "Fig. 1(b)",
    "Fig. 1a",
    "Fig. 1b",
    "Fig. 1c",
    "Fig. 2",
    "Fig. 2b",
    "Fig. 2c",
    "Fig. 3",
    "Fig. 4",
    "Fig. 5",
    "Fig. 6",
    "Figs 1a and 2a",
    "Figs 1b and 2b,c",
    "Figs. 1, 2, 3, 4, 5 and 6",
    "Figure 1",
    "Figure 2",
    "Figure 3",
    "Figure 4",
    "Figure 5",
    "Figures 7 and 8",
    "Final DCE survey",
    "Finally the last latent factor",
    "Financial Reward",
    "Financial Reward Contingencies",
    "Findings",
    "Findings Suggest",
    "Findings of Normalization of Reduced Pain Perception by MPH Treatment in Children",
    "Findings of Reduced Pain Perception",
    "Findling et al,24",
    "Fine",
    "Fine and gross motor skills",
    "Finland",
    "Finlayson",
    "Fiore",
    "First",
    "First Step",
    "First-degree relative history of ADHD",
    "Five of the studies",
    "Five patients",
    "Flanker",
    "Flexible Interview Framework",
    "Flouri",
    "Flynn et al.",
    "Focal clonic movement",
    "Focal tremor",
    "Foley and Fleshner",
    "Follow-up visit",
    "For example",
    "For example in Fig 2",
    "Forget et al.",
    "Formal analysis",
    "Four individuals",
    "Four patients",
    "Four to Five Times",
    "Fourth Edition",
    "Fractional Anisotropy",
    "Fragile X mental retardation protein",
    "Fragile X syndrome (FMR1)",
    "France",
    "Frank A. López",
    "French parents",
    "Frequency",
    "Frequency of medication",
    "Frey",
    "Friedman",
    "Fries",
    "Frith-Happé Animated Triangles Task",
    "Froberg",
    "From these analyses",
    "Frontiers in Cellular Neuroscience",
    "Frontiers in Nutrition",
    "Frontiers in Psychiatry",
    "Frontiers in Psychology",
    "Full scale Intelligence Quotient",
    "Fulwiler et al. 1997",
    "Funding acquisition",
    "Funding arrangements",
    "Further Research",
    "Further research",
    "Furthermore",
    "Furukawa et al. (2014)",
    "Future Fellowship FT120100086",
    "Future Studies",
    "Future studies",
    "G allele",
    "G.B.",
    "GABAergic function",
    "GDP",
    "GE Healthcare",
    "GFAP",
    "GFP",
    "GFPspiked groups",
    "GG",
    "GIBCO",
    "GIH",
    "GIdZ",
    "GT",
    "GTP nucleotide",
    "GWA study",
    "GXR",
    "Gabriel Bernardes",
    "Gabriel Lima",
    "Gapin and Etnier",
    "Garson",
    "Gau et al",
    "Gau et al,27",
    "Gau et al’s",
    "Gaub and Carlson",
    "Gaub and Carlson (1997)",
    "Gender",
    "Gender (Men v. Women)",
    "Gender and age group",
    "Gene",
    "General Anxiety Disorder (GAD-7)",
    "General Practitioners",
    "Generalizability of the Findings",
    "Generalized tonic and clonic epilepsy",
    "Generalized tonic-clonic movement",
    "Gene–environment correlations",
    "Genome-Wide Association analysis",
    "Genomic DNA",
    "Gentile",
    "Gentile et al.",
    "Geomin rotation",
    "Georgiou et al.",
    "German",
    "German Children and Adolescents",
    "German Health Interview and Examination Survey for Children and Adolescents",
    "German Shepherd Dogs",
    "German Wechsler Adult Intelligence Scale Revised",
    "German parents",
    "German versions",
    "German-Speaking Population",
    "Germans",
    "Germany",
    "Gestational age at birth, weeks",
    "Gestational age, days",
    "Geurts and Jansen",
    "Ghuman et al16",
    "Giagante",
    "Gibson",
    "Gil-Or et al.",
    "Gilbert et al.",
    "Ginsberg & Lindefors, 2012",
    "Gioia et’s original version",
    "Giraldi",
    "Girl",
    "Given the limited knowledge",
    "Glaxo-Smith-Kline",
    "Glazer",
    "Glenngard et al. [13]",
    "Glial-fibrillary-acidic protein",
    "Gmaj",
    "Go trials",
    "Go/No-Go",
    "Go/No-Go ACC",
    "Go/No-Go RT",
    "Go/No-Go task",
    "Goal of Our Study",
    "Gold-plated disk electrodes",
    "Goldenson",
    "Goldzweig",
    "Gongsook (2012)",
    "Good Clinical Practice",
    "Google",
    "Google Forms",
    "Google Scholar",
    "Gordon & Moore, 2005",
    "Gothelf",
    "Govek et al.",
    "Goyal",
    "Grandin",
    "Grass Machine",
    "Grassi",
    "Graves",
    "Greenhill et al,26",
    "Groen et al. (2013)",
    "Groenman et al 116",
    "Groningen",
    "Group",
    "Group Differences",
    "Group Status",
    "Grøntved",
    "Grünewald",
    "Grüsser et al.",
    "Gudjonsson et al. 2009",
    "Gudjonsson et al. 2012",
    "Gutiérrez-Maldonado",
    "GxE",
    "GxE effect",
    "GxE effects",
    "GxE effects in an ADHD-enriched sample",
    "GxE effects on both reward-related behavior and neural activation",
    "GxE interactions",
    "GxE interactions in reward sensitivity",
    "GxE interplay",
    "Gámez-Guadix et al.",
    "H",
    "H = N",
    "H1a",
    "H1b",
    "H2a",
    "H2b",
    "H2c",
    "H3",
    "H5N5S",
    "H=N=S",
    "HADS",
    "HADS and PCS",
    "HAPLOVIEW 4.1 software",
    "HAWIE-R",
    "HC",
    "HC group",
    "HD Canine SNP-chip",
    "HEK293T",
    "HHIM Brain Research Institutional Review Board",
    "HHIM exercise",
    "HI",
    "HM",
    "HM and ADHD",
    "HM and Inattention or Hyperactivity-Impulsivity",
    "HM and maternal reports of HyperactivityImpulsivity",
    "HM and psychological trait",
    "HM and the SWAN scores",
    "HM and the brain phenotype",
    "HM association with the trait of interest",
    "HM bias",
    "HM regression",
    "HM univariate modelling",
    "HM, Impulsivity and the MRI phenotype",
    "HMD",
    "HR",
    "HRQoL",
    "HTTLPR L/L genotype",
    "HTTLPR short allele",
    "HTTLPR short-allele carriers",
    "Ha et al.",
    "Hackmann",
    "Haertling et al",
    "Halperin et al.",
    "Hanewinkel",
    "Haplotype analyses",
    "Hapmap database",
    "Happé and Charlton",
    "Happé et al.",
    "Happé study",
    "Hardy-Weinberg equilibrium",
    "Harmful",
    "Harris et al.41",
    "Hartman",
    "Harvard Youth/Adolescent Food Frequency Questionnaire",
    "Hasson-Ohayon",
    "Hategan et al.",
    "Having birth problems",
    "Having mental illness in own family",
    "Having other children living at home",
    "Hayes",
    "Hazard ratios",
    "Hazell",
    "Head Motion",
    "Head motion",
    "Headache or abnormal sensation",
    "Health Behavior",
    "Health-Related Quality of Life",
    "Healthy Adults with Impulsiveness Traits",
    "Healthy Controls",
    "Healthy control group",
    "Healthy controls",
    "Heart Rate",
    "Heavy smokers",
    "Heightened or Reduced Sensitivity for Pain",
    "Helles et al.",
    "Helsinki Ethics Committee",
    "Hence",
    "Hendriksen",
    "Henrik Larsson",
    "Hepburn",
    "Herbert Roeyers",
    "Herrmann et al.",
    "Hertz-Palmor",
    "Heym et al.",
    "High",
    "High school",
    "Higher magnitude of increased serum levels of blood biomarkers",
    "Highest 10th percentile",
    "Highest of vitamin D",
    "Highest tertile",
    "Highly Valued Reward Contingencies",
    "Hilde M. Geurts",
    "Hillman et al.",
    "Hirvikoski et al.",
    "Histogram",
    "History of stimulant use",
    "Histrionic",
    "Ho et al.",
    "Hoang et al",
    "Hockey",
    "Hoekstra et al.",
    "Hommer",
    "Homozygous TT",
    "Hong et al",
    "Hospital Discharge Form",
    "Hospital de Clinicas de Porto Alegre",
    "Hours",
    "Housden",
    "How long effects last",
    "However",
    "Howlett",
    "Howlin et al.",
    "Hu Cheng",
    "Hu and Bentler (1999)",
    "Huang",
    "Huang et al.",
    "Hue City",
    "Hue city",
    "Huge Representative Sample",
    "Hughes and Beer",
    "Human Genome Variation Society Guidelines",
    "Human Neurology 4-Plex A assay (N4PA)",
    "Human Research Ethics Boards",
    "Huss et al",
    "Huss et al54,55",
    "Hygen",
    "Hyperactive-impulsive symptom severity",
    "Hyperactive/Impulsive",
    "Hyperactive–impulsive subtype",
    "Hyperactivity / Impulsivity",
    "Hyperactivity-Impulsivity",
    "Hyperactivity-Impulsivity Symptoms",
    "Hyperactivity-Impulsivity or Inattention",
    "Hyperactivityimpulsivity",
    "Hyun-Seung Rhyu",
    "I2 test",
    "IBH",
    "IBM",
    "IBM SPSS Statistics",
    "IBM SPSS Statistics 23",
    "ICC",
    "ICD-10",
    "ICD-10 Classification of Mental and Behavioural Disorders",
    "ICD-10 Classification of Mental and Behavioural Disorders.",
    "ICD-10 research protocol",
    "ICD-10-CA codes",
    "ICD-9-CM codes",
    "ICD-9/ICD-10 codes",
    "ID",
    "ID and epilepsy cohorts",
    "ID and seizure gene",
    "ID or epilepsy cohorts",
    "ID/DD severity",
    "IDC 10",
    "IGT",
    "IGT decision making",
    "IGT impairment",
    "IGT net scores",
    "IGT performance",
    "IH-O",
    "IHO",
    "IM",
    "INTRODUCTION",
    "IQ",
    "IQ 570",
    "IQ measures",
    "IQ tests",
    "IQ-like domain",
    "IQArfGEF/BRAG1",
    "IQSEC family",
    "IQSEC1",
    "IQSEC2",
    "IQSEC2 cDNA",
    "IQSEC2 mutations",
    "IQSEC2-containing vectors",
    "IQSEC2E849K",
    "IQSEC3",
    "IR",
    "IR MPH",
    "IR dMPH",
    "IR dex-MPH [d-MPH]",
    "IR mixed amphetamine salts",
    "IR-MPH",
    "IRB",
    "IRI",
    "IRIs",
    "IRR",
    "IRRs",
    "Iaboni et al.",
    "Icahn School of Medicine at Mount Sinai",
    "If So",
    "If found effective",
    "If such trials",
    "Ilgen",
    "Illegal Drug Use",
    "Illumina HT-12.v4 BeadChips",
    "ImageJ",
    "Imaging Studies",
    "Imm",
    "Immersive VR",
    "Impaired Performance",
    "Impax",
    "Imperial College London",
    "Implication of the Opioid System in Impulsiveness",
    "Important Link to the Observation",
    "Improvement",
    "Impulsive Behaviors",
    "Impulsive Choice",
    "Impulsiveness",
    "Impulsivity and the RS-fMRI phenotype",
    "In Vietnam",
    "In a last set of analyses",
    "In a subdomain analysis of ADHD symptoms",
    "In adolescents",
    "In conclusion",
    "In one case",
    "In other words",
    "In the final model",
    "In this study",
    "In this table",
    "Inattention",
    "Inattention or Hyperactivity-Impulsivity",
    "Inattentive",
    "Inattentive subtype",
    "Inattentiveness",
    "Inclusion criteria",
    "Increased axonal bouton dynamics",
    "Indeed",
    "Independent Institutional Review Board",
    "Indiana University Institutional Review Board",
    "Individuals",
    "Individuals diagnosed with ADHD",
    "Induced Pain Perception via Thresholds",
    "Information",
    "Inhibit",
    "Inhibit and Working Memory scales",
    "Inhibit and the Working Memory scales",
    "Inhibit problem scale",
    "Inhibition",
    "Inhibitory Control",
    "Initial Task Motivation",
    "Instituto D’Or de Pesquisa e Ensino",
    "Intellectual Disability Research",
    "Intellectual Disability research program",
    "Intellectual disability",
    "Intellectual functioning",
    "Intelligence quotient (IQ)",
    "Intelligence quotient tests",
    "Interestingly",
    "Interictal EEG",
    "Internalization of Stigma toward Mental Illness",
    "Internalizing and Externalizing Behavior",
    "Internalizing disorder",
    "International 10/20 system",
    "International Classification of Diseases",
    "International Classification of Diseases (ICD-10)",
    "International Hapmap Project",
    "International Multicenter ADHD Genetics (IMAGE) study",
    "International Personality Disorder Examination",
    "International Statistical Classification of Diseases and Related Health Problems",
    "Interpersonal",
    "Interpersonal Reactivity Index",
    "Interviews",
    "Intron 1/18",
    "Intron 2 rs4565946",
    "Intron 9/16",
    "Investigation",
    "Invitrogen",
    "Ioannidis et al.",
    "Iowa Gambling Task",
    "Iowa Gambling Task (IGT)",
    "Iqsec1",
    "Iqsec2",
    "Iqsec2 knockout mouse",
    "Iqsec2/IQSEC2",
    "Iqsec3",
    "Iriarte",
    "Ironshore",
    "Irregularities in Marital and Interpersonal Relations",
    "Irritability",
    "Is easily distracted",
    "Isensee",
    "Israel Child and Adolescent Psychiatry Association",
    "Israel Medical Association",
    "Israeli Medical Association",
    "Issue 6",
    "It",
    "It is less studied than the school-age version",
    "Italian parents",
    "Italy",
    "Izmir 35100",
    "J Child Neurol",
    "J Neurol",
    "J.H.",
    "JE",
    "JG",
    "JLE",
    "JMDH.S301091",
    "JMIR",
    "JPT",
    "JS Richards et al",
    "JUGS soccer machine",
    "JW",
    "Jaap Oosterlaan",
    "Jacka",
    "Jackson and colleagues",
    "Jackson et al.",
    "Jacques R. Leroux",
    "Jain",
    "Jain et al.",
    "Jan K. Buitelaar",
    "Jankovic",
    "Janssen",
    "Janssen Ortho",
    "Janssen-Cilag",
    "Janssen-Cilag Turkey",
    "January 2019",
    "January 8, 2016",
    "Japanese version-Hospital Anxiety and Depression Scale",
    "Japanese version-Pain Catastrophic Scale",
    "Jäncke et al.",
    "Jenkins",
    "Jennifer.Richards@radboudumc.nl",
    "Jiang",
    "Jihyung Hong",
    "Jones",
    "Jones et al.",
    "Josep Maria Haro",
    "Joseph A. Sergeant",
    "Journal of Autism and Developmental Disorders",
    "Journal of Multidisciplinary Healthcare",
    "July 9, 2015",
    "Jung et al.",
    "Juvenile Bipolar Disorder Outpatient Programs",
    "KCNA2 gene",
    "KDM5C",
    "KDT",
    "KDT performance",
    "KDT time",
    "KLM",
    "KME, Kaplan–Meier product-limit survival estimate",
    "KO neurons",
    "Kaess et al.",
    "Kandola",
    "Kanner",
    "Kantini et al.",
    "Kappa",
    "Kappa values",
    "Karakter Child and Adolescent Psychiatry University Centre",
    "Karnieli-Miller",
    "Kate Borg",
    "Katusic et al",
    "Keitner",
    "Kemner et al,28",
    "Kenya",
    "Kern et al.",
    "Kessler",
    "Kessler et al.",
    "Kessler et al. (2005)",
    "Kessler et al. (2006)",
    "Kessler et al. 2006",
    "Khajehpiri et al",
    "Khalid",
    "Khalifa and Knorring",
    "Khan",
    "KiGGS",
    "KiGGS Data",
    "Kicking-control group",
    "King",
    "King et al.",
    "King-Devick test",
    "Kirino",
    "Kirino et al. (2015)",
    "Király et al.",
    "Klassen",
    "Knapen et al.",
    "Knopf",
    "Knopf et al.",
    "Knussen",
    "Ko et al.",
    "Kohls et al.",
    "Konrad et al.",
    "Konrad-Bindl et al",
    "Kooij et al",
    "Kooij et al45",
    "Kopera",
    "Korea Government (MEST)",
    "Korean Society of Exercise Rehabilitation",
    "Korean Wechsler Intelligence Scale for Children III",
    "Korean-Attention Deficit Hyperactivity Disorder (ADHD) rating scale",
    "Korean-Child Behavior Checklist",
    "Korean-Wechsler Intelligence Scale for Children-third edition",
    "Kotagal",
    "Kratochvil et al.30",
    "Kremer",
    "Krig",
    "Kubey et al.",
    "Kuczinsky",
    "Kuja-Halkola",
    "Kuntsi",
    "Kuntsi et al.",
    "Körhegyi",
    "L1",
    "LAR",
    "LDX",
    "LDX Overall Study Population",
    "LDX dose received",
    "LDX treatment",
    "LINCS/CMap database",
    "LSC",
    "LaFrance",
    "Labeling and Stigma",
    "Laboratory Assessments",
    "Labrador Retrievers",
    "Lancman",
    "Landaas et al",
    "Langevin, 2003",
    "Language",
    "Large-Numbered Study",
    "Larger Rewards",
    "Lavi-Rotenberg",
    "Lavigne et al.",
    "Laxtha Inc.",
    "Le regroupement PANDA",
    "LeGris Borderline Personality Disorder and Emotion Dysregulation (2018) 5:16",
    "Leckman",
    "Leckman et al.",
    "Lee",
    "Lee et al. (2001)",
    "Lempert",
    "Leslie",
    "Less Ability to Generate Prevention Strategies and Safety Rules",
    "Leung",
    "Leventhal",
    "Lever and Geurts",
    "Lever and Geurts (2016b)",
    "Lewis",
    "Li",
    "Liberati et al. 2009",
    "Lichtenstein",
    "Liebrenz et al.",
    "Life Technologies",
    "Lifetime presence",
    "Lighthall et al.",
    "Lighthall et al. (2012)",
    "Limitations of Our Study",
    "Lindsay et al. 2012",
    "Linkage disequilibrium heat map",
    "Liptai",
    "Liu",
    "Liu et al.",
    "Lloyd et al. [9]",
    "Lobban",
    "Location",
    "Loewen",
    "Logistic regression analyses",
    "Logistic regression analysis",
    "London",
    "London W6 8LN",
    "London, UK",
    "Long Version of Conners’ Parent (CPRS-R:L)",
    "Long-Term Stimulant Medication",
    "Long-acting stimulants",
    "Long-term effects",
    "Longer Exposure to Stimulant Medication",
    "Longer Period",
    "Lonza",
    "Loo and Barkley",
    "Loo et al.",
    "Lord et al.",
    "Louwerse et al.",
    "Low",
    "Low Rate of Comorbid Disorders",
    "Low Symptom Severity",
    "Lower Expectations of Personal Risk in Hazardous Situations",
    "Lower Pain Perception",
    "Lower concentrations",
    "Lowest 10th percentile",
    "Lowest 10th percentile group",
    "Lowest 10th percentiles",
    "Luan et al.",
    "Lucas",
    "Luders",
    "Lukito",
    "Lukito et al.",
    "Luman et al.",
    "Lundbeck",
    "Luria Hand Game",
    "Luty",
    "M",
    "MA",
    "MANCOVA",
    "MANOVA",
    "MAS",
    "MAXqda software",
    "MBCT program",
    "MD",
    "MDD",
    "MDRT",
    "MEX",
    "MGH sample",
    "MJW",
    "ML",
    "MN",
    "MPH",
    "MPH CD",
    "MPH Treatment Sample",
    "MPH [methylphenidate]",
    "MPH formulations",
    "MPH medicated",
    "MPH medication",
    "MPH treatment",
    "MRI",
    "MRI scanners/protocols",
    "MRI scans",
    "MRT non-reward condition (ms)",
    "MRT reward condition (ms)",
    "MSI-BPD",
    "MTA study",
    "MZ",
    "MZ covariance",
    "Maayan et al",
    "Maayan et al,17",
    "MacArthur-Bates",
    "MacArthur-Bates Communicative Development Inventory",
    "Machan",
    "Machimbarrena et al.",
    "Maenner",
    "Magnani",
    "Mahadevappa",
    "Main objective",
    "Major depressive disorder",
    "Maladaptive Behavior domain",
    "Malaysia school-age children",
    "Male",
    "Male participants",
    "Male/Female",
    "Male:female",
    "Males",
    "Malloy-Diniz et al.",
    "Mann–Whitney U test",
    "Mansﬁeld",
    "MantelHaenszel method",
    "March 1, 2021",
    "March 2021",
    "March 5, 2021",
    "Marcus and Durkin",
    "Marjolein Luman",
    "Markand",
    "Markov chain Monte Carlo method",
    "Marsh et al.",
    "Martin E. Rickert",
    "Marx et al. [28]",
    "Mass ARRAY Workstation 4.0 software",
    "MassARRAY technology",
    "Masur et al.",
    "Maternal age at childbirth, years",
    "Maternal criticism/deviant peer afﬁliation",
    "Maternal smoking or exposure during pregnancy",
    "Maternal warmth/positive peer afﬁliation",
    "Maternal, birth year",
    "Matthew Meredith",
    "Maximova",
    "Maximum Performance",
    "May et al.",
    "Mayo Clin Proc",
    "McClernon et al",
    "McInerney and colleagues",
    "McLean Screen (MSI-BPD)",
    "McNeil",
    "Mean (SD) ADHD-RS-IV Total Score",
    "Mean (SD) CPRS-R ADHD Index Scores",
    "Mean age",
    "Measures of Induced Pain Perception",
    "Mechanism of Action of Stimulant Medication",
    "Median",
    "Medicaid claims data",
    "Medical Dictionary for Regulatory Activities",
    "Medical Fields",
    "Medication",
    "Medline",
    "Meff",
    "Meff procedure",
    "Meitar",
    "Mekong River Delta",
    "Mental Disorder",
    "Mental Health",
    "Mentioned Pilot Study in Children",
    "Messina",
    "Meta-analysis",
    "Metaanalytic evidence",
    "Methodology",
    "Methodology of Assessing Pain Perception",
    "Methods",
    "Methylphenidate",
    "Methylphenidate treatment",
    "Methylphenidate-naïve",
    "Methylphenidate-naïve participants",
    "Michael",
    "Microsoft Excel",
    "Middle tertile",
    "Migo et al. (2006)",
    "Mild head impacts",
    "Milin et al. 1991",
    "Miller",
    "Millipore AB15452",
    "Millipore MAB3420",
    "Milliseconds",
    "Mini International Neuropsychiatric Interview",
    "Ministry of Education, Science and Technology",
    "Minkovitz",
    "Minnesota Multiphasic Personality Inventory",
    "Minshew and Hobson",
    "Mission to Mars task (Kantini et al., 2011a,b)",
    "Mistry",
    "Mixed Sample of Physicians",
    "MoBa cohort",
    "Model 3",
    "Moderate",
    "Moderate smokers",
    "Molecular Autism",
    "Molecular Autism (2021) 12:36",
    "Molecular Autism category including negative alleles",
    "Molecular Probes",
    "Molecular mechanisms",
    "Monetary Rewards",
    "Monotherapy",
    "Montag et al.",
    "Mood Disorders",
    "Mood Stabilizers",
    "Moodie",
    "Moraes et al.",
    "Moran",
    "More Challenging Task",
    "Moreover",
    "Morning",
    "Moroney",
    "Morris",
    "Mossner et al.",
    "Most of the studies",
    "Motion during functional imaging",
    "Motivation",
    "Motivation and Cognition in ADHD",
    "Motivational Deficits",
    "Motivational Factors",
    "Motivational Power of Financial Reward",
    "Motor Control",
    "Motor function",
    "Mount Sinai Institutional Review Board",
    "Movement during functional MRI",
    "Mplus",
    "Mr. K.",
    "Mrs. F.",
    "Mrs. G.",
    "Mrs. J.",
    "Mueller et al",
    "Mueller et al.",
    "Muhlberger et al.",
    "Mullen Scales",
    "Mullen Scales of Early Learning",
    "Mullen subscales",
    "Multicenter Study",
    "Multivariate",
    "Munich 82054",
    "Mutation Surveyor version 4.0.5",
    "Mutations",
    "Mühlbacher et al. [8]",
    "Myszka",
    "Møller",
    "N",
    "N (children/adolescents)",
    "N = 1,546",
    "N = 135 for Conditioned Inhibition ratio; N = 50 for executive inhibition measures; *p < 0.05, **p < 0.01, ***p = 0.001 (FDR adjusted; Benjamini and Hochberg, 1995); CI, Conditioned Inhibition; ACC, accuracy; RT, reaction time.",
    "N = 2,246",
    "N = 373",
    "N = 707",
    "N-back Task",
    "N5S",
    "NAG",
    "NB",
    "ND",
    "ND assessment",
    "ND attributes",
    "NDDs",
    "NDDs in girls",
    "NF-L",
    "NGM",
    "NH-P",
    "NHMRC",
    "NIH",
    "NMA",
    "NMA study",
    "NMDA receptor complex",
    "NM_001005475",
    "NM_001114664",
    "NNT",
    "NNT (95% CI)",
    "NNT values",
    "NNTs",
    "NPC",
    "NPDD",
    "NPDD scores",
    "NS",
    "NSW",
    "Nail biting",
    "Naltrexone",
    "Nanda N. J. Rommelse",
    "Naqvi and Bechara",
    "Naqvi et al.",
    "Narcissistic",
    "Narcotics Drug Act",
    "Narrative Opening Questions",
    "Narrative discourse",
    "Natália Bezerra Mota",
    "National Heart, Lung, and Blood Institute",
    "National Institute for Children’s Health Quality (NICHQ) Vanderbilt assessment scales",
    "National Institute for Developmental Psychiatry",
    "National Institute of Child Health and Development",
    "National Institute of Mental Health",
    "National Institute of Mental Health (NIMH)",
    "National Institute on Drug Abuse (NIDA)",
    "National Institutes of Health",
    "National Research Foundation",
    "National Research Foundation of Korea (NRF)",
    "National adult ADHD out-patient clinic",
    "Nausea",
    "Near point of convergence",
    "Neg.Social",
    "Negative Implications",
    "Negative Perceptions of DD",
    "Negative/Social",
    "Negativistic",
    "Negrão",
    "Neguț et al.",
    "Neguț et al. (2016)",
    "Netherlands",
    "Network analysis of discourse",
    "Neural Correlates of These Alterations",
    "Neural basis of mind wandering",
    "Neural integrity",
    "Neural-injury blood biomarkers",
    "Neuro-ophthalmologic function",
    "Neuro-ophthalmologic functions",
    "NeuroLifeSciences",
    "Neurobasal-A medium",
    "Neurodegenerative conditions",
    "Neurodevelopmental disorder",
    "Neurofeedback training",
    "Neurofilament light polypeptide",
    "Neurological alterations",
    "Neurological distress",
    "Neurology",
    "Neuronal activity-regulated gene transcription",
    "Neuronal network",
    "Neuropsychiatr Dis Treat",
    "Neuropsychiatric Disease and Treatment",
    "Neuropsychiatric Disease and Treatment 2016:12",
    "Neurovance",
    "Never",
    "New River Pharmaceuticals",
    "New Zealand",
    "Newcorn et al,25",
    "Newton",
    "Next-generation sequencing",
    "Ngu Binh",
    "Nicotine Consumption Patterns",
    "Nicotine Dependence",
    "Nigg",
    "Nihon Kohden",
    "Nijmegen",
    "Nijmegen scale",
    "Nikkelen et al.",
    "Nine patients",
    "No",
    "No ADHD",
    "No stimulant treatment",
    "No-stimulant treatment v. stimulant treatment group",
    "Noel et al.",
    "Nolin et al. (2016)",
    "Non-ADHD",
    "Non-demographically matched controls",
    "Non-smoking ADHD patients",
    "Non-syndromic X-linked mental retardation",
    "Noncompensated Study Participation",
    "None",
    "Nonweiler et al.",
    "North America",
    "North American university",
    "North Ryde",
    "North and South of Vietnam",
    "Northern European countries",
    "Northern and Southern parts of Western Europe",
    "Norway",
    "Norwegian Regional Committee of Ethics in Medical Research",
    "Norwegian ancestry",
    "Norwegian national registry",
    "Note",
    "Notley",
    "Novartis",
    "Novel missense mutation A789V",
    "November 2015",
    "Number",
    "Number of patients",
    "Numbers",
    "Numerous studies",
    "O'Connor",
    "O'Neil",
    "O.S.",
    "OCBs",
    "OCBs linked to TS",
    "OCD",
    "OCD-ADHD comorbidity",
    "ODD",
    "ODD and anxiety",
    "ODD diagnosed cases",
    "ODD diagnosis",
    "ODD-related deficits in WM",
    "OK-M",
    "OPHN1",
    "OROS",
    "OROS MPH",
    "OW",
    "Objective Tests",
    "Occupational Attainment",
    "Occurrence of side effects",
    "Oculomotor",
    "Oddo",
    "Odds ratio",
    "Odds ratios",
    "Of the students",
    "Office of the Surgeon General",
    "Offspring, birth year: 1973–2008 (n = 3 291 773)",
    "Ogilvy CommonHealth Scientific Communications",
    "Ohinmaa",
    "Okie (2006)",
    "Older Children and Adolescents",
    "Oman population",
    "Omission Errors",
    "Oncology",
    "One Minute",
    "One Possible Explanation",
    "One additional administration in dosage per day",
    "One of the studies",
    "One patient",
    "One study",
    "One subject",
    "Only countries",
    "Oosterlaan et al.",
    "Open Access",
    "OpenMx",
    "Opioid Antagonist",
    "Opioid System",
    "Opioid System May Be Abnormal in ADHD",
    "Opioid and Dopamine Systems",
    "Opioids are Released After Stimulant Medication in ADHD",
    "Opposite Worlds",
    "Oppositional defiant disorder",
    "Optimal Performance",
    "Order Effects",
    "Order of Experiments",
    "Osborn",
    "Osborne",
    "Oslo, Norway",
    "Other Substances",
    "Other countries",
    "Other vitamins",
    "Others",
    "Othmer and Kaiser",
    "Otsuka",
    "Our Additional Analysis",
    "Our Findings on ADHD",
    "Our analysis",
    "Our findings",
    "Our study",
    "Our study group",
    "Outcome measurements",
    "Outcomes",
    "Outpatient Clinic",
    "Overall Efficacy Population",
    "Overall Study Population",
    "Overexpression studies",
    "OvidSP Medline",
    "Owing to",
    "Oxford PharmaGenesisTM Ltd",
    "Oz",
    "Ozonoff et al.",
    "O’Brien et al.",
    "P < 0.001",
    "P = .0063",
    "P Wald, w",
    "P Wald, w2",
    "P-value",
    "P-values",
    "P0447",
    "P0448",
    "PA",
    "PACS",
    "PACS and CTRS-R:L",
    "PALL",
    "PAPA",
    "PAQ-C",
    "PAQ-C score",
    "PAXgene tubes",
    "PBO",
    "PBS",
    "PCR",
    "PD",
    "PDZ domain binding motif",
    "PFC",
    "PHG",
    "PIQ",
    "PLOS ONE",
    "PLoS ONE Network analysis of narrative discourse and attention-deficit hyperactivity disorder",
    "PMT",
    "PMT NGM GIdZ KLM SEM MJW",
    "PNES",
    "PNES onset",
    "PNES, psychogenic non-epileptic seizure",
    "PONS",
    "PR",
    "PSD-95",
    "PTV",
    "PTVs",
    "PUI",
    "PZ and HA",
    "Page 15 of 17",
    "Page 4 of 10",
    "Page 4 of 12",
    "Page 5 of 10",
    "Page 7 of 10",
    "Page 8 of 10",
    "Page 9 of 10",
    "Pain Distribution",
    "Pain Perception",
    "Pain Perception Sample",
    "Pain Threshold in ADHD",
    "Painful Events",
    "Pan",
    "Papandonatos",
    "Parasomnia",
    "Parent PONS ADHD",
    "Parent Ratings",
    "Parent Report Form",
    "Parent Report Form of the Child Health and Illness Profile-Child Edition (CHIP-CE)",
    "Parent SDQ hyperactivity",
    "Parent SRS total raw score",
    "Parent education",
    "Parent-/ Child-Rated Questionnaires",
    "Parental Account of Childhood Symptoms (PACS)",
    "Parental divorce, separation, or discord",
    "Parental emotional problems",
    "Parents",
    "Parents in School A",
    "Parra",
    "Parsons et al. (2007)",
    "Part A",
    "Partial epilepsy with secondary generalization",
    "Participant",
    "Participant Group",
    "Participants",
    "Participants Who Achieved Clinical Response During the Study",
    "Participants up to 30 years of age",
    "Participants with Pure ADHD",
    "Participants' Characteristics",
    "Pasco",
    "Past Neurologic History",
    "Past Psychiatric History",
    "Past history",
    "Patient Health Questionnaire (PHQ-9)",
    "Patient Preference and Adherence 2013:7",
    "Patient Preference and Adherence 2013:7 Dovepress",
    "Patient group",
    "Patient's Life",
    "Patient-Centered Outcomes Research Institute Program Award XPPRN-1512-33786",
    "Patients",
    "Patients only",
    "Patients with PNES",
    "Patients with frequent events",
    "Patton",
    "Paul Broca",
    "Paul Lichtenstein",
    "Paulo Mattos",
    "Paulus et al.",
    "Peabody Picture Vocabulary Test",
    "Pearson correlation coefficient",
    "Pediatric",
    "Pediatric Neurology Department",
    "Pediatric neurologists",
    "Pediatrics",
    "Peer afﬁliation selection",
    "Penner",
    "Pennington and Ozonoff",
    "Penny Hiding Game",
    "Penny hiding game",
    "People’s Republic of China",
    "Perceived Severity",
    "Perception of Induced Pain",
    "Perception of Pain",
    "Performance Improvements",
    "Performance Increase",
    "Performance-Increasing Effect",
    "Performed the Experiments",
    "Perkins",
    "Perkins and Berkman",
    "Perkins et al.",
    "Perrino",
    "Persisting ADHD",
    "Personal Relevance",
    "Pervasive Developmental Disorder Behavior Inventory",
    "Peryer",
    "Peter Hobden",
    "Petry et al.",
    "Pfeiffer",
    "Pfizer",
    "Pharmaceutical companies",
    "Pharmaceutical industry",
    "Phelan-McDermid syndrome",
    "Phenotype of the Disorder",
    "Philadelphia",
    "Phu Cat",
    "Physical Activity Questionnaire for Children",
    "Physical Contact behavior",
    "Physician",
    "Physicians",
    "Physicians' Experience",
    "Physiological effects of methylphenidate",
    "Pierre-Louis",
    "Pieter J. Hoekstra",
    "Pijnenborge",
    "Pilar Erthal",
    "Pillay",
    "Pilot Sample",
    "Piven and Rabins",
    "Piven et al.",
    "Piñero Casas",
    "Placebo",
    "Plan/ Organize",
    "Plan/Organize",
    "Planning/drawing",
    "Plasma NF-L expression",
    "Pleckstrin Homology domain",
    "Polanczyk et al. 2007",
    "Pollak et al. (2009)",
    "Pollak et al.34",
    "Pollak et al.48",
    "PolyG-I",
    "Polytherapy",
    "Ponde et al. 2011",
    "Pool et al.",
    "Poor Concentration and Increased Impulsivity",
    "Poor IGT Performance in Women with BPD",
    "Position",
    "Positive Effect of MPH Treatment on Reduced Accident Proneness",
    "Post-CBT VAS scores",
    "Posttraumatic Stress Disorder",
    "Potential of treatment abuse",
    "Prado",
    "Prado et al.",
    "Preacher et al. (2007)",
    "Precipitating Factors",
    "Predominantly Hyperactive-Impulsive type (ADHD-HI)",
    "Predominantly Inattentive type (ADHD-I)",
    "Preferred Reporting Items for Systematic reviews and Meta-Analyses",
    "Prefrontal cortex",
    "Preliminary findings",
    "Prematurity",
    "Preschool ADHD",
    "Preschool Age Psychiatric Assessment interview (PAPA)",
    "Preschool Age Psychiatric Assessment interview.",
    "Preschool children with symptoms of ADHD",
    "Prescribing practices",
    "Present Data",
    "Present Findings",
    "Present Study",
    "Prevalence of PNES",
    "Prevalence of nicotine dependence",
    "Prevalence of substance use disorder",
    "Previous Miscarriage",
    "Previous Pilot Study",
    "Previous studies",
    "Previous studies investigating language in children with ADHD",
    "Primary hypothesis",
    "Prior exposure to methylphenidate",
    "Privitera",
    "ProLong Gold Antifade",
    "Problematic",
    "Problems with illicit drugs",
    "Process of DD",
    "Professional Experience",
    "Professional Staff Member",
    "Professional experience",
    "Professional experience range",
    "Professionals",
    "Professionals Working in Psychiatry",
    "Professionals' Perspectives",
    "Programming of Experimental Tasks",
    "Project administration",
    "Prone to crying",
    "Provided detailed manuscript feedback",
    "Provocation",
    "Provocation Test",
    "Psychiatric Counseling Session",
    "Psychiatric Illness",
    "Psychiatric Morbidity",
    "Psychiatric Services Aargau",
    "Psychiatric Services Canton Aargau",
    "Psychiatric and socioeconomic outcomes",
    "Psychiatric disorders",
    "Psychiatric side effects",
    "Psychiatrist",
    "Psychiatrists",
    "Psychiatrist’s own perception",
    "Psychiatry",
    "Psychoeducation in Terms of Decreased Pain Perception",
    "Psychogenic Non-Epileptic Seizure",
    "Psychogenic non-epileptic seizures (PNES)",
    "Psychopathology",
    "Psychosis",
    "Psychosomatics",
    "Psychotic or bipolarb",
    "Psychotic side effects",
    "Psychotropic Medications",
    "Ptacek",
    "Ptacek et al.",
    "PubMed",
    "Published online by Cambridge University Press",
    "Purdue Pharma",
    "Pure ADHD",
    "Pﬁzer",
    "QCM Scores",
    "QCM-scores",
    "QEEG measurement system",
    "Qiagen",
    "Qualitative Content Analysis Approach",
    "Qualitative Content Analysis Framework",
    "Qualitative Exploratory Component",
    "Qualitative Interviews",
    "Quality Assessment Tool for Quantitative Studies",
    "Quality and Amount of Reinforcement",
    "Quantification of Hand Preference (QHP) task",
    "Quantitative PCR",
    "Quay",
    "Question of Whether ADHD and MPH are Associated with Altered Pain Perception",
    "Questionnaire-Assessed Pain Perception",
    "Quetzal A. Class",
    "Quintana",
    "Quirk",
    "R Control Affect Inter personal Ideation Mediation Adaptations Non-adaptations Average SD Average SD U-test 19.00 3.28 24.80 7.72 0.06 lambda 0.53 0.27 0.62 0.42 0.75 EA 6.06 3.57 7.70 3.51 0.15 es 8.13 3.14 11.75 6.92 0.30 D − 0.50 1.58 − 1.45 2.40 0.50 AdjD − 0.50 1.58 − 1.15 2.24 0.71 FM 4.25 1.48 5.80 3.51 0.44 m 0.50 0.71 0.40 0.66 0.78 SumC’ 1.50 1.58 2.50 2.29 0.35 SumV 0.25 0.43 1.25 1.17 0.04 SumT 0.75 1.09 1.65 1.88 0.28 SumY 0.88 1.27 1.65 2.48 0.78 FC 3.73 0.97 2.55 2.36 0.67 CF + C 1.55 0.97 1.80 1.47 0.50 PureC 0.13 0.33 0.45 0.86 0.57 SumC’ 2.55 2.25 2.55 2.25 0.28 WSumC 1.50 1.58 3.30 1.97 0.33 Afr 0.51 0.14 0.57 0.21 0.57 S 1.00 1.00 1.95 1.80 0.28 Blends 7.75 3.56 4.65 3.41 0.05 CP 0.00 0.00 0.05 0.22 0.86 COP 1.75 2.05 0.85 1.06 0.41 GHR 4.00 2.74 4.10 1.89 0.64 PHR 1.63 1.49 3.30 2.05 0.05 a 4.63 2.83 5.80 3.17 0.35 p 4.50 2.50 5.20 3.40 0.47 Food 0.38 0.70 1.00 1.32 0.04 Human content 5.00 3.74 5.75 2.02 0.20 Pure H 3.50 3.04 2.50 1.66 0.22 PER 0.75 1.39 1.75 1.87 0.98 Isolation index 0.08 0.07 0.11 0.15 0.50 AG 0.38 0.48 0.50 0.81 0.35 Ma 2.00 2.74 1.90 1.37 0.44 Mp 2.13 1.69 2.75 1.30 0.15 2Ab + Art + AY 1.00 1.22 1.75 1.97 0.14 MOR 0.75 1.09 1.65 1.53 0.86 Sum6 1.88 1.17 3.30 2.28 0.61 Level2 0.00 0.00 0.05 0.22 0.11 Wsum6 5.00 3.91 9.75 7.30 0.47 M− 0.13 0.33 0.40 0.66 1.00 Mnone 0.00 0.00 0.00 0.00 0.12 XA% 0.91 0.07 0.87 0.08 0.14 WDA% 0.91 0.07 0.87 0.07 0.09 X−% 0.09 0.07 0.14 0.07 0.60 S- 0.13 0.33 0.30 0.56 0.60 P 4.63 1.49 5.10 1.89 0.03 (P) 1.00 0.50 0.40 0.58 0.11 X+% 0.74 0.11 0.64 0.12 0.20 Xu% 0.17 0.10 0.23 0.10 0.78 Continued",
    "R and D Departments of the Nottinghamshire Lincolnshire Partnership NHS Trust (Derbyshire REC)",
    "R with VAS value",
    "R+",
    "R-squared",
    "R2",
    "RAC (2011)",
    "RAC report",
    "RBS-R",
    "RCT",
    "RCT setting",
    "RCT studies",
    "RCTs",
    "RE",
    "REAL Kids Alberta survey",
    "REQ-01555",
    "RIN",
    "RKI",
    "RL",
    "RME",
    "RMSEA",
    "RN",
    "RNA",
    "RNA and protein analysis",
    "RNA concentration",
    "RNA or protein",
    "RNeasy Mini Kit",
    "ROC analysis",
    "RS-fMRI",
    "RS-fMRI phenotype",
    "RS-fMRI study",
    "RSfMRI phenotype variance",
    "RW",
    "Ra",
    "Radboud University Medical Center",
    "Rafael Martins Coelho",
    "Ramakrishna",
    "Ramos-Quiroga et al. (2013)",
    "Randazzo et al.",
    "Range",
    "Range, 13–17 years",
    "Rao",
    "Raquel Molina",
    "Ras superfamily",
    "Rash Quantification",
    "Rasmussen et al. 2000",
    "Rasmussen et al. 2001",
    "Rates of withdrawal due to side effects",
    "Raylu and Oei",
    "Reaction Time Variability",
    "Reading the Mind in the Eyes Task",
    "Received: 25 December 2020",
    "Recently",
    "Recorded changes in behavior",
    "Recruitment",
    "Reduced Attainment",
    "Reduced Educational Performance",
    "Reduced Pain Perception",
    "Reduced Pain Perception in Unmedicated Children with ADHD",
    "Reduced Perception of Induced Pain",
    "Reed",
    "Regional Medical Ethics Committee, South-East Norway",
    "Regressing out HM",
    "Regulation",
    "Rehbein et al.",
    "Reimherr et al.",
    "Reinforcer Quality and Quantity",
    "Reinier Postlaan",
    "Relations between ADHD symptoms and behavioral ratings of EF",
    "Relatively Low Symptom Severity",
    "Relatives",
    "Remaining participants",
    "Remaining patients",
    "Repeated edges (RE)",
    "Repeated prevalence",
    "Repeated-measures ANCOVA",
    "Repeated-measures ANOVA",
    "Repetitive Behavior Scale-Revised",
    "Reported side effects",
    "Reports",
    "Research",
    "Research addressing WM in anxious children",
    "Researchers",
    "Resilience",
    "Responders to Stimulant Medication",
    "Response Inhibition",
    "Response Time Variability",
    "Rest",
    "Restless leg syndrome",
    "Restrepo et al.",
    "Resultant Findings",
    "Results",
    "Results Sources",
    "Results Table 1",
    "Results Table 3",
    "Results are given as odds ratios (ORs)",
    "Results of the Present Study",
    "Rett-like phenotypes",
    "Retz & Rosler, 2010",
    "Reuber",
    "Rev",
    "Reviewed data",
    "Reviews",
    "Revised Children’s Manifest Anxiety Scale",
    "Revising the Article Critically for Important Intellectual Content",
    "Reward",
    "Reward Circuit",
    "Reward Contingency",
    "Reward Diagnostic Group X Reward",
    "Reward Efficacy",
    "Reward Valence",
    "Reward and Cognition in Adult ADHD",
    "Reward and Motivation",
    "Reward and Response Cost Options",
    "Reward sensitivity",
    "Reward-Induced Increases in Cognitive Performance",
    "Reynolds",
    "Rhabdomyolysis",
    "Rho GTPase activating protein (RhoGAP)",
    "Rho GTPases",
    "Rho guanine exchange factor (RhoGEF)",
    "RhoA/Rho-kinase signaling pathway",
    "Richard Parker",
    "Richman et al.",
    "Ridler",
    "Riedel et al",
    "Risk Avoidance",
    "Risk avoidance",
    "Risks",
    "Rizzo et al. (2000)",
    "Rizzo et al.32",
    "RoS",
    "Robert D. Oades",
    "Robert Koch Institute",
    "Robertson",
    "Robertson and Simmons",
    "Robertson et al.",
    "Robinson Research Institute",
    "Roe",
    "Roessner et al.",
    "Roisman et al.68",
    "Role",
    "Rolfson",
    "Rommel",
    "Rorschach Test",
    "Rorschach test",
    "Rorschach tests",
    "Rose et al. 2009",
    "Rosemary Tannock",
    "Rosen et al.",
    "Rosenberg",
    "Rosler et al. 2009",
    "Rothner",
    "Rothon",
    "Rowland",
    "Rubia",
    "Ruzich et al.",
    "Ryan",
    "Ryan and Xenos (2011)",
    "Rydell",
    "Ryding",
    "S1 File",
    "S6 Fig",
    "SA",
    "SA Pathology Animal Ethics committee",
    "SAND",
    "SAS software",
    "SB",
    "SB and diet quality",
    "SB or diet quality",
    "SB variables",
    "SCH",
    "SCID-I and II",
    "SCL-ADHD scale",
    "SD",
    "SDQ",
    "SDQ Item “Hyperactivity” and the “ADHD Diagnosis Question”",
    "SDQ teacher report",
    "SDRT",
    "SEC7 domain containing Protein 2 (IQSEC2)",
    "SEM",
    "SEM model 1",
    "SES",
    "SEZ6L",
    "SEZ6L gene",
    "SEZ6L-SNP",
    "SGA graph networks",
    "SGA parameters",
    "SGDP/BRC BioResource Illumina core lab",
    "SH",
    "SITUT",
    "SITUT-CPM",
    "SITUT-CPM generalizability",
    "SITUT-CPM network strength",
    "SITUT-CPM predictions",
    "SITUT-based neural model",
    "SJ Hinze et al",
    "SLC1A2 and CACNA1A",
    "SMN",
    "SMR",
    "SNP",
    "SNP BICF2G630798942",
    "SNP database",
    "SNP rs4565946",
    "SNP rs4570625",
    "SNP-associations",
    "SNP-marker",
    "SNPs",
    "SNS",
    "SNS Craving",
    "SNS Use Habit",
    "SNS cues",
    "SNS use While Driving",
    "SNS use habit",
    "SNS use while driving",
    "SNS users",
    "SNSs",
    "SPSS 22",
    "SPSS 23",
    "SPSS version 20.0",
    "SPSS, Inc.",
    "SR",
    "SR MPH",
    "SR-X with single molecule array (Simoa™, Quanterix)",
    "SRS",
    "SRS-2",
    "SSP",
    "SSQ",
    "SSQ questionnaires",
    "SSQs",
    "SSRT",
    "SST",
    "STAI",
    "STATA 11",
    "STATA 12.0 software",
    "SUCRA",
    "SUCRA ranking",
    "SUD",
    "SUNY Upstate Medical University",
    "SUPPLEMENTARY MATERIAL",
    "SV2",
    "SVA R package",
    "SVF",
    "SWAN questions",
    "SWAN samples",
    "SWAN scores",
    "SWAN sub-scales",
    "Saccadic eye movements",
    "Sackler School of Medicine Ethics Committee",
    "Sadness",
    "Sae-Koew",
    "Safety",
    "Saizar",
    "Saline Solution",
    "Sample Characteristics.",
    "Samples with Higher Symptom Severity",
    "San Diego",
    "Sanz-Garcia et al. 2010a, b",
    "Satisfaction",
    "Saudi Arabia",
    "Sauerlach",
    "Scandinavian countries",
    "Schachar and Logan",
    "Schachar et al.",
    "Scheres et al.",
    "Scheres et al. [73]",
    "Schizophrenia",
    "Schmidt",
    "School A",
    "School C",
    "School of Medicine",
    "School of Psychology Research Ethics Committee of the University of Nottingham",
    "Sciberras et al.",
    "Science Direct",
    "Scientific Communications and Information (SCI)",
    "Scientific Reports",
    "Scientific Reports | 6:33439 | DOI: 10.1038/srep33439 4 www.nature.com/scientificreports/",
    "Screen time",
    "Screening",
    "Screening (+)",
    "Screening (−)",
    "Seaver Autism Center",
    "Sebastien",
    "Sec7",
    "Sec7 and IQ-like domains",
    "Sec7 domain-containing protein",
    "Sec7 family",
    "Second",
    "Second Edition",
    "Seconds",
    "Seidman et al.",
    "Seizure",
    "Self PLOS ONE",
    "Self Reported SWAN scores",
    "Self-Control in Impulsive Disorders",
    "Self-Defeating Personality Scales",
    "Self-Imposing Cognitive Strategies",
    "Semiology",
    "Semiology of Psychogenic Non-Epileptic Seizure",
    "Sensitive time-windows",
    "Sensory Assessment for Neurodevelopmental Disorders",
    "Sensory Features",
    "Sensory Sensitivity Questionnaire",
    "Seoul",
    "Separately Showed Reduced Pain Perception",
    "September 2, 2014",
    "September 2014",
    "Sequenom Inc.",
    "SequenomW",
    "Sera",
    "Serrien et al.",
    "Serum vitamin levels",
    "Sessay",
    "Seven of the studies",
    "Several factors",
    "Several other factors",
    "Severity",
    "Sex",
    "Shanghai",
    "Shanghai Health Bureau",
    "Shapira et al.",
    "Shattuck et al.",
    "Sheba Medical Center",
    "Sheba Medical Center Institutional Review Board",
    "Sheldon et al. (2011)",
    "Shen",
    "Shenghu Wu",
    "Sheppard et al.",
    "Shift",
    "Shift scale",
    "Shire",
    "Shire Development LLC",
    "Shire Pharmaceuticals",
    "Shire US",
    "Short Form: Conners’ Parent Rating Scale-Revised",
    "Short Sensory Profile",
    "Shouldice",
    "Side effects",
    "Siegler",
    "Sigma",
    "Sigma A2228",
    "Sigma F1804",
    "Sigma T2200",
    "Significance",
    "Silva",
    "Silva et al,14",
    "Silva et al.",
    "Silva et al14",
    "Simon",
    "Simon and Rudell",
    "Simon effect",
    "Simon et al. (2009)",
    "Simon et al. 2009",
    "Simon task",
    "Simple or complex partial epilepsy",
    "Singh",
    "Singhammer",
    "Sinoff",
    "Six patients",
    "Sixth Edition",
    "Skogan et al.",
    "Sleep disturbance",
    "Sleep length",
    "Sleep problems and sleep length",
    "Small sample size",
    "Smaller Sample",
    "Smith et al,19",
    "Smokers",
    "Smoking Cessation",
    "Smoking Cessation Program",
    "Smoking status",
    "Soccer",
    "Soccer headers",
    "Soccer heading model",
    "Soccer headings",
    "Soccer players diagnosed with ADHD",
    "Soccer players with ADHD",
    "Soccer players without ADHD",
    "Social Background",
    "Social Desirability",
    "Social Isolation",
    "Social Networking Sites",
    "Social Responsiveness Scale",
    "Social Rewards",
    "Social SciSearch",
    "Social Stigma of Mental Illness",
    "Social distress",
    "Social welfare receiptb",
    "Social-economic Status",
    "Sociodemographic characteristics",
    "Socioeconomic outcomes",
    "Softgenetics",
    "Software",
    "Somatization Disorder",
    "Some studies",
    "Someone Else’s Pain",
    "Sousa et al.",
    "South Korea",
    "South-East London Research Ethics Committee",
    "Southern European countries",
    "Spada",
    "Spain",
    "Spanish parents",
    "Spanish parents of children",
    "Special Needs and Autism Project (SNAP)",
    "Specific Aims",
    "Specific Cognitive Functions",
    "Specific Hypothesis",
    "Speech Graph Analyses",
    "Standard Deviation of Reaction Time",
    "Stanford Binet 5th Edition",
    "Stanford-Binet Intelligence Scales",
    "Stanford-Binet Intelligence Scales (5th edition)",
    "Stanford-Binet-5",
    "Stansfeld",
    "Staring",
    "Stata vs 9.0",
    "Statham et al.",
    "Statham et al. (2011)",
    "Statistical Group Comparisons",
    "Statistical Package for Social Sciences (SPSS)",
    "Statistical Package for the Social Sciences",
    "Statistical analyses",
    "Stavropoulos et al.",
    "Stavropoulos et al. 2019",
    "Stebbins",
    "Steele",
    "Steinsbekk",
    "Stenseng",
    "Step-by-Step Models",
    "StepOnePlus Realtime PCR system",
    "Stephen V. Faraone",
    "Stereotyped Movements",
    "Stigmatic Attitudes",
    "Stigmatic Way",
    "Stimulant therapy",
    "Stimulant treatment",
    "Stimulant treatment for attention-deficit hyperactivity disorder",
    "Stimulant treatment for attention-deficit hyperactivity disorder treatment",
    "Stimulant treatment v. healthy control group",
    "Stimulant-treated group",
    "Stimulants",
    "Stimulants Enhance Dopamine Release in ADHD Patients",
    "Stone",
    "Stop Smoking",
    "Stop Task",
    "Stop-Signal",
    "Stop-Signal Omission Errors",
    "Stop-Signal Task",
    "Stopping and Thinking",
    "Strange Stories",
    "Strange Stories Test",
    "Strange stories",
    "Stratagene",
    "Strategy Use",
    "Strengths and limitations",
    "Stress",
    "Stress from family",
    "Stressful Factors",
    "Strobino",
    "Stroop",
    "Stroop ACC",
    "Stroop RT congruent",
    "Stroop RT incongruent",
    "Stroop RT interference",
    "Structural Equation Model",
    "Structural changes",
    "Structured Clinical Interview for DSM Axis II",
    "Struggle",
    "Stubbs",
    "Studied the characteristics and clinical outcomes of PNES in children",
    "Studies",
    "Studies on DD",
    "Studies on the Perceptions of DD among Child Psychiatrists",
    "Study",
    "Study Design",
    "Study Participation",
    "Study Sample",
    "Study design",
    "Study funding",
    "Study of Stray",
    "Study of Treister et al.",
    "Study on Pain Perception",
    "Study participants",
    "Study subjects",
    "Study's first author",
    "Subconcussive head impacts",
    "Subjective Questionnaires",
    "Subjects",
    "Subjects with ADHD",
    "Substance Dependence and Abuse",
    "Substance use problemb",
    "Subthreshold ADHD",
    "Such beneficial effects",
    "Suchert",
    "Suicide attemptb",
    "SumT",
    "SumV",
    "Summary of Product Characteristics",
    "Sundin et al.",
    "SuperScript III Reverse Transcriptase Kit",
    "Supervision",
    "Supplementary Figure S1",
    "Supplementary Figures S3–S5",
    "Supplementary Figures S6–S8",
    "Supplementary Information",
    "Supplementary Material",
    "Supplementary Methods",
    "Supplementary Table S2",
    "Supplementary Table S2–S5",
    "Supplementary Table S4",
    "Supplementary Table S5",
    "Suszek",
    "Suter et al. 2018",
    "Swain et al.",
    "Swanson et al,29",
    "Swartwood et al.",
    "Sweden",
    "Swedish Council for Working Life and Social Research",
    "Swedish Research Council",
    "Swedo",
    "Swing",
    "Swiss mice",
    "Switzerland",
    "Sydney",
    "Symptom",
    "Symptom Severity Scores",
    "Symptom severity",
    "Symptoms",
    "Syracuse, NY, USA.",
    "Szabó",
    "Szaflarski",
    "São Paulo",
    "Sørensen and colleagues",
    "T",
    "T > 65",
    "T allele",
    "T-scores",
    "T1",
    "T2",
    "T3",
    "TABLE 2",
    "TABLE 4",
    "TANGO2",
    "TCPDF",
    "TD",
    "TD + ADHD",
    "TD Groups",
    "TD children",
    "TD group",
    "TD only",
    "TEAE",
    "TMT",
    "TNW",
    "TOL",
    "TOT",
    "TOVA",
    "TPH2",
    "TPH2 SNPs",
    "TPH2 gene",
    "TPH2 gene polymorphisms",
    "TPH2 polymorphisms",
    "TPH2 rs4565946",
    "TPH2 rs4570625",
    "TR-K",
    "TS",
    "TS-OCB",
    "TS-OCB scale",
    "TS-like behaviors",
    "TS-motor",
    "TS-overall",
    "TS-phonic",
    "TS-related OCBs",
    "TSI",
    "TSPYL2",
    "TSmotor",
    "TSphonic",
    "TT",
    "TT genotype",
    "TXNRD2",
    "Table",
    "Table 1",
    "Table 1 (Continued)",
    "Table 2",
    "Table 228",
    "Table 3",
    "Table 3.",
    "Table 4",
    "Table 6",
    "Table 7",
    "Table C in S1 File",
    "Table D in S1 File",
    "Table S1",
    "Table S10",
    "Table S2",
    "Table S3",
    "Table S4",
    "Table S5",
    "Table S6",
    "Table S7",
    "Table S8",
    "Table S9",
    "Taiwan",
    "Taiwanese retrospective studies",
    "Talks less",
    "Tamás Treuer",
    "Tang et al.",
    "Tantillo et al.",
    "Task",
    "Task Performance",
    "Tasks addressing ND",
    "Tasks and Measures",
    "Tau",
    "Taylor",
    "Teacher Rating Scale (CTRS-R:L)",
    "Teacher SDQ hyperactivity",
    "Tel Aviv University",
    "Tel Aviv University Institutional Review Board",
    "TeleScan",
    "Temptation and Restraint Inventory",
    "Temptation and Restraint inventory",
    "Ten",
    "Ten of the studies",
    "Tertiary Care Hospital in Korea",
    "The 4-week study duration",
    "The ADHD study",
    "The ADHDRS-IV",
    "The Behavior Rating Inventory of Executive Function (BRIEF)",
    "The CSHQ",
    "The Cronbach’ s alpha coefficient",
    "The Genetic of Learning Disability Service",
    "The Korean Pediatric Society",
    "The Netherlands",
    "The Norwegian Data Inspectorate",
    "The Norwegian Institute of Public Health",
    "The Norwegian Mother and Child Cohort Study (MoBa)",
    "The Royal College of Psychiatrists",
    "The Wilcoxon rank-sum test",
    "The X-linked mental retardation protein oligophrenin-1",
    "The association",
    "The correspondence between performance-based measures and behavior ratings of EF",
    "The cutoff point of 26",
    "The final model",
    "The first one",
    "The genetic landscape",
    "The genetic nature",
    "The inventory",
    "The inventory’s ability to discriminate",
    "The items",
    "The majority of research",
    "The model including age at first stimulant use as a covariate",
    "The moderating effects",
    "The molecular and phenotypic spectrum",
    "The other patient",
    "The preschool period",
    "The preschool version (BRIEF-P)",
    "The present article",
    "The reliability and validity",
    "The role",
    "The sample",
    "The second factor",
    "The specific assessment instruments",
    "The subscale of anxiety/depression",
    "The sum of all the scores",
    "The third factor",
    "The two questionnaires",
    "The unique characteristics of target-shooting sport",
    "The use of twin and family data",
    "Their Experimentally Induced Pain",
    "Their HCs",
    "Their Reduced Pain Perception",
    "Theoretical Model Specifications",
    "Therapeutic Interventions",
    "There are",
    "There are clearly defined, nonnegotiable rules",
    "Therefore",
    "Thermo Fisher",
    "These Questions",
    "These Specifics",
    "These analyses",
    "These athletes",
    "These variations",
    "They",
    "They are thought to underlie a wide range of more complex regulatory processes",
    "Third",
    "Thirteen of 25 patients",
    "Thirteen patients",
    "Thirty five children",
    "This",
    "This hypothesis",
    "This preference",
    "This source of variance",
    "This study",
    "This theory",
    "This variant",
    "Thomasius",
    "Thomé-Souza",
    "Three Groups",
    "Three Months",
    "Three of the studies",
    "Three participants",
    "Thuan Loc",
    "Tic Disorders",
    "Tidefors & Strand, 2012",
    "Time Discrimination",
    "Time Perception",
    "Time Reproduction",
    "Time Reproduction Accuracy",
    "Time Reproduction Task",
    "Time Reproduction Task.",
    "Time from first symptoms to diagnosis",
    "Time to recovery",
    "ToM",
    "ToM impairments",
    "ToM measures",
    "ToM performance",
    "ToM, EF, ASD, and ADHD latent factors",
    "Tobacco Consumption Patterns",
    "Tong et al.",
    "Topic Guide",
    "Torrent",
    "Total (n)",
    "Total RNA",
    "Total follow-up duration",
    "Total n",
    "Total number of words (TNW)",
    "Toumbourou",
    "Tourette Syndrome",
    "Tourette's",
    "Tourette's like behaviors",
    "Tourette’s syndrome",
    "Traditional Chinese medicines",
    "Trail Making Test",
    "Trail making",
    "Translational Psychiatry",
    "Trauma induced brain injury",
    "Treatment",
    "Treatment Group",
    "Treatment delay",
    "Treatment option A",
    "Trial Durations",
    "Trigger Factors",
    "Tris-acetate SDS polyacrylamide gel electrophoresis",
    "Tris-buffered saline",
    "Triton",
    "Trizol",
    "Truong An elementary school",
    "TuckerLewis Index",
    "Tuebingen",
    "Turel",
    "Turel and Bechara",
    "Turel et al. (2014)",
    "Turkey",
    "Tween-20",
    "Two Adult Studies",
    "Two Studies",
    "Two decades",
    "Two groups of smokers",
    "Two of eight patients",
    "Two patients",
    "Two reaction time measures of inhibitory control",
    "Two subjects",
    "Type of Main Pain",
    "Typically developing controls",
    "U",
    "U-test",
    "U.S. Food and Drug Administration",
    "U.S. Public Health Service",
    "UCH-L1",
    "UCL School of Pharmacy",
    "UI",
    "UK",
    "UK parents",
    "UPPS",
    "US",
    "US National Survey on Drug Use and Health",
    "USA",
    "Ubiquitin-C-terminal hydrolase-L1",
    "Ubiquitin-Cterminal-hydrolase-L1",
    "Unadjusted",
    "Unadjusted model",
    "Unaffected ADHD severity (CPRS)",
    "Uncertainty",
    "United Kingdom",
    "United States",
    "United States of America",
    "Univariate ANCOVA",
    "Univariate GLM",
    "University Hospital",
    "University Hospital—Charité in Berlin",
    "University Medical Center Groningen",
    "University of Adelaide",
    "University of Alberta",
    "University of Bergen",
    "University of Connecticut",
    "University of Groningen",
    "University of Munich",
    "University of Rostock",
    "Universität Zürich",
    "Unproductive",
    "Upon follow-up children with persistent PNES",
    "Upper secondary education",
    "Upregulate Reduced Pain Perception",
    "Urgent treatment",
    "Ursula Gresser Outpatient Clinic for Internal Medicine",
    "Use of AEDs",
    "Uterwijk",
    "VAS score",
    "VAS score improvement",
    "VAS scores",
    "VAS values",
    "VAS: 73.80 ± 17.78",
    "VAYA Pharma",
    "VC",
    "VCI",
    "VIQ",
    "VMI-6",
    "VMPFC lesioned patients",
    "VR",
    "VR Neurofeedback",
    "VR classroom",
    "VR combined with interactive tests",
    "VR environments",
    "VR feedback",
    "VR games",
    "VR system type",
    "VR systems",
    "VR technologies",
    "VR technology",
    "VR use",
    "VR-CPT",
    "VRC-CPT",
    "VS",
    "VS BOLD response",
    "VS activation",
    "VSV-g",
    "VU University Amsterdam",
    "Vacant staring with tonic posture",
    "Val158Met",
    "Valdizán-Usón et al62",
    "Valente",
    "Valle",
    "Van Praag et al.",
    "Vanderbilt Assessment scales",
    "Vanderklish and Edelman",
    "Variability non-reward condition (ms)",
    "Variability reward condition (ms)",
    "Variables",
    "Ventral Striatum and Ventromedial Orbitofrontal Cortex",
    "Verdejo-Garcia and Bechara",
    "Verplanken and Orbell",
    "Very High",
    "Very Low",
    "Veugelers",
    "Vicente",
    "Victoria Stroop Task (VST)",
    "Video EEG Monitoring",
    "Vietnam",
    "Vigna-Taglianti et al.",
    "Vincentiis",
    "Vineland Adaptive Behavior Scales",
    "Vineland-3",
    "Viner",
    "Virginia S Haynes",
    "Virtual classroom",
    "Virtual reality",
    "Virtual reality environments",
    "Virtual reality in the rehabilitation of ADHD patients",
    "Virtual reality side effects",
    "Virtual reality technology",
    "Visual",
    "Visual Analog Scale",
    "Visualization",
    "Vitamin B2",
    "Vitamin B6 levels",
    "Vitamin B9",
    "Vitamin D",
    "Vitamin D 10th percentile",
    "Vitamin D levels",
    "Vitamin concentration",
    "Vitamin deficiency",
    "Vitamin levels",
    "Vitamins",
    "Vitamins B2",
    "Vitelli, 1996",
    "Vocabulary and Blocks subtests of Wechsler Adult Intelligence Scale (WAIS-III)",
    "Volkow et al.",
    "Volume 12",
    "Volume 5",
    "Volume 7",
    "Volume 8",
    "Vomiting",
    "W:M",
    "WAIS-III–Wechsler Adult Intelligence Scale",
    "WAIS-IV",
    "WGCNA package",
    "WHO",
    "WHO (2003)",
    "WM",
    "WM as measured by clinically administered tests",
    "WM in this clinical group",
    "WRAADDS",
    "WRI",
    "WT-IQSEC2",
    "WURS-k",
    "Walsh",
    "Waltham",
    "Walusinski et al.",
    "Wang and Reid. (2011)",
    "Wang et al",
    "Wang et al.",
    "Wang et al. 2017",
    "Waratah",
    "Warren",
    "Waschbusch et al. [12]",
    "Waterloo Handedness Questionnaire",
    "We",
    "We Suggest",
    "Web of Science",
    "WebGestalt",
    "Wechsler",
    "Wechsler Abbreviated Scale of Intelligence (WASI)",
    "Wechsler Adult Intelligence Scale third edition",
    "Wechsler Adult Intelligence Scale-IV",
    "Weight at birth, grams",
    "Weighted gene co-expression analysis",
    "Weinstein et al.",
    "Weisbrot",
    "Wender Utah Rating Scale",
    "Wender et al. (2001)",
    "Wender-Reimherr Interview",
    "WenderReimherr Interview",
    "Werling et al.",
    "Werner",
    "While there is no study",
    "White",
    "White descent",
    "Who Achieved Symptomatic Remission During the Study",
    "Whole KiGGS Sample",
    "Whole blood samples",
    "Wichstrøm",
    "Wiggins",
    "Wikipathways database",
    "Wilens et al",
    "Wilks’ Lambda",
    "Willcutt et al.",
    "Willcutt, 2012",
    "William Montgomery",
    "Williams",
    "Willis and Naidoo",
    "Wilsson and Sundgren20",
    "WinBUGS software",
    "With ADHD-RS-IV Total Score",
    "Withdrawal",
    "Withdrawal of antiepileptic drugs after PNES diagnosis",
    "Withdrawal rates",
    "Wolff et al.",
    "Wolgamuth",
    "Women’s and Children’s Hospital",
    "Wong",
    "Woodbury-Smith et al.",
    "Working Memory",
    "Working Memory scale",
    "Working Memory scales",
    "Working Memory subscales",
    "World Health Organization—Five Well-Being Index (WHO-5) wellbeing index",
    "World Health Organization’s",
    "Worldwide prevalence rates",
    "Wright et al.",
    "Writing – original draft",
    "Writing – review & editing",
    "Written Informed Consent",
    "Wrote the Paper",
    "Wrote the paper",
    "Wu",
    "Wu et al.",
    "Wyllie",
    "Wyllie, et al.",
    "X-Linked intellectual disability",
    "X-chromosome",
    "X-chromosome gene",
    "X-linked familial cases",
    "X-linked intellectual disability",
    "X-linked intellectual disability with seizures",
    "X27",
    "XLSX",
    "Xp11.22",
    "YAQ",
    "YAWNING",
    "YGTSS",
    "YWN",
    "YWN-active",
    "YWN-activity",
    "YWN-inactive",
    "YWN-inactivity",
    "YWN-overall",
    "YWN-stress",
    "Yanos",
    "Yao et al.",
    "Yawning scales",
    "Yawning-active",
    "Year at first symptoms",
    "Yeh et al. (2012)",
    "Yes",
    "Yonsei Med J",
    "Young",
    "Young et al.",
    "Young et al. 2003",
    "Young et al. 2007",
    "Young et al. 2009a",
    "Young et al. 2009b",
    "Young et al. 2010a",
    "Young et al. 2011",
    "Young et al. 61 study strata",
    "Younger people",
    "Younger psychiatrists",
    "Yu et al.",
    "Z-score",
    "ZM",
    "Zahl",
    "Zeiss LSM 510",
    "Zhang & Horvath",
    "Zhang et al.",
    "Zheng et al.",
    "Zhou",
    "Zink",
    "Zubek",
    "Zurich",
    "Zurich University Hospital",
    "Zywica and Danowski",
    "[104]",
    "[105]",
    "[106]",
    "[11]",
    "[12]",
    "[13]",
    "[14]",
    "[15]",
    "[15–17]",
    "[16]",
    "[17]",
    "[18]",
    "[18– 23]",
    "[19]",
    "[1]",
    "[21]",
    "[22]",
    "[23]",
    "[24]",
    "[25]",
    "[26]",
    "[27]",
    "[27–29]",
    "[28]",
    "[28–37]",
    "[29]",
    "[29–32]",
    "[2]",
    "[30]",
    "[31]",
    "[32]",
    "[33]",
    "[34]",
    "[35]",
    "[36]",
    "[38]",
    "[39]",
    "[3]",
    "[40]",
    "[41, 42]",
    "[41]",
    "[42]",
    "[43–45]",
    "[44]",
    "[45]",
    "[46]",
    "[47]",
    "[48]",
    "[48–52]",
    "[49–52]",
    "[4]",
    "[50]",
    "[53]",
    "[54, 55]",
    "[54]",
    "[55]",
    "[56, 57]",
    "[56]",
    "[58]",
    "[5–12]",
    "[5–9]",
    "[60]",
    "[64]",
    "[65]",
    "[66]",
    "[67–71]",
    "[6]",
    "[72]",
    "[73]",
    "[74]",
    "[75]",
    "[76]",
    "[77]",
    "[78]",
    "[79]",
    "[7]",
    "[7–9, 14]",
    "[8, 10]",
    "[80]",
    "[81]",
    "[82–84]",
    "[85]",
    "[86]",
    "[87]",
    "[88]",
    "[8]",
    "[9, 15–17]",
    "[9]",
    "a slightly hypoplastic vertebral artery",
    "a small sample size",
    "a student self-report questionnaire",
    "a tendency to form a self-image based on fantasy and distorted actual experience",
    "a.",
    "a. KME at 25 years of age.",
    "aOR",
    "abdominal breathing",
    "abdominal pain",
    "ability",
    "ability of this technology",
    "ability to draw upon learned information",
    "ability to perform well (on tasks)",
    "abnormal brain MRI",
    "abnormal density of protrusions",
    "abnormal findings",
    "above average age at first stimulant use",
    "abrupt unannounced changes in topic conversations",
    "absolute discrepancy score",
    "absolute power",
    "abuse",
    "abuse potential",
    "academic achievements",
    "academic administrative records",
    "academic failure",
    "academic or occupational failure",
    "academic performance",
    "academic problems",
    "acceptability of treatments",
    "accepted",
    "accommodative ruler (Gulden Ophthalmics, Elkins Park, PA)",
    "accuracy",
    "accuracy coefficient scores",
    "accuracy of their sample",
    "achievement of treatment",
    "acknowledgments",
    "across all trials",
    "actin cytoskeleton",
    "actin dynamics",
    "action-based answers",
    "activation",
    "activation of ARFs",
    "active",
    "active lifestyles",
    "active treatment",
    "activity",
    "activity-dependent maturation",
    "activity-dependent processes",
    "actual duration",
    "acupuncture",
    "acute bout of the exercise",
    "acute exercise",
    "acute exercise effects",
    "acute exercise study",
    "acute postsynaptic translational regulation",
    "adaptation and customization",
    "adaptation group",
    "adaptations",
    "adaptive behavior deficits",
    "adaptive functioning",
    "addiction",
    "addiction disorders",
    "addictive symptom perspective",
    "addictive syndromes",
    "additional 29 studies",
    "additional appointments",
    "additional nine studies",
    "additional sample",
    "additional subsample modules",
    "additive sources",
    "adequacy",
    "adherence",
    "adherence as a time-varying covariate",
    "adherence on outcomes",
    "adherence to ADHD medications",
    "adherent and nonadherent patients",
    "adherent patients",
    "adjusted analyses",
    "adjustment disorder",
    "adjustment failure",
    "adjustment reaction",
    "administrative health care data",
    "administrative health care records",
    "administrative health data",
    "adolescence",
    "adolescence and young adulthood",
    "adolescent",
    "adolescent and child groups",
    "adolescent reward speeding",
    "adolescent sample",
    "adolescent survey",
    "adolescents",
    "adolescents (N = 60)",
    "adolescents (aged 13–17 years)",
    "adolescents (≥ 14 years)",
    "adolescents with ADHD",
    "adolescents with attention-deﬁcit/hyperactivity disorder",
    "adolescents with authoritarian parents",
    "adolescents with the 7-repeat allele",
    "adopted CBT techniques",
    "adult (mean age 32 years)",
    "adult ADHD",
    "adult ADHD discourse",
    "adult ADHD patients",
    "adult ADHD patients and controls",
    "adult ADHD population",
    "adult ADHD prevalence rate",
    "adult and childhood ADHD",
    "adult mouse brain cDNA",
    "adult outpatients",
    "adult participants",
    "adult rats",
    "adult smokers with ADHD",
    "adulthood",
    "adults",
    "adults carrying the dopamine receptor D4 (DRD4) 7repeat allele",
    "adults with ADHD",
    "adults with mild dementia",
    "adverse consequences",
    "adverse effect",
    "adverse effects",
    "adverse environment",
    "adverse environments",
    "adverse event",
    "adverse events",
    "adverse finance for treatment and education",
    "adverse responses",
    "advisory board member",
    "aetiological theory",
    "aetiology",
    "afebrile seizures",
    "affability",
    "affect psychiatrists’ level of distress",
    "affective decision-making",
    "affective disorders",
    "after translation",
    "after-exercise measurements",
    "against another",
    "age",
    "age and gender",
    "age at first nicotine use",
    "age at first stimulant use",
    "age at first substance use",
    "age at suicide attempt",
    "age difference",
    "age equivalents",
    "age of 14 years",
    "age of 18",
    "age of patients",
    "age range",
    "age ranges of adolescents and children",
    "age(2)",
    "age- by subgroup interactions",
    "age-and-sex-related findings",
    "age-related differences",
    "age-specific effects",
    "aged",
    "aged 18–50 years",
    "aged between 4 and 5 years",
    "aggressive and violent criminality",
    "aggressive reactions",
    "aging mouse cortex",
    "agreement",
    "agreement percentage",
    "alcohol abuse",
    "alcohol dependence",
    "alcohol drinking",
    "alcohol or drug use disorders",
    "alcohol- and drug-related substance use disorders",
    "alcoholic drinking",
    "all RNA samples",
    "all attributes",
    "all authors",
    "all cause withdrawal",
    "all cause withdrawals",
    "all countries",
    "all five BRIEF-P subscales",
    "all individuals",
    "all main effects",
    "all of the participants",
    "all other available medical records",
    "all target interventions",
    "all the subjects of first wave",
    "all those characteristics",
    "all-cause withdrawal",
    "allele and genotype frequencies",
    "allele frequencies",
    "allele frequency",
    "alpha",
    "alphaPix/Arhgef6 mouse model",
    "alternating attention",
    "alternative treatments",
    "ambiguous reference",
    "amblyopia",
    "ambulatory care database",
    "amendments",
    "amino acids",
    "amphetamine",
    "amphetamine-based",
    "amygdala",
    "an array of occupational, academic, social and domestic difficulties",
    "an exclusively categorical approach to ADHD",
    "an unexplainable/vague sense of anxiety",
    "analyses",
    "analysis",
    "analysis of brain changes",
    "analytical plan",
    "analyzed group",
    "anchoring mechanisms",
    "anger problems",
    "animal models",
    "animal studies",
    "anonymous survey on media and COVID-19",
    "another child",
    "another main point",
    "another predictor of non-adherence",
    "another sample",
    "another study",
    "another ten",
    "anterior cingulate",
    "anterior inferior parietal lobule",
    "antidepressants",
    "antiepileptic drugs (AEDs)",
    "antipsychotics",
    "antisocial behaviour",
    "anxiety",
    "anxiety and depression disorders",
    "anxiety disorder",
    "anxiety disorder29",
    "anxiety disorders",
    "anxiety problems",
    "anxiety symptoms",
    "anxiety, OCD and autism39",
    "anxiety-related deficiencies in WM",
    "anxiety/depression",
    "anxiety/depression problems",
    "anxiety/depression symptoms",
    "anxious children",
    "anxious symptoms",
    "apathy",
    "application of this technology",
    "applied methods",
    "appropriate credit",
    "appropriateness of choices/questions",
    "approximately 5000 years",
    "aripiprazole",
    "arising from chromosome X",
    "arm or leg pain",
    "around 0.2",
    "arousal",
    "arousal and activation",
    "arrows",
    "article",
    "articles",
    "artistic medium",
    "assault",
    "assay",
    "assessment",
    "assessment and training of attention",
    "assessment criteria",
    "assessment of adherence",
    "assessment of pain perception",
    "assessments of Health Behaviors",
    "association",
    "association between HM and the trait of interest",
    "association between low education and CC",
    "association networks",
    "association of module eigengenes",
    "association study",
    "association with DQ scores",
    "associations",
    "associations between EF and symptoms of ADHD",
    "associations found in our study",
    "associations with CC",
    "astigmatism",
    "astrocyte activation",
    "atomoxetine",
    "atomoxetine group",
    "atonic feature with unresponsiveness",
    "attention",
    "attention deficit disorder",
    "attention deficit hyperactivity disorder",
    "attention deficit/hyperactivity disorder (ADHD)",
    "attention deﬁcit disorder",
    "attention switching",
    "attention to detail",
    "attention-deficit hyperactivity disorder",
    "attention-deficit hyperactivity disorder (ADHD)",
    "attention-deficit hyperactivity disorder disorders",
    "attention-deficit/hyperactivity disorder",
    "attention-deficit/hyperactivity disorder (ADHD)",
    "attention-deficit/hyperactivity disorder group",
    "attention-deﬁcit hyperactivity disorder",
    "attention/concentration",
    "attention/inattention",
    "attentional lapses in ADHD",
    "attitudes",
    "attribute",
    "attribute (independent variable)",
    "attribute describing duration",
    "attributes",
    "attributes included in the survey",
    "attributes of 'Treatment option B'",
    "attributes of the other treatment alternatives",
    "augmentation",
    "author",
    "authority of the journals",
    "authors",
    "authorship",
    "autism",
    "autism cases",
    "autism spectrum disorder",
    "autism spectrum disorder (ASD)",
    "autism spectrum disorders",
    "autism tendency",
    "autistic spectrum disorders",
    "automatic attentional response inhibition",
    "automatic response inhibition deficits",
    "automatic thought",
    "autonomic bodily somatic markers",
    "available data",
    "available literature",
    "average",
    "average AQ and ASRS scores",
    "average age of first words",
    "average defference",
    "average intellectual level",
    "average verbal comprehension index (VCI)",
    "avoid medication",
    "avoid potential multicollinearity among the variables in the regression equation",
    "avoiding drugs",
    "awareness and early diagnosis",
    "axon length",
    "axons",
    "a­ ge2",
    "b. ME at 35 years of age.",
    "back pain",
    "background questionnaire",
    "background variables",
    "balance and coordination",
    "balanced mood",
    "baseline",
    "baseline amphetamine",
    "baseline characteristics",
    "baseline characteristics of the participants",
    "baseline data",
    "baseline diagnosis of ADHD",
    "baseline measures",
    "baseline patient characteristics",
    "baseline to 12 months",
    "basic EF components",
    "basic executive capacities measured by neuropsychological tests",
    "bedtime",
    "bedtime activities",
    "bedtime diet",
    "bedtime eating",
    "bedtime resistance (six items)",
    "bedtime resistance problems",
    "bedtime screen activities",
    "bedtime screen time and diet and anxiety/depression",
    "before and after the diagnosis of PNES",
    "before bedtime",
    "before-exercise distributions",
    "before/after the CBT intervetion",
    "behavior",
    "behavior ratings of EF",
    "behavior scores",
    "behavior traits",
    "behavioral activation",
    "behavioral addictions",
    "behavioral and adaptive functioning scores",
    "behavioral and emotional problems",
    "behavioral and neural measures of reward processing",
    "behavioral and neural measures of reward sensitivity",
    "behavioral and neural sensitivity to rewards",
    "behavioral and physical patterns",
    "behavioral and psychiatric comorbidities",
    "behavioral changes",
    "behavioral comorbidities",
    "behavioral competencies",
    "behavioral data",
    "behavioral inhibition",
    "behavioral interventions",
    "behavioral phenotype",
    "behavioral problems",
    "behavioral problems of children with ADHD",
    "behavioral ratings of EF",
    "behavioral response to rewards",
    "behavioral reward sensitivity",
    "behavioral sciences",
    "behavioral strategies",
    "behavioral symptoms and problems",
    "behavioral therapies",
    "behavioral therapy",
    "behavioral therapy interventions",
    "behavioral, medical, and developmental challenges",
    "behaviors and behavioral disorders",
    "behaviour",
    "behaviour disorganized",
    "behaviour/disorganized",
    "being able to go out and socialize",
    "benefits",
    "benefits of drug treatment for ADHD",
    "benefits of treatments",
    "benzodiazepines",
    "best estimate diagnoses of substance use disorders",
    "best estimate procedure",
    "best method",
    "beta",
    "better diet quality",
    "between 22 and 40 days",
    "between 41 and 80 days",
    "between-group difference",
    "between-group differences",
    "between-subjects effect for d9",
    "bias",
    "biases",
    "big cities",
    "bilateral distribution",
    "bimodal pattern",
    "binary variable",
    "biochemical analyses",
    "biological mechanisms",
    "biomarker analyses",
    "biomarker determination",
    "biomarkers",
    "biomarkers of disease",
    "bipolar disorder",
    "birth weight",
    "birth weight category",
    "birth weight category (g)",
    "birth-weight-discordant monozygotic twins",
    "bivariate (unadjusted) and multivariate (adjusted) logistic regression models",
    "bivariate AE model",
    "black box medication warning",
    "blind",
    "blinding",
    "blindness",
    "blood and tissue DNA kit",
    "blood pressure",
    "blood sample",
    "blood samples",
    "blue color",
    "board-certified clinicians",
    "board-certified radiologist",
    "body of DCE research",
    "bootstrapping",
    "both PNES and epilepsy",
    "both genders",
    "both groups",
    "both hypomorphic and dominant",
    "both these methods",
    "bottom-up emotionality",
    "bottom-up strong emotional responses",
    "boutons",
    "bovine serum albumin",
    "boy",
    "boys",
    "boys diagnosed with ADHD",
    "boys with ADHD",
    "bp",
    "brain",
    "brain abnormalities",
    "brain damage",
    "brain development and function",
    "brain disorders",
    "brain imaging techniques",
    "brain injury",
    "brain lesions",
    "brain network interactions",
    "brain phenotype",
    "brain regions",
    "brain systems",
    "brain volume",
    "breed specific diseases",
    "breeds",
    "brief 3-session mindfulness intervention",
    "brief drug holidays",
    "brief mindfulness",
    "brief mindfulness condition",
    "brief mindfulness program",
    "brief, 3-session mindfulness program",
    "bulls-eye",
    "bullying",
    "bupropion",
    "burden",
    "burdens stemming from the core ADHD symptoms",
    "calcium-channel activity genes",
    "calculating",
    "calibration",
    "cancer",
    "candidate EF and ToM measures",
    "candidate genes",
    "candidate plasticity gene",
    "candidate plasticity variant",
    "candidate susceptibility variants",
    "card sorting task",
    "cardiovascular problems",
    "care their children had received",
    "caregivers",
    "caregivers and clinicians",
    "carrier females",
    "case report forms",
    "case-control status",
    "cases",
    "catabolizing cathecholamines",
    "catastrophic thinking",
    "catechol O-methyltransferase gene (COMT) polymorphism",
    "categorical analyses",
    "categorical measures of ADHD",
    "categorical variables of demographic information",
    "caudate",
    "caudate volume",
    "causal inferences",
    "causal pathway",
    "causal relationship",
    "causal relationships",
    "causality",
    "causes",
    "cell and tissue growth and differentiation",
    "cell culture reagents",
    "cell metabolism",
    "cell migration",
    "cellphone users with data plans",
    "cells",
    "censoring of the highly noisy images",
    "center for outpatients of orthopedic spine surgery and pain",
    "central serotonergic system",
    "cerebellum",
    "cerebral control for speech",
    "cerebral palsy disorders",
    "cerebrospinal fluid",
    "certain copy number variations (CNVs)",
    "certain duration",
    "certain sleep-related behaviors",
    "certainty of diagnosis",
    "certainty of the different psychiatric disorders",
    "certified psychiatrist",
    "cervical dislocation",
    "cessation program",
    "challenges",
    "change in CSI-4 scores",
    "change in agreement",
    "changes",
    "changes in CHIP-CE scores",
    "changes in SITUT",
    "changes in blood pressure",
    "characteristics of the studies",
    "chart review",
    "chatrooms / chat groups",
    "chemical composition",
    "chi square analysis",
    "chi-square test",
    "chicken anti-MAP2",
    "child",
    "child and adolescent psychiatrist",
    "child and adolescent psychiatrists",
    "child and adolescent psychiatry",
    "child behavior",
    "child or adolescent",
    "child psychiatrists",
    "child who was psychiatrically ill",
    "child will receive the appropriate treatment",
    "child with ADHD",
    "childhood",
    "childhood (mean age 10 years)",
    "childhood ADHD",
    "childhood ADHD–ASD",
    "childhood adverse experience",
    "childhood adversity",
    "childhood and adolescence",
    "childhood and adolescent mental health disorders",
    "childhood diagnosis of ADHD",
    "childhood dual diagnosis ADHD–ASD",
    "childhood schizophrenia",
    "children",
    "children (N = 66)",
    "children (aged 6–12 years)",
    "children (≤ 13 years)",
    "children aged 2 through 5 years",
    "children aged 6 to 7 years",
    "children and adolescents",
    "children and adolescents themselves",
    "children and adolescents with DDX3X syndrome",
    "children and juveniles with ADHD",
    "children and preadolescents",
    "children and youth",
    "children at age 10 or 11 years",
    "children combined ADHD and anxiety/depression",
    "children in our sample who met the diagnostic criteria for ADHD",
    "children in the ADHD symptomatic group",
    "children who met diagnostic criteria for ADHD",
    "children who met diagnostic criteria for ADHD, ODD and anxiety",
    "children with ADHD",
    "children with ADHD symptoms",
    "children with and without ADHD",
    "children with anxiety disorders",
    "children with attention-deficit/hyperactivity disorder (ADHD)",
    "children with high ADHD symptoms",
    "children with high Depression/ Anxiety scores",
    "children with high screen time",
    "children with impairing symptoms of inattentiveness, hyperactivity and impulsivity",
    "children with internalizing problems",
    "children with low Depression/Anxiety scores",
    "children with low as well as with high Depression/ Anxiety scores",
    "children with low as well as with high screen time before bedtime",
    "children with low screen time before bedtime",
    "children with maternal cigarette smoking and alco_ hol drinking",
    "children with more ADHD symptoms",
    "children with or without ADHD",
    "children with prenatal alcohol exposure",
    "children with schizophrenia",
    "children with symptoms of ODD, anxiety",
    "children with symptoms of inattentiveness, hyperactivity and impulsivity",
    "children without ADHD symptoms",
    "children, adolescents and young adults with and without an ADHD diagnosis",
    "children/ mothers’ demographic characteristics",
    "children/adolescents",
    "children’s average sleep time",
    "children’s behavior",
    "children’s behavioral problems",
    "children’s sleep length on weekdays",
    "children’s sleep problems in general",
    "children’s socio-demographic characteristics",
    "child’s activities",
    "child’s current medication",
    "child’s current treatment",
    "child’s diagnosis",
    "child’s survey information",
    "child’s typical behaviour",
    "choice",
    "choice reaction time task",
    "choice responses",
    "choice set",
    "choice set #1",
    "choices",
    "chronic diseases",
    "chronic low back pain",
    "circle",
    "citizens",
    "city",
    "clarified subtype specification",
    "clarity of the instructions",
    "class website",
    "classified as nonremitters",
    "classroom",
    "classroom time",
    "classroom-CPT",
    "clear structure",
    "clear, direct, and honest DD",
    "clinical ADHD and TS",
    "clinical ADHD sample",
    "clinical ASD diagnosis",
    "clinical and neuropsychiatric phenotype",
    "clinical assessments",
    "clinical characteristics",
    "clinical comorbidity",
    "clinical correlates",
    "clinical diagnosis of ASD",
    "clinical evaluation by a psychiatrist",
    "clinical experience",
    "clinical experience in child psychiatry",
    "clinical expressions of emotional dysregulation (ED)",
    "clinical genetic",
    "clinical geneticist",
    "clinical global impressions of improvement (CGI-I)",
    "clinical group",
    "clinical history form",
    "clinical implications for ADHD",
    "clinical interviews",
    "clinical outcome of children with PNES",
    "clinical outcomes",
    "clinical perspective",
    "clinical populations",
    "clinical psychologists",
    "clinical reports",
    "clinical responders*",
    "clinical response",
    "clinical sample of outpatients with ADHD",
    "clinical settings",
    "clinical severity",
    "clinical significance",
    "clinical state of the patient",
    "clinical trial",
    "clinical trial design",
    "clinical utility",
    "clinically administered tests",
    "clinically irrelevant",
    "clinically meaningful",
    "clinically significant findings",
    "clinically significant hyperactivity and attention problems",
    "clinically significant mental health problem",
    "clinician input",
    "clinician supervision",
    "clinician- and teacher-reported improvements in ADHD symptoms",
    "clinicians",
    "clone preparations",
    "clonidine hydrochloride",
    "co-morbid disorders",
    "co-occurring ADHD and ODD",
    "co-twin control",
    "coefficients",
    "cofactors",
    "coffee",
    "cognitive abilities",
    "cognitive behavioral therapy techniques",
    "cognitive control network",
    "cognitive debrief findings",
    "cognitive deficits",
    "cognitive deﬁcits",
    "cognitive factors",
    "cognitive flexibility",
    "cognitive function",
    "cognitive functioning",
    "cognitive functioning scores",
    "cognitive functions",
    "cognitive or personality measure",
    "cognitive performance",
    "cognitive processes",
    "cognitive processing speed",
    "cognitive rehabilitation",
    "cognitive requirements",
    "cognitive restructuring",
    "cognitive task performance",
    "cognitive tasks",
    "cognitive-energetic model",
    "cohesion",
    "cohort-wide comparison",
    "coiled-coiled domain",
    "collaboration",
    "colleagues",
    "color-word Stroop task (Stroop, 1935)",
    "colour",
    "combinations of case/control status and experimental conditions",
    "combined",
    "combined (ADHD-C) type",
    "combined ADHD",
    "combined type (ADHD-C)",
    "commercial",
    "commercial or financial relationships",
    "common aetiological pathways",
    "common factors",
    "common genetic factors",
    "common practice",
    "common side effects",
    "common underlying factors",
    "communication",
    "communication with patients",
    "community standards",
    "community study",
    "comorbid anxious and depressive disorders",
    "comorbid conditions",
    "comorbid conduct disorder",
    "comorbid disorder",
    "comorbid oppositional defiant disorder",
    "comorbid oppositional deﬁance disorder or conduct disorder diagnosis",
    "comorbid psychosocial problems",
    "comorbidity",
    "comorbidity in adults with ASD",
    "comorbidity of other psychiatric disorders",
    "comparable efficacy",
    "comparative effectiveness studies",
    "comparative fit index (CFI)",
    "comparison",
    "comparison adjusted",
    "comparison adjusted funnel plot",
    "comparison group",
    "comparison group (COM)",
    "comparison groups",
    "comparison of ratings",
    "comparisons",
    "comparisons of the scores",
    "compassion",
    "competing interests",
    "complete description of the study",
    "completed the interview",
    "completely knockout Iqsec2/IQSEC2 expression",
    "complex linguistic skill",
    "complexity",
    "compliant to the treatment regimen",
    "composite score",
    "composite variable for substance misuse",
    "composite variable for substance use disorders",
    "comprehension and elaboration of the main plot",
    "comprehensive clinician-administered evaluations",
    "comprehensive ranking score",
    "compromise of functions other than just the Sec7 catalytic activity of IQSEC2",
    "compulsive TS behaviors",
    "compulsive-impulsive continuum",
    "computer",
    "computer codes",
    "computer-simulated reality",
    "computerized",
    "conceived and designed the experiments",
    "concentration",
    "concentration problems",
    "concentrations of folate and cobalamin",
    "concept of emotional dysregulation (ED)",
    "conception or design of the work",
    "conclusions",
    "conclusions about causality",
    "concomitant medications",
    "concomitant psychiatric disorders",
    "conditional logit model",
    "conditional logit models",
    "conditioned inhibition",
    "conduct disorder",
    "conduct disorder symptoms",
    "conduct disorders",
    "conductive paste",
    "conference",
    "confidence interval",
    "confidence interval.",
    "confirmatory factor analysis",
    "conflicting results",
    "conflicts of interest",
    "conflicts within the family",
    "connectedness",
    "connectivity among words",
    "connectivity mapping",
    "connectivity measure",
    "consensus diagnoses",
    "consequences in discourse organization",
    "considering DD",
    "considering their ADHD symptomatology",
    "consistency",
    "consistency/long term",
    "consistency/long term subscale",
    "consistent phenotyping",
    "constipation and reflux",
    "constraints",
    "contacts on the target SNS",
    "contemporary theories of addiction",
    "content of this paper",
    "continuous effects",
    "continuous performance test (CPT)",
    "continuous score",
    "continuous variables (i.e., age)",
    "contralateral motor areas",
    "control",
    "control boys/control girls",
    "control group",
    "control sample",
    "control subjects",
    "controlled children",
    "controlled delivery",
    "controlled soccer headers",
    "controlled-release formulations",
    "controls",
    "controls in the non-reward condition",
    "controls in the stopsignal task",
    "controls on potentially addictive medications",
    "convenience sample",
    "conventional meta-analysis",
    "convergent validity",
    "conversational samples",
    "cooccurring symptoms of ADHD",
    "copyright holder",
    "core ASD-related characteristics",
    "core self-regulatory processes",
    "core survey",
    "corpus callosum abnormalities",
    "correct calibration of a VR system",
    "corrected gene expression data",
    "correction for age and age difference between ADHD scoring and MRI scanning",
    "correlated comparisons",
    "correlation of HM with self report Inattention or Hyperactivity-Impulsivity",
    "correlations",
    "corresponding author",
    "cortex",
    "cortical cultures",
    "cortical microcircuits",
    "cortical surface area",
    "cost",
    "costs",
    "cotinine levels",
    "cough",
    "counseling interviews",
    "counseling sessions",
    "countries",
    "country",
    "country differences",
    "country level",
    "country-specific differences",
    "court",
    "cousin-comparison",
    "cousins",
    "covariance between ADHD and smoking",
    "covariance between externalising disorders and substance use",
    "covariance between smoking and substance use",
    "covariances",
    "covariate",
    "covariates",
    "covert aggression",
    "craving",
    "cravings",
    "cravings to use the SNS",
    "crime",
    "criminal activity",
    "criminal acts",
    "criminal behaviour",
    "criminal conviction (CC)",
    "criminal justice",
    "criminal law",
    "criminal psychology",
    "criminality",
    "criminals",
    "criminology",
    "crisis",
    "criteria",
    "criteria for ADHD",
    "criteria used by each project",
    "critical revision of the manuscript",
    "criticism",
    "cross-European lifestyle differences",
    "cross-country differences",
    "cross-disorder gene expression analysis",
    "cross-national comparison",
    "cross-national differences",
    "cross-sectional",
    "cross-sectional investigations",
    "cross-sectional observational design",
    "cross-sectional study",
    "crossloaded",
    "crossnational comparison",
    "crossover trial design",
    "crosssectional design",
    "crosssectional study design",
    "cultural background",
    "cultural differences",
    "cultural effect",
    "cultural variations",
    "culturally adapted",
    "culturally-sensitive",
    "culture",
    "current ADHD symptoms",
    "current DCE method",
    "current age",
    "current body of literature",
    "current diagnoses",
    "current diagnoses methodology",
    "current inattention",
    "current interventions available for children with ADHD",
    "current or past facts",
    "current results",
    "current sample size",
    "current study",
    "current study design",
    "current treatment options",
    "current use of",
    "customization",
    "cyberbullying",
    "cybersickness",
    "cybersickness as a complex problem",
    "cybersickness or virtual reality sickness",
    "d-amphetamine",
    "d9",
    "dMPH",
    "daily conversations",
    "daily dosage",
    "daily functioning",
    "dampened processing of sensory input",
    "data",
    "data acquisition",
    "data analysis",
    "data and safety monitoring board",
    "data collection",
    "data interpretation",
    "data linkage",
    "data management",
    "data presented herein",
    "data structure",
    "data-set",
    "datasets",
    "date of collection",
    "day",
    "daydreaming frequency scale scores (DDFS)",
    "days",
    "days in vitro (DIV)",
    "daytime sleepiness",
    "daytime sleepiness (eight items)",
    "daytime sleepiness problems",
    "de Bildt and de Jonge",
    "de Corte et al.",
    "de Silva-Sanigorski",
    "de novo lossof-function IQSEC2 mutations",
    "de novo status",
    "de-identified databases",
    "decapitation of embryos",
    "decision makers",
    "decision making",
    "decision making abilities",
    "decision making processes under stress",
    "decision-making and impulse control",
    "decision-making systems",
    "declared only conflict of interest",
    "decreased appetite",
    "decreased mental health",
    "decreased odds of educational attainment",
    "decreased organization and monitoring of medication compliance",
    "decreased performance accuracy in the CPT",
    "decreased productivity",
    "deficits",
    "deficits in attention",
    "deficits in discriminating stimuli",
    "deficits in executive functions",
    "definition of overall medication non-adherence",
    "definitive diagnoses of ASD and ADHD",
    "definitive role",
    "definitive sensory changes",
    "degree of ADHD symptom control",
    "degree of connectedness",
    "degree of effective symptom control",
    "degree of symptom control",
    "degree of symptom control after each dose",
    "delay aversion",
    "delay aversion task performance",
    "delay aversion to rewards",
    "delayed results",
    "delayed reward discounting",
    "delayed-larger rewards",
    "delayrich",
    "deliberate mind wandering",
    "delinquency",
    "delirium",
    "deliver the diagnosis in a vague and optimistic way",
    "delivery formulation",
    "delivery mechanisms",
    "demographic data",
    "demographics",
    "dendrites",
    "dendritic branching",
    "dendritic development",
    "dendritic spine development",
    "dendritic spine morphogenesis",
    "dendritic spine morphology",
    "dendritic spines",
    "dentate gyrus",
    "dependent variable",
    "dependent variables",
    "depression",
    "depressive disorder",
    "depressive episode",
    "depressive symptoms",
    "design coefficient (D)",
    "design of the study",
    "designated adult",
    "designated adult instructor",
    "desire for social interaction",
    "desktop VR",
    "details of the CBT session",
    "deterioration of ADHD symptoms",
    "determinants",
    "determining the effect of stimulant medication",
    "devastation",
    "development",
    "development of VR systems",
    "development of drug- and alcohol-related substance use disorders",
    "development of new ADHD medications",
    "development of reward learning",
    "developmental delays",
    "developmental disorders",
    "developmental origins of health and disease hypothesis",
    "developmental psychopathology research",
    "developmental stage",
    "developmentally appropriate tasks",
    "developmentally inappropriate levels",
    "deviances in EF",
    "deviant peer afﬁliation",
    "deviant work and interpersonal behaviors",
    "deviation from the equilibrium",
    "deviations from intended interventions",
    "dexamphetamine",
    "dexmethylphenidate",
    "dextroamphetamine",
    "df",
    "diagnosed with ADHD",
    "diagnoses of diseases and procedures received",
    "diagnoses of internalizing disorder",
    "diagnosis",
    "diagnosis and management of ADHD",
    "diagnosis and treatment patterns",
    "diagnosis of ADHD",
    "diagnosis of ADHDs",
    "diagnosis of substance misuse",
    "diagnosis of substance use disorders",
    "diagnosis results",
    "diagnostic assessment or drug treatment",
    "diagnostic categories",
    "diagnostic clinical interview",
    "diagnostic clinical interviews",
    "diagnostic criteria",
    "diagnostic group",
    "diagnostic group 6 reward condition interaction",
    "diagnostic group and block order",
    "diagnostic groups",
    "diagnostic interview",
    "diagnostic process",
    "diagnostic stability",
    "diathesis-stress or dual-risk models",
    "diathesisstress model",
    "dichotomous outcome",
    "did not include a comparison group",
    "did not specify",
    "diet",
    "diet behavior",
    "diet quality",
    "dietary information",
    "diets",
    "differ in their susceptibility to environmental experiences",
    "difference",
    "differences in dosing schedules",
    "differences in polygenic risk scores",
    "differences in sample selection",
    "differences in symptom severity",
    "different ADHD treatment patterns",
    "different approaches to ADHD management",
    "different attributes of interventions",
    "different countries",
    "different definitions of therapeutic response",
    "different drug product",
    "different experiments",
    "different forms of methylphenidate",
    "different frequencies of punishment",
    "different methodology",
    "different patterns of medication availability",
    "different populations",
    "different socioeconomic strata in China",
    "different treatment approach",
    "differential genetic susceptibility",
    "differential group effect",
    "differential pattern toward warmth",
    "differential responses",
    "differential susceptibility",
    "differential susceptibility research",
    "differential susceptibility theory",
    "differential susceptibility theory framework",
    "differing national and cultural approaches",
    "difficulties in cognitive performance",
    "difficulties in emotional control",
    "difficulties in inhibition and emotional regulation",
    "difficulties with discourse management",
    "difficulties with new/unexpected situations",
    "difficulty paying attention",
    "digressions",
    "dilemmas",
    "dimensional diagnosis",
    "direct and indirect estimate",
    "direct comparison",
    "direct comparisons",
    "direct effect of stimulant medication",
    "direct evidence",
    "directionality",
    "disability-adjusted life years lost",
    "disconnection",
    "discontinuation of the drug",
    "discontinued",
    "discontinued methylphenidate",
    "discontinuing medication",
    "discourse",
    "discourse comprehension",
    "discourse interruptions",
    "discrete choice experiments (DCEs)",
    "discretion",
    "discuss this",
    "discussion",
    "disks large MAGUK scaffold protein 4 (DLG4)",
    "disorder",
    "disorder-related gene expression profiles",
    "disorders",
    "disorientation",
    "disparity",
    "disruptive behavior",
    "disruptive behavior disorder",
    "disruptive behavior disorders prevalence rates",
    "disruptive behaviour",
    "dissemination",
    "dissimilarity measure",
    "dissociated neurons",
    "dissociative symptoms",
    "distinct brain networks",
    "distinct classes of genetic variants",
    "distinct definitions of mind wandering",
    "distorted actual experience",
    "distractibility",
    "distraction",
    "distractions",
    "distributed functional connectivity pattern",
    "distributed nature of interactions",
    "distribution",
    "distribution of allele and genotypes",
    "disturbances in expression",
    "divided attention",
    "dizziness",
    "documents",
    "dogs",
    "doi.org",
    "doi:10.1371/journal.pone.0067002.g001",
    "doi:10.1371/journal.pone.0067002.t002",
    "doi:10.1371/journal.pone.0067002.t003",
    "doi:10.1371/journal.pone.0146271.g002",
    "domestication",
    "domestication process",
    "dominant genetic effect",
    "dominant negative missense variants",
    "dominant-negative IQSEC2E849K mutation",
    "donkey anti-mouse IgG Alexa555",
    "donkey anti-mouse IgG Alexa647",
    "donkey anti-rabbit IgG Alexa555",
    "dopamine",
    "dopamine D4 receptors",
    "dopamine and serotonin",
    "dopamine and serotonin variation",
    "dopamine increase",
    "dopamine levels",
    "dopamine system",
    "dopamine transporters",
    "dopamine-based learning processes",
    "dopaminergic release",
    "dorsal attention network",
    "dosage",
    "dosage of IQSEC2",
    "dosage of IQSEC2 and/or KDM5C",
    "dosage sensitivity for IQSEC2",
    "dosage sensitivity of IQSEC2",
    "doses",
    "dosing",
    "dosing flexibility",
    "dosing schedules",
    "double-blind",
    "downstream analyses",
    "drafting the work",
    "drowsiness",
    "drug",
    "drug abuse",
    "drug environments",
    "drug misuse",
    "drug regimen",
    "drug rewards",
    "drug side effects",
    "drug therapy",
    "drug treatment",
    "drug use disorder",
    "drug- and alcohol-related substance use disorders",
    "dual-pathway model",
    "duration of ADHD symptom control",
    "duration of effect",
    "duration of pain complaint",
    "duration of symptom control",
    "duration of symptom control after each dose",
    "durations",
    "during the study",
    "dysfunctional interoceptive system",
    "dysfunctional mesolimbic dopamine/striatal system",
    "dysfunctional prefrontal system",
    "dysmorphic features",
    "dystonia after hyperventilation",
    "e67002",
    "eTMT",
    "each anxiety/depression symptom",
    "each attribute",
    "each country",
    "each measurement",
    "each module",
    "each movement",
    "each of the ADHD symptoms",
    "each of the five BRIEF-P subscales",
    "each project",
    "ear",
    "ear pain",
    "earlier age of stimulant initiation",
    "earlier educational termination",
    "earlier initiation of smoking",
    "earlier publication",
    "earlier study",
    "early age at stimulant treatment initiation",
    "early childhood",
    "early childhood onset",
    "early detection and treatment",
    "early forms of ADHD",
    "early gestational age at birth",
    "early identification and intervention for substance use disorders",
    "early identification of ADHD",
    "early intervention",
    "early point in development",
    "early postnatal periods",
    "early speech disturbances",
    "early spines",
    "early symptoms of ADHD",
    "early symptoms of ODD",
    "early-stage identification of CBT inhibitors",
    "easing of measures",
    "eating",
    "eating before bedtime",
    "eating disorders",
    "ecological language measure",
    "ecological measure of language",
    "ecological validity",
    "ecologically valid distracters",
    "ecologically valid information",
    "economic stability",
    "education",
    "education under 10 years",
    "educational achievements",
    "educational and training",
    "educational attainment variables",
    "educational level",
    "educational levels",
    "educational problems",
    "effect of HM",
    "effect of HM on FC",
    "effect of age at first stimulant use",
    "effect of treatment",
    "effect sizes",
    "effective interventions",
    "effective number (Meff)",
    "effective treatment",
    "effectiveness",
    "effectiveness of treatment",
    "effects of peers",
    "efficacy",
    "efficacy outcomes",
    "efficacy population",
    "efficacy profile",
    "efficacy profiles",
    "efficiency of transcription",
    "effortful executive inhibition",
    "effortful response inhibition deficits",
    "ehealth trials",
    "eight senior physicians",
    "eight subscales",
    "eight were event-free",
    "electrocardiogram",
    "electrode site",
    "electrodes",
    "electroencephalographic data",
    "electroencephalographic signal",
    "electronics",
    "electrophysiological",
    "elementary forms of its two core components",
    "elementary school teachers",
    "elementary schools",
    "elevated SB",
    "elevated risk",
    "eligibility screener",
    "embellishment",
    "embryonic day 17.5 (E17.5)",
    "emergency department visits",
    "emotional disorders",
    "emotional dysregulation",
    "emotional dysregulation (ED)",
    "emotional lability",
    "emotional lability (EL)",
    "emotional reactions",
    "emotional searching behavior for pain",
    "emotional state",
    "emotional temperament scale",
    "emotions",
    "emotive",
    "emotive and interpersonal subscales",
    "emotive prediction of poor DM",
    "emotive subscale",
    "empathic concern",
    "empathy",
    "encephalitis",
    "encopresis",
    "end date",
    "end of 2012",
    "enhanced evidence",
    "enrichment analyses",
    "entertainment",
    "entire IQSEC2 complementary DNA (cDNA)",
    "entire cortex",
    "enuresis",
    "environment",
    "environmental",
    "environmental confounding",
    "environmental correlation",
    "environmental effects",
    "environmental factors",
    "environmental predictors",
    "environmental risks",
    "environmental variables that were studied",
    "enzymatic activity",
    "enzymatic activity of IQSEC2",
    "epidemiological information",
    "epidemiological study",
    "epidemiological study findings",
    "epigenetic factors",
    "epilepsy",
    "epilepsy and intellectual disability genes",
    "epilepsy center",
    "epileptic encephalopathies",
    "epileptic encephalopathy",
    "equally sized samples",
    "error margin (d)",
    "escitalopram",
    "essential information",
    "essentially unchanged",
    "estimates",
    "estimates of common variance",
    "estimates of relationships between variables of interest",
    "et al.",
    "etc.",
    "ethical approval",
    "ethical approval for the study",
    "ethical question",
    "ethics committee",
    "ethnic minorities",
    "ethnicity",
    "etiologic role",
    "even higher",
    "event sequencing errors",
    "event-free",
    "events",
    "events of diverse severity",
    "evidence-based findings",
    "evidence-based prevention strategies",
    "evolutionary important construct",
    "examiners’ expertise",
    "excessive TV use",
    "excessive and inappropriate emotional expressions",
    "excessive desire for a close relationship",
    "excessive gaming",
    "excessive parental involvements",
    "excessive search for pain",
    "excessive speech",
    "excessive use",
    "excessive use of computer and video games",
    "excitatory synapses",
    "exclusion criteria",
    "exclusion criterion",
    "exclusion of children",
    "exclusioninclusion criteria",
    "execution",
    "executive behavior",
    "executive dysfunction",
    "executive dysfunctions",
    "executive function",
    "executive function (EF)",
    "executive function deficits",
    "executive functioning",
    "executive overload model of OCD",
    "executive response inhibition deficits",
    "exercise",
    "exercise bout",
    "exercise therapy",
    "existed evidence",
    "existing Norwegian translation",
    "existing findings",
    "existing knowledge",
    "existing therapies",
    "expectations",
    "expected coherence in narrative production",
    "experience of ADHD",
    "experiment",
    "experimental conditions",
    "experimental design",
    "experiments",
    "expert review",
    "explained",
    "explained variance",
    "exploratory factor analysis (EFA)",
    "exposure during pregnancy",
    "exposure to VR environments",
    "exposure-outcome measures",
    "expressed emotion selection",
    "expression",
    "expressive and receptive language challenges",
    "expressive language",
    "expressive language scores",
    "extendedrelease",
    "extensive phenotyping",
    "external datasets",
    "external factors",
    "externalising disorder",
    "externalizing problems",
    "externalizing problems (ADHD, ODD)",
    "exteroceptive input",
    "extracellular signals",
    "extrapolate",
    "extreme testing day separation",
    "extremely high dependency needs",
    "eye pain",
    "eyes-closed EEG",
    "eyes-closed resting condition",
    "fMRI",
    "fMRI analyses",
    "face validity of the choices",
    "factor analytic studies",
    "factors that influence its incidence",
    "fail in maintaining appropriate topics",
    "failing grades",
    "failing grades in grade 9 (13–16 years old)",
    "false negative rate",
    "false negative results",
    "false positive discoveries",
    "false positive findings",
    "false positive rate",
    "false positive results",
    "false positives",
    "false starts",
    "familial and social distress",
    "familial dependency",
    "familial distress",
    "familial or interpersonal distress",
    "familiar ADHD traits",
    "familiar environment",
    "families",
    "families’ resilience",
    "family",
    "family history",
    "family history of ADHD",
    "family life",
    "family situations",
    "family studies",
    "family therapy",
    "fantasy",
    "fast Fourier transform power spectral analysis",
    "fast pace of entertainment media",
    "father",
    "fatigue",
    "fats",
    "fears he / she might think or do something bad",
    "feature",
    "febrile convulsions",
    "feelings of loneliness",
    "female",
    "female ADHD patients",
    "female inmates",
    "female pairs",
    "female same sex",
    "females",
    "fetal bovine serum",
    "fetal bovine serum-depleted media",
    "fetal development",
    "fetal growth",
    "fetal growth differences",
    "fetal growth factors",
    "fetal-growthimpaired individuals",
    "few studies",
    "fewer autocorrections",
    "fewer inhibitory problems",
    "fewer long-range",
    "fewer than 30 participants",
    "fewer utterances",
    "fewer utterances of resolution",
    "fewer utterances related to the main plot",
    "fewer verbal production",
    "field",
    "films, series or clips",
    "filopodia",
    "filopodia to spines",
    "filopodia-to-spine ratio",
    "final approval",
    "final form of model 2",
    "final manuscript",
    "final model",
    "final scores",
    "final study attributes",
    "final survey",
    "financial relationships",
    "finding",
    "findings",
    "findings from these and other studies",
    "findings of this study",
    "first",
    "first 23 ODD (+) cases",
    "first and fourth waves",
    "first and second waves",
    "first and third waves",
    "first author",
    "first contribution",
    "first hypothesis",
    "first nicotine use",
    "first principal component",
    "first study",
    "first wave",
    "first-degree relative history of ADHD",
    "first-degree relative with ADHD",
    "first-degree relatives",
    "five",
    "five and seven times",
    "five levels of attention",
    "five parents",
    "five possible candidate genes",
    "five-point Likert scale",
    "fixed",
    "fixed power (b = 12)",
    "fixed-effects model",
    "fixed-effects modelling",
    "fixed-effects models",
    "flexibility",
    "flexible",
    "flowchart of participant inclusion",
    "fluoxetine",
    "focal clonic movement",
    "focal slowing",
    "focal tremor",
    "focus/concentrate",
    "focused attention",
    "follow-up",
    "follow-up studies",
    "follow-up study",
    "follow-up visits",
    "followed up for 5 years",
    "following",
    "followup comparisons",
    "food response",
    "forced-dose titration",
    "formal neuropsychological tests",
    "formaldehyde",
    "former being a proxy of connectedness",
    "former studies of DD interaction",
    "four",
    "four spinal surgeons",
    "four times",
    "frequency",
    "frequency and intensity of stimulus correlated motion",
    "frequency band",
    "frequency of administration",
    "frequency of medication",
    "frequent daily dosing",
    "frequent follow-up",
    "frontal/striatum areas",
    "frontoparietal networks",
    "fruits and vegetables",
    "frustration",
    "frustration intolerance",
    "full dataset",
    "full diagnostic interview",
    "full informed consent",
    "full range of patients with ADHD",
    "full safety analyses",
    "full time employment",
    "full#supplementary-material",
    "full-length IQSEC2",
    "full-scale IQ (FSIQ)",
    "full-scale intelligent quotient (FSIQ)",
    "full-term births",
    "fully attenuated relationship",
    "functional and structural neuroimaging studies",
    "functional brain differences in ADHD",
    "functional brain networks",
    "functional connectivity",
    "functional connectivity-based features",
    "functional consequences associated with linguistic abnormalities in ADHD",
    "functional heterogeneity",
    "functional magnetic resonance imaging",
    "functional magnetic resonance imaging (MRI)",
    "functional network-based predictions",
    "functional studies",
    "functional transcranial sonography",
    "functionality",
    "functioning",
    "funded using government or university funding",
    "funding",
    "funding source",
    "funnel plot",
    "further research",
    "further studies",
    "furthermore",
    "future prospective studies",
    "future research",
    "future researchers",
    "future studies",
    "gag/pol",
    "gait abnormalities",
    "gait disturbance",
    "gambling",
    "gambling and substance use behaviors",
    "gaming",
    "gaming console",
    "gamma frequency oscillations",
    "gamma oscillation power",
    "gamma oscillations",
    "gang",
    "gastrointestinal abnormalities",
    "gastrointestinal difficulties",
    "gateway theory",
    "gender",
    "gender disparity",
    "gender ratio",
    "gender representation",
    "gene content of modules of interest",
    "gene expression",
    "gene variants",
    "gene x sex interaction",
    "gene-environmental interaction",
    "gene-environmental interactions",
    "general Internet population",
    "general Norwegian population",
    "general adjustment problems",
    "general adult population",
    "general anxiety disorders",
    "general communication abilities",
    "general methodological differences",
    "general patient population",
    "general population",
    "general population in Beijing",
    "general population in German speaking countries",
    "general school-age children",
    "general sex limitation model",
    "general task performance",
    "general user population",
    "generalisability of our results",
    "generalised estimated equations model",
    "generalising our results",
    "generalizability",
    "generalizable",
    "generalized anxiety",
    "generalized anxiety disorder",
    "generally required in managing ADHD",
    "generic HRQoL measure",
    "generosity of time",
    "genes",
    "genes associated with epilepsy",
    "genes called ‘plasticity genes’",
    "genes involved in GxE",
    "genes linked to neurotransmitters involved in reward sensitivity",
    "genes we identified",
    "genetic aetiology",
    "genetic and environmental components",
    "genetic and environmental correlations of HM and ADHD",
    "genetic and environmental influences on gene expression",
    "genetic and shared environmental factors",
    "genetic basis of dog-human communicative behaviors and sociability",
    "genetic confounding",
    "genetic contribution",
    "genetic correlation",
    "genetic correlation coefficients",
    "genetic correlation coefficients with HM",
    "genetic correlations",
    "genetic factor",
    "genetic factors",
    "genetic heterogeneity",
    "genetic inﬂuences",
    "genetic moderation",
    "genetic mutations",
    "genetic pathway analysis",
    "genetic risk factors",
    "genetic structure of the associations",
    "genetic testing",
    "genetic variants",
    "genetics",
    "genetics of traits examined",
    "genome-wide genetic-risk level",
    "genome-wide study",
    "genomic overlaps",
    "genomic regions",
    "genomic risk factors",
    "genotype",
    "genotype and allele distributions",
    "genotype and allele frequencies",
    "genotype data",
    "genotypes",
    "genotype–phenotype correlations in DDX3X syndrome",
    "genotyping procedure",
    "geographical differences",
    "geographical, cultural Table 2",
    "gestational age",
    "gestational age at birth",
    "gestational age extremes",
    "girls",
    "girls with ADHD",
    "glutamate",
    "glutamine",
    "goal-directed cognition",
    "goat anti-mouse HRP",
    "goat anti-rabbit HRP",
    "gold standard diagnostic instruments",
    "good and poor IGT performance",
    "good reason to take that hope away",
    "good-quality study design",
    "government’s one child policy",
    "grade five students",
    "grain products",
    "grant",
    "graph analysis of speech",
    "graph size (ASP)",
    "greater symptom severity",
    "grief",
    "gross motion",
    "group",
    "group comparison",
    "group differences",
    "group differences in speed measurements",
    "group status",
    "groups (ADHD and non-ADHD)",
    "groups of patients with diseases",
    "growth and development",
    "growth background",
    "guanfacine extended release",
    "guanine nucleotide exchange factor",
    "guanine nucleotide exchange factor gene IQSEC2",
    "guanine nucleotide exchange factors",
    "guanine nucleotide exchange factors (GEF)",
    "guidelines and regulations",
    "guilt",
    "h2HM",
    "habit",
    "habit correction interventions",
    "habituation",
    "had a better fit",
    "had been treated for ADHD",
    "had recovered symptomatically from ADHD",
    "had their dosage decreased",
    "half",
    "half-life",
    "hallmark of ADHD",
    "haplotype",
    "haptic interfaces",
    "harm",
    "harmful or age-inappropriate content",
    "having no other children living at home",
    "hazard ratio for low birth weight",
    "head impact kinematics",
    "head motion",
    "head-mounted dis­ play (HMD)",
    "headache",
    "headache or abnormal sensation",
    "headaches",
    "health and safety",
    "health authorities",
    "health behaviors",
    "health benefits",
    "health care data",
    "health care provider contacts",
    "health care service utilization",
    "health care services",
    "health happiness improvement movement exercise",
    "health promotion initiatives",
    "health-related behavior",
    "health-related behaviors",
    "health-related quality of life",
    "health-related quality of life (HRQoL) measures",
    "healthcare practitioners",
    "healthy adults",
    "healthy behaviors",
    "healthy control",
    "healthy control group",
    "healthy control participants",
    "healthy controls",
    "healthy diet habits",
    "healthy group",
    "healthy individuals",
    "healthy participants",
    "heart disease",
    "heat colors",
    "heat plot",
    "heavy responsibility",
    "heightened-responsive neural reward system",
    "helicase ATP-binding domain",
    "helicase-C domain",
    "hemizygous Iqsec2 knockout mice",
    "hemizygous males",
    "herbal treatments",
    "heritability",
    "heritability estimates",
    "heritability of HM",
    "heritability of Inattention",
    "herterozygous females",
    "hesitations",
    "heterogeneity within an individual",
    "heterogeneous and sometimes discordant results",
    "heterozygotes",
    "hierarchical clustering tree",
    "hierarchical regression analyses",
    "high",
    "high (bottom pair; 18 ADHD symptoms)",
    "high SB",
    "high and low ADSA ratings",
    "high exposure to games and TV",
    "high impulsivity",
    "high incidence",
    "high intragroup variability",
    "high levels of anxiety/depression",
    "high levels of tic symptoms",
    "high levels of warmth",
    "high mind wandering in ADHD",
    "high pain/temperature",
    "high positive peer afﬁliation",
    "high risk",
    "high score subgroup",
    "high screen time",
    "high warmth",
    "high-risk groups",
    "high-throughput sequencing",
    "higher ADHD symptomatology",
    "higher and lower magnitudes of punishment",
    "higher education",
    "higher education and work",
    "higher hit rates",
    "higher levels of awareness and concern",
    "higher mean age",
    "higher number of false positives",
    "higher number of short-range recurrences",
    "higher overall BRIEF-P problem scores",
    "higher overall screen time",
    "higher parental educational level",
    "higher prevalence of FP",
    "higher problem ratings",
    "higher rate of regular smoking",
    "higher rates of coherence errors",
    "higher rates of embellishment errors",
    "higher reading abilities",
    "higher score",
    "higher socioeconomic status",
    "higher values",
    "higher-order cognitive abilities",
    "highest socioeconomic status (SES)",
    "highly relevant articles",
    "highly restrictive",
    "highrisk families",
    "hippocampal neurons",
    "hippocampal sclerosis",
    "hippocampal vs cortical neuronal cultures",
    "hippocampus",
    "histories of ADHD",
    "home activities",
    "home survey",
    "home surveys",
    "home version of the ADHDRS-IV",
    "homeopathy",
    "homozygotes",
    "hope",
    "hospital facility",
    "hours",
    "household income",
    "how reward sensitivity was operationalized",
    "however",
    "http://creativecommons.org/licenses/by/4.0/",
    "http://journal.frontiersin.org/article/10.3389/fpsyg.",
    "http://neilsloane.com/oadir/",
    "http://www.frontiersin.org",
    "https://doi.org/10.1192/bjp.bp.112.124784",
    "https://doi.org/10.1371/journal.pone.0245113",
    "https://doi.org/10.1371/journal.pone.0245113.g003",
    "https://doi.org/10.1371/journal.pone.0245113.t003",
    "https://doi.org/10.1371/journal.pone.0245113.t004",
    "https://doi.org/10.3345/kjp.2017.60.11.337",
    "hub genes",
    "human",
    "human TPH2",
    "human X-linked brain diseases",
    "human behavior model",
    "human disease state",
    "human emotions",
    "human social behavior disorders",
    "human social behavioral disorders",
    "human social disorders",
    "human social impairments",
    "human-directed contact seeking behaviors",
    "human-directed social behavior in dogs",
    "human-directed social behaviors",
    "hydrolysis",
    "hyper-active impulsive brain systems",
    "hyper-responsive neural reward system",
    "hyperactive",
    "hyperactive amygdala-striatal system",
    "hyperactive and impulsive",
    "hyperactive-impulsive severity",
    "hyperactive-impulsive symptoms subscale",
    "hyperactive-impulsivity",
    "hyperactive/impulsive",
    "hyperactive/impulsive ADHD-like behaviors",
    "hyperactive/impulsive type",
    "hyperactivity",
    "hyperactivity disorder",
    "hyperactivity scale",
    "hyperactivity-impulsivity",
    "hyperactivity-impulsivity symptoms",
    "hyperactivity/ impulsivity",
    "hyperactivity/impulsivity",
    "hyperactivity/impulsivity and inattention",
    "hyperactivity/restlessness",
    "hyperkinetic conduct disorder",
    "hyperkinetic syndrome",
    "hyperopia",
    "hypersensitivity to food",
    "hyperventilation syndrome",
    "hypnosis",
    "hypo-active inhibition systems",
    "hypoactive prefrontal cortex system",
    "hypomorphic missense",
    "hypothesis (iii)",
    "hypothesis 1",
    "hypothesis 2",
    "hypothetical treatment preferences",
    "hypotonia",
    "iPLEX ™ reaction products",
    "iPLEX™ assay",
    "ideal treatment for ADHD",
    "identification",
    "identification of deviancies",
    "identified genes",
    "identify with the child",
    "identify with the parents",
    "illegal",
    "image processing",
    "image processing pipeline",
    "image processing pipelines",
    "images",
    "imagination",
    "imaging paradigms",
    "imaging phenotype",
    "immature neurons",
    "immediate behaviors",
    "immediate choices",
    "immediate feedback",
    "immediate reward",
    "immediate smaller over delayed larger rewards",
    "immediate-release",
    "immediate-release methylphenidate",
    "immediate-release methylphenidate (MPH)",
    "immersion/crystallization analysis method",
    "immigration status",
    "immunoblot analysis",
    "impact of non-adherence",
    "impaired fetal growth",
    "impaired performance on several cognitive tests",
    "impaired structural and synaptic plasticity",
    "impairment criteria",
    "impairments and disabilities",
    "impairments in ToM",
    "implementation",
    "implications",
    "implications for resting-state fMRI biomarkers",
    "implicit, intuitive learning",
    "important insights",
    "important predictors of non-adherence",
    "improvement in HRQoL",
    "improvement in oppositionality",
    "improvement in symptoms at school",
    "improvements in QoL",
    "impulse control system",
    "impulsion",
    "impulsions",
    "impulsive",
    "impulsive behavior",
    "impulsive behaviors",
    "impulsive individuals",
    "impulsivity",
    "impulsivity symptoms",
    "in utero nutrition",
    "in years",
    "in-frame deletions",
    "in-house 18item behavior checklist",
    "in-scanner motion",
    "in-utero exposure",
    "in-utero exposure to maternal cigarette smoking",
    "inactive",
    "inactive lifestyle",
    "inappropriate",
    "inattention",
    "inattention and distraction",
    "inattentive",
    "inattentive behavior",
    "inattentive subtype",
    "incarcerated populations",
    "incarcerated/prison populations",
    "incentive reward",
    "incentives",
    "included",
    "included patients",
    "including",
    "including an or any electronic music player, tablet, or other device",
    "inclusion criteria",
    "inclusion of such measures",
    "incomplete clauses",
    "incomplete narratives",
    "inconsistency",
    "increased BOLD and FC variance",
    "increased obsessive-compulsive symptoms",
    "increased or decreased expression",
    "increased reward sensitivity",
    "increased risk taking",
    "increased risk-taking behaviour",
    "increasing ADHD symptoms",
    "increasing time interval lengths",
    "incremental quality",
    "independent large data sets",
    "independent populations of laboratory beagles",
    "independent risk",
    "independent variable",
    "independently",
    "indicate",
    "indicators",
    "indifferent parenting",
    "indirect evidence",
    "individual",
    "individual QCMscores",
    "individual cases",
    "individual cells",
    "individual child",
    "individual differences",
    "individual differences in mind wandering questionnaire scores (MWQ)",
    "individual differences in specific contents of experience",
    "individual movements",
    "individual patient-level information",
    "individual separate cubicle",
    "individual treatment options",
    "individual user",
    "individual-speciﬁc topographic patterns of correlated brain activity",
    "individuallevel fixed effects",
    "individuals",
    "individuals carrying speciﬁc variants in such genes",
    "individuals with ADHD",
    "individuals with ADHD symptoms",
    "individuals with ASD",
    "individuals with ASD and ADHD",
    "individuals with DDX3X syndrome",
    "individuals with OCD",
    "individuals with PTVs",
    "individuals with higher cognitive ability",
    "individuals with known ADHD",
    "individuals without ASD",
    "individuals’ behavior",
    "individual’s comprehension skills",
    "individual’s treatment preferences",
    "inferential production",
    "informant",
    "information from performance-based measures of EF",
    "information processing and storage in WM",
    "informed consent",
    "inhibition",
    "inhibition and working memory (WM)",
    "inhibition and, to a lesser degree, in WM",
    "inhibitory control",
    "inhibitory control tasks",
    "inhibitory problems",
    "initial analysis",
    "initial classification",
    "initial main effects’ model",
    "inpatient admission",
    "insights beyond language",
    "insomnia",
    "instructor",
    "instrument",
    "instruments for assessing Narrative discourse",
    "instruments with uncertain ecological validity",
    "insula",
    "insula system",
    "intellectual ability",
    "intellectual disability",
    "intellectual disability (ID)",
    "intellectual disability and epilepsy",
    "intelligence level",
    "intelligence quotient",
    "intelligence quotients",
    "intense arousal",
    "intensity",
    "intent-to-treat (ITT) population",
    "intention-to-treat analysis",
    "inter-rater reliability",
    "interaction",
    "interaction age6age at first stimulant use",
    "interaction between genetic and environmental factors (GxE)",
    "interaction effect of diagnostic group and reward condition",
    "interaction effects",
    "interactions",
    "interactions with parents and peers",
    "interactive effect of moderators",
    "interand intra-patient variability",
    "interestingly",
    "interference",
    "interference control",
    "intermediate phenotype group",
    "internal focus",
    "internalizing disorder",
    "internalizing disorders",
    "internalizing problems",
    "international leaders",
    "internet",
    "internet access",
    "interpersonal",
    "interpersonal domain of communicating DD",
    "interpersonal relationships",
    "interpretation",
    "interpretation biases",
    "interpretation of results",
    "interspecies communication in dogs",
    "interventions",
    "interview guide",
    "interviewed subjects",
    "interviewees",
    "interviews",
    "intoxicants",
    "intra- and inter-network dynamic communication",
    "intra- and inter-network interactions",
    "intractable case conference",
    "intractable epilepsy",
    "intron 2 of TPH2",
    "invalid parity information",
    "inventory by teachers",
    "inventory’s predictive ability",
    "inversely correlated with negative symptoms",
    "investigating the relationship between HM and the trait of interest",
    "investigators",
    "irritability",
    "irritable",
    "it",
    "journal",
    "journal article",
    "journal.pone.0245113",
    "jurisprudence",
    "juvenile delinquency",
    "key factors",
    "key factors/attributes",
    "kidnapping or epilepsy surgery",
    "knockdown",
    "knockdown approach",
    "knockdown of Iqsec2",
    "knockout mouse",
    "knockout mouse model",
    "knowledge gap",
    "knowledge of the prevalence of CC",
    "knowledge on ED",
    "lack of a significant effect",
    "lack of impulse control",
    "lack of objective thinking process",
    "lack of time",
    "lack of training",
    "language and adaptive functioning",
    "language characteristics",
    "language impairment",
    "language milestones",
    "language problems",
    "language scores",
    "language structure",
    "language subdomains",
    "language/communication disorders",
    "large 1-year observational study",
    "large European sample",
    "large datasets",
    "large genome-wide studies",
    "large sample",
    "large samples",
    "large study",
    "large-scale functional networks",
    "larger randomized controlled trials",
    "larger sample sizes",
    "larger samples",
    "largest strongly connected component",
    "largest strongly connected component (LSC)",
    "late embryonic periods",
    "latent factors",
    "latent traits",
    "later",
    "later development of substance use disorders",
    "later onset of ADHD",
    "law",
    "law enforcement",
    "learning activities at school",
    "learning objective",
    "left",
    "left and right columns",
    "left anterior temporal lobectomy",
    "left handers",
    "left hemisphere",
    "left primary motor cortex",
    "left temporal lobectomy",
    "legal evidence",
    "legal guardians",
    "legal liability",
    "legal obligation",
    "legal principle",
    "legal procedure",
    "leisure activities",
    "length of the relationship",
    "length of time",
    "lentiviral particles",
    "lentiviral transduction",
    "lesion studies of mind wandering",
    "less cohesive",
    "less dominant interactions",
    "less emphasis in the main story plot",
    "less impaired",
    "less interaction with parents",
    "less overall recall of story units",
    "less research",
    "less sustained use of the goal plan",
    "less syntactic flexibility",
    "less-negative attitudes",
    "level of nicotine dependence",
    "levels of adherence",
    "lexical",
    "life transitions",
    "life-like environments",
    "lifestyle changes",
    "lifetime mental health disorders",
    "lifetime prevalence",
    "like",
    "likelihood ratio chi-square",
    "limitations",
    "limited allocation for reservations",
    "limited duration",
    "limited evidence from the US",
    "limited number",
    "limited number of treatment practices",
    "limited the sample",
    "limits",
    "linear model",
    "link",
    "linkage",
    "linkage disequilibrium",
    "linkage disequilibrium window",
    "links between anxiety and reduced mental flexibility (shifting)",
    "liquid- or gas chromatography-tandem mass spectrometry",
    "lisdexamfetamine dimesylate",
    "list",
    "listening",
    "literature",
    "literature review",
    "literature search terms",
    "literature searches",
    "literatures",
    "local Danish shooting associations",
    "local ethics committees (Centrale Commissie Mensgebonden Onderzoek)",
    "local institutional ethical review board",
    "local public middle school",
    "local shooting associations in Denmark",
    "lockdown",
    "log2 transformation",
    "logistic LeGris Borderline Personality Disorder and Emotion Dysregulation",
    "logistic regression",
    "logit model",
    "long and short-range recurrences of nodes",
    "long range FC",
    "long-acting formulations",
    "long-acting medications",
    "long-acting stimulants",
    "long-range recurrence",
    "long-range recurrences",
    "long-term effects",
    "long-term effects of methylphenidate",
    "long-term nature",
    "long-term therapy",
    "long-term treatment",
    "long-term treatment with methylphenidate",
    "long-term treatment with stimulant drugs",
    "longer break",
    "longer duration",
    "longer duration of ADHD symptom control",
    "longer duration of stimulant use",
    "longer duration of symptom control",
    "longer term gain",
    "longer time frame",
    "longitudinal data",
    "longitudinal design",
    "longitudinal prevalence study",
    "longitudinal studies",
    "longitudinal studies on DDX3X syndrome",
    "longitudinal study",
    "longitudinal twin modelling",
    "longitudinally",
    "longrange recurrences",
    "loops of one node",
    "loops of one node (L1)",
    "lorazepam",
    "loss of appetite",
    "loss of power",
    "loss-of-function variants in IQSEC2",
    "low (top pair; no ADHD symptoms)",
    "low ADSA category",
    "low SB",
    "low VCI",
    "low back pain",
    "low birth weight",
    "low categories",
    "low educational achievement",
    "low educational attainment",
    "low income",
    "low levels of PA",
    "low levels of some vitamins",
    "low levels of tic symptoms",
    "low maternal warmth",
    "low overlap",
    "low pain/temperature",
    "low parental warmth",
    "low positive environments",
    "low positive peer afﬁliation",
    "low reliability",
    "low score subgroup",
    "low screen time",
    "low socioeconomic status",
    "low verbal comprehension ability",
    "low warmth",
    "low-birth-weight births",
    "low-quality expression profiles",
    "lower LSC",
    "lower RoS threshold",
    "lower birth weight (42500 g)",
    "lower birth weights",
    "lower childhood IQ",
    "lower connectedness",
    "lower hit rate",
    "lower intellectual, language, and adaptive functioning",
    "lower prevalence of ADHD",
    "lower self-control",
    "lowest SES",
    "luciferase",
    "lunch",
    "lymphocytes",
    "macro- and micronutrients",
    "magnetophathy",
    "main contribution of this study",
    "main diagnosis",
    "main effect of diagnostic group",
    "main effect of reward condition",
    "main limitation of our study",
    "main pain",
    "main plot",
    "main psychopathological problem",
    "major depression disorder",
    "major depressive disorder",
    "major depressive disorder (MDD)",
    "major themes",
    "majority of respondents",
    "majority of the participants",
    "maladaptive behavior",
    "male",
    "male ADHD patients",
    "male TD children",
    "male adults",
    "male controls",
    "male gender",
    "male inmates",
    "male participant",
    "male participants",
    "male patients",
    "male pupils",
    "male to female ratio",
    "male/female",
    "male/female ODD ratio",
    "males",
    "males and females",
    "malfunction of patients",
    "mammalian brain",
    "management",
    "mandatory programs",
    "manual midline crossing",
    "manufacturers",
    "manuscript",
    "marginal rates of substitution",
    "marihuana users",
    "married, single, divorced",
    "martial status",
    "material",
    "maternal 5-HTT",
    "maternal EE",
    "maternal age at childbirth",
    "maternal alcohol drinking during pregnancy",
    "maternal cigar_ette smoking",
    "maternal criticism",
    "maternal deprivation",
    "maternal expressed emotions (EEs)",
    "maternal interpersonal afﬁliation",
    "maternal overprotection/control",
    "maternal pregnancy risk exposures and complications",
    "maternal psychological distress",
    "maternal report",
    "maternal report scores",
    "maternal reports",
    "maternal scoring",
    "maternal warmth",
    "maturation",
    "mature spines",
    "maximizing ADHD symptom control",
    "maximum likelihood with robust standard error (MLR)",
    "maximum of only 2 weeks",
    "maximum variation sampling",
    "mean",
    "mean (s.d.)",
    "mean 33.60±21.79 months",
    "mean ADHD symptom count",
    "mean Diffusivity",
    "mean absolute discrepancy score",
    "mean age",
    "mean age at diagnosis",
    "mean age at first alcohol use",
    "mean age at first drug use",
    "mean age at first nicotine use",
    "mean age at first substance use",
    "mean age of the participants",
    "mean delay",
    "mean deviation",
    "mean educational level",
    "mean number of substance misuse diagnoses",
    "mean number of substance use disorders diagnoses",
    "mean severity of tic symptoms",
    "mean situational pervasiveness of ADHD",
    "mean subscale scores",
    "meaningful information",
    "measurement of pain",
    "measurement of the outcome",
    "measurement tools",
    "measurements of the prevalence of CC",
    "measures",
    "measures of executive functioning",
    "meat products",
    "mechanical controlled-release systems",
    "mechanisms underlying the increased risk of substance use disorders",
    "media",
    "media change",
    "media consumption",
    "media related behavior",
    "media time",
    "media times",
    "media use",
    "median age",
    "median±SD",
    "mediating mechanisms",
    "medical and mental health professionals",
    "medical and surgical areas",
    "medical care systems",
    "medical comorbidities",
    "medical evaluation",
    "medical evaluations",
    "medical history",
    "medication",
    "medication adherence",
    "medication adherence in ADHD",
    "medication attributes",
    "medication history",
    "medication non-adherence",
    "medication use",
    "medication use history",
    "medication-free period",
    "medication-naı̈ve children",
    "medications",
    "medicines other than methylphenidate",
    "medium",
    "medium effect sizes",
    "membrane trafﬁcking",
    "memory",
    "memory functionality",
    "memory recall of events",
    "memory span",
    "men",
    "men with ADHD",
    "mental health",
    "mental health disorder",
    "mental health disorders",
    "mental health indicators",
    "mental health internalizing disorders",
    "mental health issues",
    "mental health outcomes",
    "mental health problems",
    "mental health problems/demands",
    "mental health professionals",
    "mental illness",
    "mental model generation",
    "mental status",
    "meta-analyses",
    "meta-analysis",
    "metadoxine",
    "methodological limitations",
    "methodology",
    "methylphenidate",
    "methylphenidate administration",
    "methylphenidate at different doses",
    "methylphenidate group",
    "methylphenidate prescriptions",
    "methylphenidate treatment",
    "methylphenidate-naïve",
    "methylphenidate-naïve participants",
    "metropolitan",
    "microbiological assays",
    "microcephaly",
    "mid-20s",
    "migratory origin",
    "mild cortical atrophy",
    "mild intellectual disability",
    "mild symptoms",
    "military",
    "milk and alternatives",
    "mind wandering",
    "mind wandering tendency",
    "mindfulness",
    "mindfulness-based stress reduction program",
    "mindfulness-based treatments",
    "minimal clinically important difference (MCID) in CSI-4 scores",
    "minimally effective dose of mindfulness",
    "minimizing side effects",
    "minimum of 3-week duration",
    "misinterpretations",
    "missense",
    "missense mutation",
    "missense variants",
    "missense variants/in-frame deletions",
    "missense/in-frame deletion variants",
    "missense/in-frame deletions",
    "missing data",
    "missing one or more doses",
    "missing outcome data",
    "mixed amphetamine salts",
    "mixed method",
    "mixed or inconsistent findings",
    "mixed or multiple convictions",
    "mixed-effects regression models",
    "mobile devices",
    "modafinil",
    "modalities",
    "model 2",
    "model fit",
    "model specification",
    "models",
    "moderate choices",
    "moderate overlap",
    "moderate to severe ADHD",
    "moderation",
    "moderators",
    "modes of administration",
    "modifiable risk factors",
    "modiﬁed version of the MID task",
    "modiﬁed version of the monetary incentive delay (MID) task",
    "module eigengene",
    "module eigengenes",
    "module membership",
    "modules",
    "modules of interest",
    "molecular constituents",
    "molecular diagnosis",
    "monetary rewards",
    "monitoring",
    "monitorization and autocorrection of speech",
    "monocytes",
    "monogenic causes",
    "month",
    "mood disorders",
    "mood regulation",
    "mood stabilisers",
    "more bedtime eating behaviors",
    "more children",
    "more difficulties with global coherence",
    "more difficulty producing a grammatical and fluent utterances",
    "more difficulty then controls to detect sequence errors",
    "more efforts",
    "more inaccurate information",
    "more medicines",
    "more natural user interface (UI)",
    "more poorly connected report",
    "more problems at home",
    "more production of ambiguous references",
    "more recent approach",
    "more sequence errors",
    "more severe ADHD-related symptoms",
    "more severe clinical outcome",
    "more severe clinical presentation",
    "more short-range recurrences",
    "more than 30 years of research",
    "more than 95%",
    "more than two of the diagnoses",
    "more verbose",
    "moreover",
    "morning and lunch recess",
    "morphological plasticity",
    "morphology",
    "morphosyntax",
    "most commonly used treatments",
    "most studies investigating ADHD and language",
    "mother",
    "mother reported Hyperactivity-Impulsivity",
    "mother-reported hyperactivity-impulsivity",
    "mother’s educational attainment",
    "motivational/emotional pathways",
    "motivations",
    "motivations for smoking",
    "motor",
    "motor and sensory skills",
    "motor delays",
    "motor tics",
    "mouse anti-FLAG",
    "mouse anti-tau",
    "mouse hippocampal neurons",
    "mouse strains",
    "mouse β-actin",
    "movement disorders",
    "ms",
    "multi-dose administration",
    "multidimensional construct",
    "multidimensional features of thought contents",
    "multidisciplinary team",
    "multimodal interventions",
    "multimodal recordings",
    "multiple births",
    "multiple comparisons correction",
    "multiple dosing",
    "multiple measures and multiple informants",
    "multiple sclerosis",
    "multiple-pathway approaches",
    "multiplicity of infection",
    "multivariate analysis of variance model",
    "multivariate logistic regression models",
    "multivitamins and minerals",
    "mutual decision-making with their parents",
    "myopia",
    "myriad of ADHD-related deficits",
    "n",
    "n (%)",
    "n = 1,352",
    "n = 18",
    "n = 20",
    "n = 290",
    "n = 339",
    "n KME",
    "n%",
    "n-Back Accuracy",
    "n-back",
    "n-back task",
    "n=1 2 0",
    "n=10",
    "n=18",
    "n=19",
    "n=24",
    "n=25",
    "n=37",
    "n=not mentioned",
    "nASD",
    "nCOM",
    "narcolepsy",
    "narrate a story",
    "narrative discourse",
    "narrative discourse problems",
    "narrative discourse production",
    "narrative discourses",
    "narrative production",
    "narrative production instructions",
    "narratives resembling those produced by younger children",
    "narrow age range",
    "narrow scope",
    "nasal congestion",
    "nasopharyngitis",
    "native Brazilian",
    "naturalistic and non-randomised",
    "nature of the sample collection",
    "nausea",
    "need",
    "negative EE or peer afﬁliation",
    "negative aspects",
    "negative environmental measures",
    "negative environments",
    "negative or positive association",
    "negative perceptions",
    "negative perceptions of DD",
    "negative provocation test",
    "negative screening group",
    "negative social",
    "negative social environment",
    "negative urgency",
    "neighborhood",
    "nervousness",
    "net IGT performance",
    "net decision making",
    "net decision scores",
    "network analysis",
    "network-based approach",
    "neural activation",
    "neural activation in regions of interest during reward anticipation",
    "neural correlates of reward sensitivity/processing",
    "neural data",
    "neural markers of individual trait-like qualities",
    "neural mechanisms",
    "neural responses",
    "neural substrates of mind wandering",
    "neural systems",
    "neurite processes",
    "neuro-behavioral models of addiction",
    "neurobehavioral and psychiatric manifestations",
    "neurocognitive correlates",
    "neurodevelopmental disorder",
    "neurodevelopmental disorders",
    "neurogenesis",
    "neuroimaging",
    "neuroimaging studies",
    "neurological",
    "neurological examination",
    "neurological function",
    "neurological phenotype",
    "neurological symptoms",
    "neurologically relevant functions",
    "neuronal axons",
    "neuronal complexes",
    "neuronal connectivity",
    "neuronal cultures",
    "neuronal morphology",
    "neurons",
    "neurophysiological evidence",
    "neurophysiological plausibility",
    "neuropsychiatric dimensions of DDX3X syndrome",
    "neuropsychiatric features",
    "neuropsychological assessment",
    "neuropsychological evaluation",
    "neuropsychological evaluation process",
    "neuropsychological measure of IQ",
    "neuropsychological test data",
    "neuropsychological testing",
    "neuropsychological tests",
    "neuropsychological variables",
    "neuroradiology",
    "neurostimulation",
    "neurotic disorders",
    "neutrophils",
    "new formulations",
    "new pathways",
    "news",
    "nicotine dependence",
    "nicotine dependency",
    "nicotine replacement therapy",
    "nicotine use",
    "night waking",
    "night waking (three items)",
    "night waking problems",
    "nightmares",
    "nine participants",
    "nine very young participants",
    "nitrocellulose membrane",
    "no difference",
    "no differences",
    "no significant difference",
    "no single questionnaire",
    "no-CC",
    "no-stimulant",
    "no-stimulant group",
    "no-stimulant treated group",
    "no-stimulant treatment",
    "no-stimulant treatment group",
    "no-stimulant treatment v. stimulant treatment",
    "nominal compensation",
    "non-ADHD",
    "non-ADHD children",
    "non-ADHD girls",
    "non-ADHD group",
    "non-adaptation group",
    "non-adaptations grouping",
    "non-adherence",
    "non-adherence in ADHD",
    "non-adherence on HRQoL in ADHD",
    "non-adherence to ADHD medication",
    "non-adherence to ADHD medications",
    "non-adherence to medication",
    "non-adherent patients",
    "non-carriers",
    "non-invasive Tasso sampling kit (Tasso inc.)",
    "non-medical use of ADHD medications",
    "non-referred school sample",
    "non-reward",
    "non-reward condition",
    "non-reward reaction times",
    "non-rewarded reactions times",
    "non-serious side effects",
    "non-significant",
    "non-stimulant ADHD medication",
    "non-stimulant medications",
    "non-stimulant therapies",
    "non-stimulants",
    "non-symptomatic group",
    "non-syndromic ID",
    "non-verbal",
    "nonadaptation group",
    "nonlinear age effects",
    "nonlinear effects of age",
    "nonpharmacological interventions",
    "nonremitters",
    "nonremitters during prior MPH treatment",
    "nonremitters on prior MPH",
    "nonstimulant products",
    "nonsyndromic ID genes",
    "nonsyndromic intellectual disability",
    "nonverbal IQ",
    "norepinephrine",
    "norm-referenced standardized CHIP-CE T-scores",
    "norm-referenced standardized CSI-4 scores",
    "normal controls",
    "normal development of these skills",
    "normal population",
    "normalisation",
    "not mentioned",
    "note",
    "notwithstanding",
    "novel environment",
    "novel quantitative approach",
    "novel sensory biomarker assessment (SAND)",
    "novel ﬁndings",
    "nucleotide and neurotransmitter synthesis",
    "nucleus accumbens",
    "nuisance covariate",
    "null findings concerning nicotine dependence",
    "number",
    "number of attributes",
    "number of hours daily",
    "number of hours per day",
    "number of omission errors",
    "number of patients",
    "number of successful inhibitions",
    "number of tests",
    "number of words",
    "number-needed-treat",
    "numbers",
    "numbers in parentheses",
    "numerous studies",
    "nutrient intake",
    "nutritional supplements",
    "nystagmus",
    "objective measure of adherence",
    "obligated to deliver the diagnosis",
    "observation",
    "observation-only and psychotherapy groups",
    "observational cross-sectional clinical study",
    "observational design",
    "observational study",
    "observed SRS score",
    "observed pattern",
    "obsessive compulsory disorder (OCD)",
    "obsessive thoughts",
    "obsessive-compulsive behaviors",
    "obsessive-compulsive disorder",
    "obtained converging evidence",
    "occasional sharp wave discharges",
    "occupational or interpersonal difficulties/failures",
    "ocular phenotype",
    "ocular/vision abnormalities",
    "odds ratio",
    "of the variance",
    "off medication",
    "off-label",
    "offender",
    "offspring missing maternal identification numbers",
    "offspring psychiatric and socioeconomic problems",
    "offspring with missing birth weight",
    "offspring with no information regarding gender",
    "older adolescents",
    "older age",
    "older children",
    "older people",
    "older psychiatrists",
    "oligophrenin (OPHNI)",
    "omitted",
    "omitted between-patient covariates",
    "once at most",
    "once per day",
    "once-daily ADHD medications",
    "oncedaily dosing",
    "one",
    "one forwardand one back-translation methodology",
    "one hemisphere",
    "one in four patients",
    "one individual",
    "one of the 18 DSM-IV (Diagnostic and Statistical Manual of Mental Disorders-IV) symptoms of ADHD",
    "one of these studies",
    "one or more TEAEs",
    "one patient",
    "one showed persistent symptom",
    "one study",
    "one variant",
    "one-stage stratified random sampling design",
    "ongoing",
    "online Fig. DS2",
    "online activities",
    "online application",
    "online consent",
    "online monitorization and organization of discourse",
    "online questionnaire",
    "online survey",
    "online task/experience sampling",
    "onset of ADHD",
    "onset of effect",
    "open",
    "open trial",
    "open-access",
    "open-ended interview",
    "open-label",
    "open-label studies",
    "opinions",
    "opportunities to share and reflect",
    "opposite associations",
    "opposite direction of effects",
    "opposite sex pairs",
    "oppositional defiant disorder",
    "oppositional defiant disorder (ODD)",
    "oppositional defiant disorder in youth",
    "oppositional deﬁance disorder",
    "optimal energetic state",
    "optimal reward learning",
    "optimal smoking cessation intervention",
    "optimal treatment option",
    "oral narrative",
    "oral, once-a-day therapy",
    "orbitofrontal cortex",
    "original ASD sample",
    "original US norms",
    "original author(s)",
    "original authors",
    "original version of the task",
    "orthopedic treatments",
    "osmotic release oral system",
    "other adverse events",
    "other attributes of treatment",
    "other children living at home",
    "other data",
    "other excessive media use",
    "other forums",
    "other internalizing problems",
    "other organizations",
    "other populations",
    "other psychiatric diagnoses",
    "other sensitivities",
    "other studies",
    "other treatment",
    "other variants",
    "other-report",
    "other-reports",
    "other-version",
    "others",
    "our cohort",
    "our finding",
    "our findings",
    "our institution",
    "our knowledge",
    "our model",
    "our pediatric epilepsy center",
    "our previous study",
    "our psychiatric clinic",
    "our psychiatrists",
    "our result",
    "our results",
    "our study",
    "our study design",
    "our study findings",
    "ours",
    "out-of-pocket payments",
    "out-patient clinics",
    "outcome assessors",
    "outcome measures",
    "outcomes",
    "outcomes of and behavioral responses to ADHD",
    "outlier",
    "outpatient day procedures",
    "over half of individuals",
    "overall",
    "overall ASRS",
    "overall IQ",
    "overall IQ test",
    "overall TS",
    "overall absolute discrepancy score",
    "overall balance",
    "overall effect of stimulant medication",
    "overall efficacy population",
    "overall findings",
    "overall length of the survey",
    "overall mean trial duration",
    "overall medication non-adherence",
    "overall percentage",
    "overall population",
    "overall sample",
    "overall study group",
    "overall study population",
    "overestimation",
    "overexpress",
    "overexpression",
    "overexpression studies",
    "overinvolvement",
    "overlap between the three clinical groups",
    "overlapping genes",
    "overlapping patterns of gene expression",
    "overlapping waves",
    "oversampled",
    "oversampling of children",
    "overweight",
    "p",
    "p < 0.001",
    "p < 0.01",
    "p < 0.05",
    "p,0.05",
    "p-value",
    "p-values",
    "p.Arg292Leu",
    "p.Arg292Leu variant",
    "p.Gln241Hisfs*53",
    "p.Gln308*",
    "p.Glu285Lys",
    "p21 protein (Cdc42/Rac)-activated kinase 3 (PAK3)",
    "pADI-",
    "pCAGGS",
    "pCAGGSFLAGIQSEC2",
    "pDSM ADHD",
    "pPONS ADHD",
    "pSDQ ADHD",
    "pacing",
    "pain",
    "pain distribution",
    "pain during the last 3 months",
    "pain during the last three months",
    "pain medications",
    "pain perception",
    "pain perception sample",
    "pairwise Pearson correlation coefficients",
    "pairwise connection strengths",
    "pan-European",
    "panel",
    "parameter pairwise comparisons",
    "parameters",
    "parasomnias",
    "parasomnias (seven items)",
    "parasomnias problems",
    "parent",
    "parent choice",
    "parent preference data",
    "parent ratings",
    "parent ratings of WM difficulties",
    "parent ratings of children with elevated levels of ADHD symptoms",
    "parent ratings of early WM",
    "parent report",
    "parent's reporting",
    "parent-completed questionnaire",
    "parent-reported difficulties",
    "parent-reported version of the ADHD Rating Scale-IV (ADHDRS-IV)",
    "parent/guardian(s)",
    "parent/teacher",
    "parental and peer factors",
    "parental answer",
    "parental consent",
    "parental education",
    "parental emotional difficulties",
    "parental informed consent forms",
    "parental inﬂuences in adolescence",
    "parental latent factor",
    "parental preferences",
    "parental psychological distress",
    "parental report of substance use disorders",
    "parental reporting latent factor",
    "parental support",
    "parental warmth",
    "parental- and peer inﬂuences",
    "parents",
    "parents and teacher",
    "parents and/or primary carers",
    "parents at home",
    "parents in France",
    "parents in School C",
    "parents in such family",
    "parents in the US",
    "parents of adolescents",
    "parents of children",
    "parents of children and adolescents",
    "parents of children in Italy",
    "parents of children in Spain",
    "parents of children/adolescents with ADHD",
    "parents of younger children",
    "parents or caregivers",
    "parents were asked to make",
    "parents who favored treatment in general",
    "parents who suffer from psychological distress",
    "parents' ratings",
    "parents/ caregivers",
    "parents/caregivers",
    "parents/guardians",
    "parents/other care­ givers",
    "parents’ behavioral ratings",
    "parents’ retrospective evaluations",
    "parent’s and teacher’s criteria",
    "parsimony",
    "partial loss of function of a particular gene",
    "participant",
    "participant Page 5 of 10 groups",
    "participant and informant",
    "participant characteristics",
    "participant group",
    "participant with polymicrogyria",
    "participants",
    "participants above the age of 12",
    "participants between 4 and 65 years of age",
    "participants not treated with stimulants",
    "participants of the category ‘ADHD with MPH’",
    "participants of the study",
    "participants receiving the drug",
    "participants that did not receive stimulant treatment",
    "participants themselves",
    "participants treated with stimulants",
    "participants who start stimulant medication early",
    "participants who were treated",
    "participants with ADHD",
    "participants with a diagnosis of ADHD",
    "participants with and without ADHD",
    "participants with full phenotype data",
    "participants with nicotine dependence",
    "participants with prior exposure to methylphenidate",
    "participants without ASD",
    "participants’ choices (dependent variable)",
    "participants’ current medication",
    "participants’ variant type",
    "participate",
    "participate in our studies",
    "participating children",
    "participating schools",
    "participation",
    "participation rate",
    "participation rates",
    "particles of virus",
    "particular breeds38",
    "particular samples",
    "particularly",
    "past",
    "past studies",
    "patient",
    "patient clinical characteristics",
    "patient demographic characteristics",
    "patient medical records",
    "patient mutations",
    "patient mutations in IQSEC2",
    "patient outcomes",
    "patient preferences",
    "patient reported outcome",
    "patient subgroups",
    "patient/parent preferences",
    "patient/parent satisfaction",
    "patients",
    "patients and their families",
    "patients attending a private clinic",
    "patients defined as ADHD cases",
    "patients from East Asia",
    "patients in public outpatient clinics",
    "patients included in our study",
    "patients living in East Asia",
    "patients living in East Asia and Central Europe",
    "patients who were nonadherent during follow-up",
    "patients with ADHD",
    "patients with ADHD cases",
    "patients with ASD",
    "patients with X-linked mental retardation",
    "patients with epilepsy",
    "patients with features of Rett syndrome",
    "patients with fragile-X syndrome",
    "patients with schizophrenia",
    "patients with various mutation types in IQSEC2",
    "patients/participants",
    "patients’ behaviors and function­ alities",
    "patients’ features",
    "patients’ requirements",
    "patients’ treating physicians",
    "patients’ treatment choices",
    "patient’s right to know",
    "pattern of findings",
    "pauses",
    "pediatric neurologist",
    "pediatric patients",
    "pediatric patients with ADHD",
    "peer afﬁliation",
    "peer afﬁliations",
    "peer victimization",
    "peers",
    "pemoline",
    "pen and paper tasks",
    "people",
    "people with ADHD",
    "people with chronic diseases",
    "per-protocol (PP) analysis",
    "perceived risks",
    "percentage",
    "perception of disorders",
    "perception of the degree of coping",
    "perception of the family’s readiness",
    "perception of visual stimuli",
    "perceptions",
    "perceptions and attitudes of psychiatrists",
    "perceptions of severity",
    "perceptual decoupling",
    "perceptual reasoning",
    "performance",
    "performance accuracy results",
    "performance accuracy to be unimpaired",
    "performance between the groups",
    "performance deficits",
    "performance time",
    "performance-based measures",
    "performed analyses",
    "period of between 11 and 21 days",
    "permanent residents",
    "personal data",
    "personal data and information",
    "personal distress",
    "personality disorders",
    "personel data",
    "persons with ADHD",
    "perspective taking",
    "perspectives of psychiatrists",
    "pervasive developmental disorder",
    "phalloidin-stained",
    "pharmaceutical companies",
    "pharmacodynamic profile",
    "pharmacokinetic profile",
    "pharmacologic treatment",
    "pharmacologic treatments",
    "pharmacological support",
    "pharmacology",
    "pharmacotherapy",
    "phenotype means",
    "phenotype of interest",
    "phenotypes of interest",
    "phenotypic correlation",
    "phenotypic correlations",
    "phenotypic expression",
    "phenotypic heterogeneity",
    "phenotypic information",
    "phenotypic, genetic and environmental correlations",
    "phonic",
    "phonic tics",
    "phonic, motor and obsessive-compulsive TS-like behaviors",
    "phonological",
    "phosphate-buffered saline (PBS)",
    "photos",
    "physical",
    "physical activities",
    "physical activity",
    "physical education teacher",
    "physical health",
    "physical or psychosocial functioning",
    "physical or/and mental illness",
    "physically active",
    "physically inactive",
    "physician",
    "physician and patient versions",
    "physician assessment of adherence",
    "physician claims database",
    "physician clinical judgment",
    "physician diagnosis",
    "physician services and claims database",
    "physician-rated version",
    "physicians",
    "physicians’ diagnoses",
    "physicians’ services and billing information",
    "physiological and biochemical processes",
    "physiological need and homeostatic imbalance",
    "physiological side effects",
    "pill counts",
    "pilot randomized control trial",
    "pilot study",
    "place of residency",
    "placebo",
    "placebo arm",
    "placebo group",
    "placebo-controlled",
    "planning",
    "planning drawing task",
    "plasticity alleles",
    "plasticity variant",
    "playing computers or video games",
    "pleiotropy",
    "plv-C-shRNA",
    "pmaxGFP DNA",
    "police",
    "poly-L-lysine",
    "polygenic risk score analysis",
    "polygenic risk scores",
    "polymicrogyria",
    "polymorphism",
    "polymorphisms",
    "polymorphisms in SEZ6L",
    "pooled odds ratios",
    "poor DM in BPD women",
    "poor IGT DM",
    "poor IGT DM in BPD women",
    "poor IGT Performance",
    "poor IGT performance",
    "poor IGT performance in women with BPD",
    "poor adherence",
    "poor adherence to IR-MPH",
    "poor comprehension of main plotline",
    "poor diet quality",
    "poor family support",
    "poor mental health",
    "poor self-control",
    "poor self-esteem",
    "poor social outcomes",
    "poor turn-taking",
    "poorer EF",
    "poorer diet quality",
    "poorer mental flexibility",
    "poorer sleep quality",
    "population-based data-set",
    "population-based studies",
    "positive EE or peer afﬁliation",
    "positive and deviant peer afﬁliation",
    "positive and negative effects",
    "positive and negative environments",
    "positive and negative social environments",
    "positive attributes",
    "positive environments",
    "positive feedback",
    "positive influences",
    "positive parenting",
    "positive peer afﬁliation",
    "positive perception of DD",
    "positive predictive value",
    "positive social environment",
    "positive social environments",
    "positive social interactions with parents",
    "positive social inﬂuences",
    "positive stimuli",
    "possible age- and disorder specific links between behavioral dysregulation and ADHD symptoms",
    "possible causes",
    "possible confounding factors",
    "possible covariates",
    "possible drug use disorders",
    "possible links between early symptoms of ADHD and parent ratings of EF",
    "post hoc analysis",
    "post-hoc analyses",
    "post-hoc analysis",
    "post-hoc comparisons",
    "postal invitation",
    "postmovement measurements",
    "postsynaptic density",
    "postsynaptic inhibition of dopamine",
    "postsynaptic scaffolds",
    "potential addiction",
    "potential alternative models in disease",
    "potential attributes",
    "potential conflict of interest",
    "potential dominant negative variants",
    "potential for abuse",
    "potential for misuse",
    "potential for treatment abuse",
    "potential of treatment being abused/ misused",
    "potential participants",
    "power analysis",
    "power calculations",
    "power distributions",
    "power loss",
    "power of detecting some brain changes",
    "power of our analyses",
    "power to detect effects",
    "practical and ethical issues",
    "practising target-shooting sports",
    "pragmatic",
    "pragmatic problems",
    "pre-CBT psychological examination",
    "pre-Corona",
    "pre-Corona levels",
    "pre-supplementary motor area",
    "preadolescence",
    "preclinical genomics",
    "preclinical research",
    "precocious puberty",
    "predefined number of participants",
    "predictable setting",
    "predicted probability",
    "predicted two additional outcomes",
    "prediction effect sizes",
    "predictions",
    "predictive modeling studies",
    "predictor",
    "predictor models",
    "predictors of medication non-adherence in ADHD",
    "predictors of medication non-adherence in the treatment of ADHD",
    "predictors of sleep length and sleep problems",
    "predominantly hyperactivity/impulsivity (ADHD-HI)",
    "predominantly inattentive (ADHD-I)",
    "preference",
    "preference and performance",
    "preference item combinations",
    "preference research",
    "preferences",
    "preferences and attributes",
    "preferences for verbal information",
    "preferences of parents",
    "preferred",
    "preferred hand",
    "prefrontal cortex",
    "pregnant Swiss dams",
    "preliminary",
    "premature births",
    "premature death",
    "prenatal and neonatal complications",
    "prenatal and perinatal factors",
    "prenatal passive exposure to tobacco smoke",
    "prenatal risk factors",
    "prenatal smoking",
    "preschool children",
    "preschool period",
    "preschool studies",
    "prescribed psychotropics",
    "prescribing decisions",
    "prescribing patterns",
    "prescription medication",
    "presence of ADHD",
    "presence of reward",
    "present",
    "present findings",
    "present one",
    "present sample",
    "present studied sample",
    "present study",
    "presupposition",
    "presurgical evaluation",
    "presynaptic compartment",
    "prevalence",
    "prevalence of ADHD",
    "prevalence of ASD",
    "prevalence of CC",
    "prevalence of diagnosis",
    "prevalence rates",
    "prevalence rates of criminality and morbidity",
    "prevention and treatment of substance use disorders",
    "previous MPH treatment",
    "previous descriptions",
    "previous evidence",
    "previous exposure to methylphenidate",
    "previous findings",
    "previous four weeks",
    "previous miscarriage",
    "previous research",
    "previous studies",
    "previous studies of night eating syndrome",
    "previous study",
    "previous week",
    "previously pooled analysis",
    "previously reported studies",
    "previously used in a few psychiatric disorders",
    "primary and high schools",
    "primary caregivers",
    "primary diagnoses of internalizing disorders",
    "primary hippocampal cultures",
    "primary hippocampal neurons",
    "primary language components",
    "primary organic factors",
    "primary outcome",
    "primary outcome of well-being",
    "primary outcomes",
    "primary school",
    "primary school pupils",
    "primary sensory and motor regions in SMNA",
    "primary sensory regions",
    "primary sensory/motor regions",
    "primer sequences",
    "principal story plot",
    "prior MPH participants",
    "prior MPH therapy",
    "prior MPH treatment",
    "prior findings",
    "prior studies",
    "prison inmates",
    "prison populations",
    "prisoner",
    "prisons",
    "privacy issues",
    "private outpatient non-inmate psychiatric clinic",
    "probability",
    "probands and affected siblings",
    "probands with ADHD",
    "probands with combined type ADHD",
    "probation",
    "probes with high module membership",
    "problem solving",
    "problematic or violent video games",
    "problems",
    "problems with syntactic planning",
    "process of DD",
    "process outcomes",
    "processes",
    "processing speed",
    "prodrug technology",
    "product profiles",
    "production difficulties",
    "professional",
    "professional experience",
    "professionals",
    "profile of impairment",
    "program O-005",
    "progressive muscle relaxation",
    "prohibited",
    "prohibited content",
    "project",
    "project collection and sample handling batch effects",
    "project support",
    "projective VR",
    "promoter rs4570625",
    "prone to crying",
    "proper management",
    "proportions",
    "prospective and in-person analyses",
    "prospective neuropsychological",
    "prospective studies",
    "prospective studies reported here",
    "prospective study",
    "prospective, integrated studies",
    "prospective, longitudinal study",
    "protected physical space",
    "protective effect",
    "protective effect of age at first stimulant use",
    "protective effect of stimulant therapy",
    "protective effect of stimulant treatment",
    "protective effect of stimulant use",
    "protective effects",
    "protein-truncating variants",
    "protocol",
    "protocol deviations",
    "protocol version",
    "protrusions",
    "province of Alberta",
    "proxies",
    "proximity of the reward",
    "ps",
    "psychiatric assessments",
    "psychiatric diagnoses",
    "psychiatric disorder",
    "psychiatric disorders",
    "psychiatric morbidity",
    "psychiatric problems",
    "psychiatric rating scales",
    "psychiatric symptoms",
    "psychiatrist",
    "psychiatrists",
    "psychiatry",
    "psycho",
    "psychoactive medication use",
    "psychoeducation",
    "psychogenic aspects of PNES",
    "psychological",
    "psychological counseling",
    "psychological disorders",
    "psychologist",
    "psychomotor restlessness",
    "psychopharmacological drugs",
    "psychopharmacological therapy",
    "psychotherapy",
    "psychotherapy protocol",
    "psychotic disorder",
    "psychotic disorders",
    "psychotic or bipolar disorder",
    "psychotropic use",
    "public health",
    "public health initiatives",
    "public health issue",
    "public registry",
    "public trial registry",
    "publication",
    "publication bias",
    "publication time",
    "published orthogonal array",
    "punishment",
    "pupil diameter",
    "pupils",
    "pupils at all grades of primary school",
    "pupils by teachers",
    "pure (and overall) TS-like behaviors",
    "pure Attention Deficit Disorder (ADD)",
    "purity",
    "purpose",
    "purpose of the tasks",
    "purposeful sampling",
    "putamen regions",
    "putative candidate genes",
    "putative transcriptional control region of TPH2",
    "pyridoxal 5’-phosphate",
    "pyrosequencing",
    "qualitative",
    "qualitative analyses",
    "qualitative data",
    "qualitative methodologies",
    "qualitative or quantitative analyses",
    "qualitative part",
    "quality controlled and preprocessed the data",
    "quality of life",
    "quantitative data",
    "quantitative methodology",
    "quantitative real-time reverse transcriptase PCR",
    "quasi-experimental designs",
    "questionable quality",
    "questionnaire",
    "questionnaires",
    "questions",
    "questions on psychiatric morbidity",
    "quetiapine",
    "quiet room",
    "r",
    "r = 0.10",
    "r = 0.34",
    "rabbit anti-IQSEC3",
    "rabbit anti-hIQSEC2",
    "rabbit anti-βtubulin-III",
    "random allocation sequence",
    "random hexamers",
    "random-effects model",
    "randomization process",
    "randomized",
    "randomized controlled trial",
    "randomized crossover studies",
    "randomized parallel-group studies",
    "randomized participants",
    "randomized, controlled trials",
    "randomly assigned",
    "range",
    "ranking",
    "ranking grams",
    "rapid feedback",
    "rapid onset of action",
    "rare outcomes",
    "rarely reported",
    "rate of maternal depression",
    "rate of medication non-adherence",
    "rate of nonadherence",
    "rate of poor adherence",
    "rate of withdrawal",
    "rater",
    "rates of ADHD",
    "ratings of WM",
    "ratings of change",
    "ratio",
    "rats",
    "raw data",
    "reaction times",
    "reaction to stress",
    "real environment",
    "real life",
    "real or imaginary events",
    "reason for this association",
    "reason through answers/express thoughts",
    "reasons",
    "reassessments",
    "reboxetine",
    "received",
    "receiving LDX",
    "recent analyses",
    "recent meta-analysis",
    "recent review Belsky et al.31",
    "recent review of adherence studies",
    "recent study",
    "recent years",
    "receptive and expressive language skills",
    "receptive language",
    "recidivism",
    "recipient of welfare or disability compensation",
    "reckless driving",
    "recognition",
    "recommended dosing schedule",
    "recreational drug use",
    "recruitment",
    "recruitment of participants",
    "recurrent common infections",
    "recurrent depressive disorders",
    "recurrent variants",
    "red color",
    "reduced ADHD symptoms",
    "reduced connectivity between DMN and putamen",
    "reduced episode frequency",
    "reduced item content",
    "reduced mental flexibility",
    "reduced quality of life",
    "reflexes",
    "refreshed",
    "region",
    "regional activity",
    "regions",
    "regions of signiﬁcance (RoS)",
    "regression",
    "regression analysis",
    "regression model",
    "regular periodic follow-up",
    "regular smoking",
    "regulatory bodies",
    "rehabilitation domains",
    "rehabilitation of children with ADHD",
    "rehabilitation techniques",
    "related outcomes",
    "relationship",
    "relationship between crime and substance use disorders",
    "relationship maladjustments",
    "relationships",
    "relationships with HM",
    "relative power",
    "relative standard curve",
    "relatively benign underlying psychological problems",
    "relatively high IQ values",
    "relatively long-term follow-up study",
    "relatives",
    "relatives of probands with bipolar disorder",
    "relaxation",
    "relevant information",
    "reliability profile",
    "remainder of the patients",
    "remaining authors",
    "remodeling",
    "repeat",
    "repeated edges (RE)",
    "repeated-measures ANOVAs",
    "repetitive transcranial magnetic stimulation",
    "replicating study",
    "replication studies",
    "report conducted in 2009",
    "reported scores",
    "representative module expression profile",
    "reproduced",
    "reproduction",
    "reproduction of a story",
    "require less attention",
    "rescue experiments",
    "research",
    "research assistants",
    "research experience in DD",
    "research focused on delineating the clinical phenotypes and natural history of this syndrome",
    "research questions",
    "research team",
    "research-reliable clinical psychologists",
    "researchers",
    "residential regions",
    "residual covariances",
    "respiratory tract infections",
    "respondents",
    "responders",
    "response",
    "response during follow-up",
    "response inhibition",
    "response inhibition deficits",
    "response rate",
    "response selection interference",
    "response to stress",
    "restfulness",
    "resting-state DMN anticorrelation",
    "resting-state fMRI samples",
    "resting-state literature",
    "restlessness",
    "result",
    "results",
    "results from as early as 1989",
    "results of this study",
    "retrospective",
    "retrospective cohort study",
    "retrospective diagnoses",
    "retrospective information",
    "retrospective studies",
    "return to school",
    "revealed different attitudes",
    "reverse gateway",
    "review by Aagaard and Hansen",
    "review of",
    "revising article critically",
    "reward",
    "reward anticipation",
    "reward centers",
    "reward circuit",
    "reward condition",
    "reward conditions",
    "reward contingencies",
    "reward learning",
    "reward outcome measure",
    "reward processing",
    "reward processing decision probe",
    "reward reaction times",
    "reward receipt",
    "reward receipt activation",
    "reward seeking and impulsive risk taking",
    "reward seeking and impulsivity",
    "reward sensitivity",
    "reward sensitivity was operationalized",
    "reward speeding",
    "reward task",
    "reward valence",
    "reward variability",
    "reward-related behavior",
    "reward-seeking behavior",
    "rewarded and nonrewarded conditions",
    "rewarded vs non-rewarded MRT",
    "rewarding contexts",
    "rewards",
    "rhabdomyolysis",
    "right",
    "right dorsolateral premotor cortex",
    "right handers",
    "right hemisphere",
    "right than left handers",
    "risk factors",
    "risk for development of several psychiatric disorders",
    "risk loci",
    "risk of ADHD",
    "risk of abuse",
    "risk of abuse potential",
    "risk of being diagnosed with autism",
    "risk of loss of appetite",
    "risk of sleep disturbance",
    "risk of substance abuse",
    "risk of vomiting",
    "risks",
    "risks of substance misuse",
    "risky actions",
    "risky and rewarding behaviors",
    "risky behaviors",
    "risky technology use while driving",
    "risperidone",
    "robust association",
    "robust spline normalisation",
    "robustness",
    "role",
    "room temperature",
    "rostrolateral prefrontal cortex",
    "routine therapy",
    "rs-fMRI",
    "rs-fMRI biomarkers",
    "rs-fMRI run number",
    "rs-fMRI scans",
    "rs4565946",
    "rs4570625",
    "rumination in depression and anxiety",
    "rural town",
    "s",
    "s.d.",
    "saccadic eye movement",
    "sadness",
    "safe environments",
    "safe training programs",
    "safety",
    "safety concerns",
    "salient stimuli",
    "saline injection",
    "sample",
    "sample and probe outliers",
    "sample characteristics",
    "sample of 440 participants",
    "sample recruitment",
    "sample size",
    "samples",
    "samples with children and adolescents",
    "sampling bias",
    "saturation sampling",
    "scale ‘hyperactivity’",
    "scans exhibiting motion",
    "scenes",
    "schizophrenia",
    "schizophrenia/ASD/ADHD",
    "school accommodations",
    "school authority",
    "school children",
    "school day",
    "school environment",
    "school failure",
    "school health programs",
    "school performance",
    "school-age children",
    "school-age groups",
    "school-aged children",
    "school-aged samples",
    "schoolchildren",
    "schools",
    "scoliosis",
    "score on each of the 29 items",
    "scores",
    "scores 2”, “often”]}, ...] // The rest of the sentences are not relevant for named entity recognition as they contain mostly methodology, analysis, and results. The schema provided does not include entities like ASRS, inattention, hyperactive-impulsivity, etc., which are specific to the context of the text. However, if you want to include these entities, you can modify the schema accordingly. For example: {",
    "scores on the AUDIT",
    "scores on this questionnaire",
    "scoring instructions",
    "screen",
    "screen (+) group",
    "screen (−) group",
    "screen activities before bedtime",
    "screen time",
    "screen time before bedtime",
    "screener",
    "screening",
    "screening and proper management for ADHD syndromes",
    "screening program",
    "screening tools",
    "second",
    "second and third waves",
    "second aspect of symptom control",
    "second author",
    "second contribution",
    "second dose",
    "secondary analyses",
    "secondary group",
    "secondary outcomes",
    "secret media use",
    "sedentary behavior",
    "sedentary behaviors",
    "seizure disorder",
    "seizures",
    "selected schools",
    "selection",
    "selection of measures",
    "selection of the reported results",
    "selective attention",
    "self and maternal reports",
    "self monitoring",
    "self report scores",
    "self reported Inattention",
    "self- and parent-report",
    "self-administered questionnaires",
    "self-and-other-report",
    "self-assessed anxiety",
    "self-confidence",
    "self-constructed questionnaires",
    "self-esteem",
    "self-harm",
    "self-observation",
    "self-quitters",
    "self-referred",
    "self-report",
    "self-report of parents",
    "self-report outcomes",
    "self-report questionnaire",
    "self-report scores",
    "self-reported",
    "self-reported AQ scores",
    "self-reported ethnicity",
    "self-reported measures",
    "self-reported use",
    "self-reports",
    "selfreport questionnaire",
    "selling or possessing drugs",
    "semantic",
    "semantically inappropriate word substitutions",
    "semi-structured",
    "semi-structured diagnostic interview",
    "semi-structured in-depth phone interviews",
    "sense",
    "sensitisation hypothesis",
    "sensitivity analyses",
    "sensitivity analysis",
    "sensory assessments",
    "sensory features",
    "sensory hyper- or hyposensitivity",
    "sensory hyporeactivity",
    "sensory motor rhythm",
    "sensory processing",
    "sensory seeking",
    "sensory sensitivity questionnaire",
    "sensory symptoms",
    "separation anxiety",
    "sequencing",
    "serious outcomes",
    "serotonin",
    "serotonin levels",
    "serotonin system",
    "serotonin transporter",
    "sertraline",
    "serum GFAP",
    "serum NF-L",
    "serum folate levels",
    "serum gel tubes",
    "serum vitamin D levels",
    "services and treatments received",
    "seven",
    "seven attributes and three levels",
    "seven healthy adult humans",
    "seven interventions",
    "seven outcomes",
    "several observations",
    "several populations of different breeds",
    "severe anxious-depressive state",
    "severe developmental delays",
    "severe diagnoses",
    "severe disorders",
    "severe mental retardation",
    "severe motor difficulties",
    "severe non-syndromic sporadic intellectual disability",
    "severe sensory deficits",
    "severe symptoms",
    "severity of ADHD",
    "severity of ED",
    "severity of hyperactive-impulsive symptoms",
    "severity of phenotypes",
    "sex",
    "sex differences",
    "sex effects",
    "shRA",
    "shRB",
    "shRC",
    "shRL",
    "shRNA",
    "shRNA constructs",
    "shRNA knockdown",
    "shRNA knockdown studies",
    "shared familial confounds",
    "shared genetic factors",
    "shared genetic liability",
    "shared genetic risk",
    "shared last authorship",
    "shared molecular genetic factors",
    "shared neighbours",
    "short allele of the serotonin transporter (SLC6A4/5-HTT) HTTLPR polymorphism",
    "short period of exposure to screen activities",
    "short screen time",
    "short termly engagement",
    "short utterances",
    "short version of the WAIS",
    "short-acting counterparts",
    "short-acting formulations",
    "short-acting medications",
    "short-acting stimulants",
    "short-range",
    "short-range recurrence",
    "short-range recurrences",
    "shortened delay reward gradient",
    "shorter 3-session mindfulness program",
    "shorter sleep durations",
    "shorter sleep times on weekends",
    "should be replicated",
    "sibling comparisons",
    "sibling-comparison",
    "sibling-comparison analyses",
    "sibling-comparison design",
    "sibling-comparison models",
    "sibling-comparison research",
    "side effect of loss of appetite",
    "side effect of sleep disturbance",
    "side effect of vomiting",
    "side effects",
    "side-effect profiles",
    "side-effect rates",
    "signal of interest",
    "signed Table 1 Sample characteristics Diagnosis n % male Age (s.d.) RIN (s.d.) % medication-free",
    "signed informed consent",
    "significance level (P)",
    "significance level (α)",
    "significant",
    "significant SNP",
    "significant and suggestive SNP",
    "significant and suggestive SNPs",
    "significant association",
    "significant between-group difference",
    "significant clinical ADHD symptoms",
    "significant differences",
    "significant differences between the missense and PTV groups",
    "significant limitation",
    "significant predictor of reduced response to treatment",
    "significant predictors",
    "significant psychiatric disorder",
    "significantly",
    "significantly higher DQ scores",
    "significantly increased frequency",
    "similar age group",
    "similar results",
    "similar study",
    "similarly sized age-matched healthy control group",
    "single core deficits",
    "single integrated team",
    "single parent families",
    "single tasks measuring executive functions",
    "singletons",
    "site-directed mutagenesis",
    "situational pervasiveness of ADHD",
    "six",
    "six of them",
    "sixty-five participants",
    "size-5 soccer ball",
    "skilled",
    "skim milk",
    "sleep anxiety",
    "sleep anxiety (four items)",
    "sleep anxiety problems",
    "sleep complaints",
    "sleep disturbance",
    "sleep disturbances",
    "sleep duration (three items)",
    "sleep duration on weekends",
    "sleep duration problems",
    "sleep durations on weekends",
    "sleep hours",
    "sleep length",
    "sleep onset delay",
    "sleep onset delay (one item)",
    "sleep periods on weekends",
    "sleep problems",
    "sleep-disordered breath",
    "sleep-disordered breathing (three items)",
    "sleep-disordered breathing problems",
    "sleepiness",
    "slider",
    "slightly lower than the normal level",
    "small G proteins",
    "small numbers of participants",
    "small sample size",
    "smaller but still relevant effects",
    "smaller-sooner rewards",
    "smart phone or computer",
    "smartphone",
    "smoking",
    "smoking cessation and withdrawal",
    "smoking cessation program",
    "smoking during pregnancy",
    "smoking history",
    "smoking initiation",
    "snacks",
    "social and academic environments",
    "social anxiety",
    "social behavior disorders",
    "social behaviors",
    "social class",
    "social connections",
    "social contact",
    "social desirability",
    "social determinants of health",
    "social disorders",
    "social distress",
    "social environment",
    "social environmental experiences",
    "social functioning",
    "social institution",
    "social interactions and communication",
    "social media",
    "social skills",
    "social skills subscale",
    "social skills training",
    "social welfare receipt",
    "society",
    "socio demographics",
    "socio-economic status",
    "sociodemographic data",
    "socioeconomic confounders",
    "socioeconomic outcomes",
    "socioeconomic problems",
    "sodium–hydrogen exchange inhibitors",
    "soft drinks",
    "soft-thresholding",
    "some studies",
    "some typical symptoms",
    "somnolence",
    "sorrow",
    "sound barrier",
    "source",
    "spatial",
    "spatial and perceptual processing",
    "speakers",
    "speakers bureau",
    "specialist patient recruitment agency",
    "specialized treatments for adult ADHD",
    "species37",
    "specific FPCN subsystem",
    "specific assessment tools",
    "specific characteristics and moderators of stimulant treatment",
    "specific cognitive processes involved in self-regulation",
    "specific dimension",
    "specific genes",
    "specific learning disabilities",
    "specific moderators",
    "specific phobia",
    "specific problem and risks subscale",
    "specific side effects",
    "specific stimuli",
    "specific time",
    "specific trajectories",
    "specific treatment attributes",
    "specific treatment characteristics",
    "specific variants or cases of interest",
    "specifically",
    "speech",
    "speech and learning",
    "speech delays",
    "speech graph analysis",
    "speech therapy",
    "speed of onset",
    "speed-accuracy trade-off",
    "speed-accuracy trade-off in adult ADHD",
    "spells",
    "spine formation",
    "spines",
    "spontaneous SITUT",
    "spontaneous mind wandering",
    "sports and physical activities",
    "spring 2020",
    "spurious functional connectivities",
    "spurious local functional connectivity",
    "standard 8-session MBCT program",
    "standard 8-session web-based MBCT program",
    "standard ACE",
    "standard MBCT",
    "standard MBCT condition",
    "standard MBCT intervention",
    "standard Stroop task",
    "standard deviation",
    "standard error",
    "standard orthopedic treatment",
    "standard pipeline",
    "standardised",
    "standardised algorithm",
    "standardized algorithm",
    "standardized diagnostic and neuropsychological assessments",
    "standardized interview",
    "standardized methods",
    "staring hyperactivity",
    "start date",
    "start of the study",
    "stated parental preferences",
    "stated preference surveys",
    "stating",
    "statistical analyses",
    "statistical analysis",
    "statistical covariates",
    "statistical differences",
    "statistical methods",
    "statistically significant difference",
    "statistics",
    "stigma attached to mental illness",
    "stimulant",
    "stimulant ADHD group",
    "stimulant drugs",
    "stimulant groups",
    "stimulant medication",
    "stimulant medications",
    "stimulant therapies",
    "stimulant therapy",
    "stimulant therapy group",
    "stimulant treatment",
    "stimulant treatment effects",
    "stimulant treatment group",
    "stimulant treatments",
    "stimulant-exposed group",
    "stimulant-naive group",
    "stimulant-treated group",
    "stimulants",
    "stimuli",
    "stimulus-independence",
    "stomach pain",
    "stop signal reaction time (SSRT)",
    "stop signals",
    "stop-signal task",
    "storage time",
    "story production",
    "story resolution",
    "story retelling",
    "strained relationships",
    "strategies",
    "strategies used",
    "strategy",
    "strength and resilience of families",
    "strength of the association",
    "strengths and difficulties questionnaire",
    "strengths and limitations",
    "stress",
    "stress induced yawning",
    "stress levels",
    "stressful events",
    "stressful factors",
    "stressful life events",
    "stressful situations",
    "striatal activation",
    "striatal responses",
    "striatum",
    "stringent guidelines",
    "stroke",
    "strong medical care dependency",
    "structural brain abnormalities",
    "structural equation modeling (SEM)",
    "structure of ND in adults",
    "structured thematic assessment at schools",
    "student identification (ID)",
    "student status",
    "student survey",
    "students",
    "students’ self-reported questions",
    "studies",
    "studies in adolescents and (young) adults with ADHD",
    "studies involving human participants",
    "studies of delay-discounting",
    "study",
    "study by Gau et al",
    "study design",
    "study group",
    "study lead",
    "study methodology",
    "study neuroradiologist",
    "study of hyperactivity-impulsivity",
    "study participation",
    "study period",
    "study population",
    "study protocol",
    "study psychiatrist",
    "study sample",
    "study team",
    "study-related documentation",
    "study14",
    "studying ADHD",
    "sub-types of ADHD",
    "subclinical assessments",
    "subconcussive head impacts",
    "subconcussive-induced neural injury",
    "subgroup",
    "subitem 22-i",
    "subitem 22-ii",
    "subjective factors",
    "subjective nature of responses",
    "subjective score of dogs’ willingness to seek human contact",
    "subjects",
    "subjects in the non-reward condition",
    "subjects with ADHD",
    "subjects with ADHD in the reward condition",
    "submicroscopic duplications",
    "submit your manuscript",
    "suboptimal doses",
    "subpopulation assessed",
    "subsample (N = 54)",
    "subscale",
    "subscale of the Achenbach Child Behavior Checklist (CBCL)",
    "subscale scores",
    "subsequent determination",
    "subsequent outcomes during follow-up",
    "subsequent tobacco use",
    "subset of East Asian patients",
    "substance abuse",
    "substance abuse history",
    "substance abuse liability",
    "substance abuse/dependence",
    "substance and nicotine use and misuse",
    "substance misuse",
    "substance use",
    "substance use and addiction",
    "substance use disorder",
    "substance use disorder development",
    "substance use disorders",
    "substance use problems",
    "substitution",
    "subtests",
    "subthreshold ADHD",
    "subtype",
    "success or failure",
    "successful clinical response",
    "such analysis",
    "sudden death",
    "sugar",
    "suggestive",
    "suggestive SNPs",
    "suicide",
    "suicide attempt",
    "suicide attempts",
    "supplementary material",
    "support",
    "support for the differential susceptibility theory",
    "supporting information",
    "supporting people with ADHD",
    "suppressor effects",
    "surgery history",
    "surrogate variable (SV)1",
    "surrogate variables or principal components",
    "survey",
    "surveys",
    "survival curves",
    "susan.young1@imperial.ac.uk",
    "susceptibility toward environmental experiences",
    "suspicious PNES",
    "sustained attention",
    "sustained attention CPM",
    "sustained-release",
    "switching",
    "symptom clusters",
    "symptom control",
    "symptom domains",
    "symptom improvement",
    "symptom measures",
    "symptom severity",
    "symptomatic information",
    "symptomatic remission",
    "symptomatic remitters*",
    "symptomatology",
    "symptoms",
    "symptoms of ADHD",
    "symptoms persisted",
    "synapse density",
    "synapse development",
    "synapse function",
    "synapse loss",
    "synapses",
    "synaptic contacts",
    "synaptic transmission",
    "synonyms",
    "system being evaluated",
    "systematic literature search",
    "systematic review",
    "system’s usability",
    "t",
    "t test",
    "t-test",
    "t-tests",
    "tSDQ ADHD",
    "tablet per day",
    "tablet/PC",
    "tactile sensitivity",
    "tailored, comprehensive and developmentally-informed assessment and treatment approaches",
    "talk and consult about the DD",
    "talks excessively",
    "talks less",
    "target SNS",
    "target country’s local language",
    "target shooting sports",
    "target-shooting sport",
    "target-shooting sports",
    "targeted interventions",
    "targeted literature search",
    "targeted nature of the search",
    "task",
    "task performance",
    "task-evoked FPCN activation",
    "task-unrelated thought",
    "tasks",
    "tasks that require sustained attention and inhibitory control",
    "tea",
    "teacher SDQ hyperactivity domain",
    "teacher-reported symptoms",
    "teachers",
    "teachers at school",
    "technology",
    "tell a story",
    "temper outbursts",
    "temporal",
    "temporal and visual cortices",
    "temporal/delay-discounting",
    "tendency to believe",
    "terminal cancer",
    "test for ‘quantitative sex limitation’",
    "test item",
    "testing day",
    "tests",
    "that study",
    "the BRIEF-P Inhibit and Working Memory subscales",
    "the BRIEF-P subscale Emotional Control",
    "the Inhibit scale",
    "the Netherlands",
    "the Working Memory subscale",
    "the amount of variance in ADHD symptoms",
    "the finding",
    "the inventory’s discriminative ability",
    "the majority",
    "the model including treatment delay as a covariate",
    "the preschool population",
    "the present study’s main objective",
    "the remaining 214 patients",
    "the specificity of EF deficits in ADHD",
    "the study",
    "the three remaining patients",
    "the two basic EF domains inhibition and WM",
    "theft",
    "their BRIEF-P profile",
    "their mean IQ",
    "their own controls",
    "them",
    "theoretical considerations",
    "theoretical knowledge",
    "theorizing",
    "theory of mind",
    "therapies",
    "therapist",
    "therapists",
    "therapy",
    "there are no such studies",
    "these 131 individuals",
    "these behaviors",
    "these challenges",
    "these countries",
    "these data",
    "these databases",
    "these disorders",
    "these events",
    "these findings",
    "these genes",
    "these interactions",
    "these measures",
    "these patients",
    "these phenomena",
    "these preliminary findings",
    "these processes",
    "these rates",
    "these relations",
    "these resources",
    "these results",
    "these skills",
    "these studies",
    "these technologies",
    "these types of parents",
    "theta",
    "theta band coupling",
    "they",
    "third party material",
    "this",
    "this approach",
    "this article",
    "this difference",
    "this finding",
    "this function",
    "this intervention",
    "this licence",
    "this link",
    "this paper",
    "this population",
    "this post hoc analysis",
    "this precluded investigations",
    "this result",
    "this study",
    "this suggests",
    "this technology",
    "this view",
    "those aspects",
    "those diagnosed with ADHD",
    "those in the non-symptomatic group",
    "those receiving psychotherapy",
    "those results",
    "those who had emigrated within the 25 year period",
    "those with ASD",
    "three",
    "three factor solution",
    "three had reduced frequency",
    "three levels",
    "three of the studies",
    "three out of five children",
    "three showed reduced frequency",
    "three symptom groups",
    "three years after",
    "three-point Likert scale",
    "tic disorders",
    "tics",
    "time and cost savings",
    "time expenditures",
    "time from diagnosis to medication",
    "time invariant covariates",
    "time of measurement",
    "time perception",
    "time reproduction",
    "time reproduction accuracy coefficient scores",
    "time reproduction paradigm",
    "time reproduction task",
    "time spent",
    "time their children fell asleep and woke up",
    "time-varying SITUT states",
    "timing",
    "to correct an error",
    "to date",
    "tobacco",
    "tobacco use",
    "tolerability",
    "toothache",
    "top 95 and tail 95 dogs",
    "top-down control",
    "top-down poorer regulation of emotions",
    "topic",
    "topological overlap measure",
    "total",
    "total ADHD patient population",
    "total ADSA score",
    "total ADSA scores",
    "total DQI-I score",
    "total DQI-I scores",
    "total media time",
    "total number of words",
    "total sample",
    "total score",
    "total sleep problems",
    "toxicity",
    "traditional treatments",
    "traffic conditions",
    "traffic crime",
    "trained PhD clinicians",
    "trained assistants",
    "trained interviewer",
    "training or rehabilitation tools",
    "trait and state mind wandering",
    "trait mind wandering",
    "trait of interest",
    "transcranial magnetic stimulation",
    "transcription factor",
    "transcription factor binding sites",
    "transcription start site",
    "transcriptional activity",
    "traumatic brain injury (TBI)",
    "travel to and from school",
    "treatment",
    "treatment A or B",
    "treatment choices",
    "treatment combinations",
    "treatment delay",
    "treatment duration",
    "treatment during adolescence",
    "treatment groups",
    "treatment guidelines for ADHD",
    "treatment ineffectiveness",
    "treatment of ADHD",
    "treatment outcomes",
    "treatment patterns",
    "treatment plans",
    "treatment side effects",
    "treatment v. healthy control group",
    "treatment-adherent individuals",
    "treatment-emergent AE",
    "treatments to improve aspects of the development of neurons",
    "trial status",
    "triangular approach",
    "triaxial accelerometer (GFroceTracker Inc., Ontario, CA)",
    "trigger situations",
    "triggering factors of PNES",
    "truth",
    "twin recruitment",
    "twin study heritability estimates",
    "twinkling",
    "twins",
    "two",
    "two ADHD groups",
    "two ASRS subscales",
    "two certified public psychologists",
    "two exhibited persistent symptoms",
    "two models",
    "two novel IQSEC2 mutations",
    "two or more days",
    "two or threefold higher risk",
    "two regions",
    "two single nucleotide polymorphisms",
    "two to four times",
    "two-factor",
    "two-factor structure",
    "two-hundred-eighty-five participants",
    "two-marker haplotype analysis",
    "type 1 diabetes",
    "type of interventions",
    "type of main pain",
    "type of outcome measures",
    "type of participants",
    "type of study",
    "typical children",
    "typically developing controls",
    "typically developing peers",
    "unable to identify precipitating factors",
    "uncontrolled epilepsy",
    "under dependency",
    "under observation",
    "underestimated",
    "underlying psychological factors",
    "underrepresentation",
    "unemployed",
    "unemployment",
    "unequal numbers",
    "unhealthy bedtime activities",
    "univariate post-hoc ANCOVAs",
    "univariate posthoc ANCOVAS",
    "university",
    "university students",
    "unmeasured selection factors",
    "unmet need",
    "unmet needs",
    "unprotected sex",
    "unskilled",
    "upbringing",
    "upper RoS threshold",
    "upper abdominal pain",
    "urban city",
    "urbanization in Vietnam",
    "urge",
    "urinary tract",
    "use",
    "use of medication",
    "use of medications",
    "use of more words",
    "use of popular SNS",
    "use of substances",
    "use of such sites",
    "userListEnrichment function",
    "users",
    "users’ needs",
    "users’ perceptions",
    "user’s needs",
    "using SNS while driving",
    "using VR technologies as computer graphics",
    "using data from a 13-week RCT with methylphenidate",
    "using network analysis",
    "usual doses",
    "utterance",
    "vacant staring with tonic posture",
    "vaccination or minor collision",
    "vague sense of anxiety",
    "validation",
    "validation procedures",
    "value of rewards",
    "variability",
    "variable number of tandem repeat polymorphism in exon 3",
    "variables",
    "variance heterogeneity",
    "variance of self-reported inattention",
    "variants at amino acid 415",
    "variations",
    "variety",
    "various block injections",
    "venlafaxine",
    "venous angioma",
    "venous blood samples",
    "ventral attention",
    "verbal",
    "verbal IQ",
    "verbal memory",
    "verbal recount",
    "verbal suggestion",
    "verbally report",
    "verbally reporting",
    "verbosity",
    "version 20.0",
    "very brief (1-3 sessions) mindfulness interventions",
    "very few previous studies investigating adult ADHD",
    "very few studies",
    "very young participants",
    "video EEG monitoring",
    "video games",
    "video-generated environments",
    "violence",
    "violent crimes",
    "violent or age-inappropriate content",
    "virtual classroom",
    "virtual gaming",
    "virtual reality",
    "virtual reality environments",
    "virtual reality interventions",
    "virtual reality technologies",
    "virtual reality traffic gap-choice",
    "virtual test",
    "virus",
    "visual",
    "visual motor integration abnormalities",
    "visual stimuli",
    "visual stimulus",
    "visual/hearing abnormalities",
    "visualmotor domain",
    "vitamin A",
    "vitamin B12",
    "vitamin B12 status",
    "vitamin B6 levels",
    "vitamin D",
    "vitamin D concentration",
    "vitamin E",
    "vitamin levels",
    "vitamin status and deficiencies",
    "vitamins",
    "vitamins B2",
    "vitamins examined in this study",
    "vitamin–mineral supplement",
    "vocational outcomes",
    "voltage attenuation",
    "vomiting",
    "w2",
    "warmth",
    "warmth vs positive peer afﬁliation",
    "watched TV before bedtime",
    "watching TV",
    "wave 1",
    "wave 2",
    "wave 3",
    "we grouped them into two classes",
    "we hypothesized",
    "week",
    "week 1",
    "week 2",
    "weekdays",
    "weekdays and weekends",
    "weekend sleep time",
    "weekends",
    "weight at birth",
    "weight gain",
    "weight loss",
    "weighted adjacency matrix",
    "weighted co-expression network",
    "weighted gene co-expression analysis",
    "weighted gene co-expression analysis (WGCNA)",
    "well-being",
    "well-characterized sample",
    "well-structured environment",
    "well-validated psychiatric interview",
    "wellbeing",
    "welldefined participants with ADHD",
    "were highly correlated",
    "which was similar to other studies",
    "white matter",
    "white matter abnormalities",
    "whole KiGGS Sample",
    "whole blood gene expression",
    "whole checklist",
    "whole-genome gene expression data",
    "wide range of different treatments",
    "widely different types of rehabilitation therapies",
    "wild-type IQSEC2",
    "willingness to accept the disease",
    "willingness to receive a diagnosis",
    "wireless data plans",
    "wish I had more opportunities",
    "wish for more professional forums",
    "wish for support",
    "wish to share and reflect",
    "withdraw due to adverse event",
    "withdrawal",
    "withdrawal due to adverse event",
    "withdrawal due to adverse events",
    "withdrawal due to lack of efficacy",
    "withdrawal symptoms",
    "within the same age group",
    "within-DMN connectivity",
    "within-DMN functional connectivity",
    "without ADHD",
    "women",
    "women with ADHD",
    "wordless picture book",
    "words from the story",
    "words or words pairs",
    "work/school",
    "working memory",
    "world population",
    "worldwide pooled prevalence",
    "worldwide prevalence estimates",
    "write-up",
    "writing",
    "writing and editing support",
    "writing of the manuscript",
    "written consent",
    "written informed consent",
    "www.dovepress.com",
    "www.frontiersin.org",
    "www.neuroimage.nl",
    "www.tcpdf.org",
    "yawning",
    "years",
    "years of education",
    "years of professional experience",
    "years on the target SNS",
    "young adults",
    "young adults with night eating syndrome",
    "young mothers",
    "young people",
    "young preschool children",
    "young, non-clinical population sample",
    "younger age",
    "younger or more educated population",
    "younger people",
    "zero correlations between the outcome measures",
    "zygosity groups",
    "Åström",
    "Δdf",
    "β-value",
    "η p2",
    "κ",
    "χ2",
    "‘A’ allele",
    "‘Potential of treatment abuse’",
    "‘hub genes’",
    "‘‘go’’-RT",
    "“Fails to give close attention to details or makes careless mistakes in schoolwork”, “Loses things necessary for tasks or activities”,",
    "“human proximity” phenotype",
    "“persistence” personality trait",
    "“physical contact” phenotype",
    "“rarely”",
    "“sometimes”",
    "†Participant",
    "€2.50",
    "≥ 1 mg/kg MPH",
    "≥ 2500",
    "≥ 35",
    "≥ 37",
    "≥3 h/day",
    "ﬂexibility"
  ],
  "triples": [
    {
      "subject": "(A)",
      "relation": "treats",
      "object": "(B)",
      "weight": 1
    },
    {
      "subject": "(e)",
      "relation": "risk for",
      "object": "(f)",
      "weight": 1
    },
    {
      "subject": "(f)",
      "relation": "risk for",
      "object": "(g)",
      "weight": 1
    },
    {
      "subject": "18 items",
      "relation": "causes",
      "object": "total score",
      "weight": 1
    },
    {
      "subject": "19 (73.1%)",
      "relation": "regulates",
      "object": "OROS MPH",
      "weight": 1
    },
    {
      "subject": "2008",
      "relation": "decreases",
      "object": "2013",
      "weight": 1
    },
    {
      "subject": "2008",
      "relation": "decreases",
      "object": "Deters and Mehl",
      "weight": 1
    },
    {
      "subject": "2009",
      "relation": "decreases",
      "object": "Bussing et al.",
      "weight": 1
    },
    {
      "subject": "2014",
      "relation": "increases",
      "object": "Zywica and Danowski",
      "weight": 1
    },
    {
      "subject": "2500g",
      "relation": "decreases",
      "object": "37 weeks",
      "weight": 1
    },
    {
      "subject": "31",
      "relation": "risk for",
      "object": "32",
      "weight": 1
    },
    {
      "subject": "31",
      "relation": "risk for",
      "object": "schizophrenia",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "associated with",
      "object": "SNS",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "associated with",
      "object": "comorbid anxious and depressive disorders",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "associated with",
      "object": "parent-reported difficulties",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "associated with",
      "object": "substance use disorders",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "causes",
      "object": "school-aged children",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "decreases",
      "object": "ADHD symptom counts",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "decreases",
      "object": "resting-state DMN anticorrelation",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "decreases",
      "object": "subconcussive-induced neural injury",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "predicts",
      "object": "B",
      "weight": 2
    },
    {
      "subject": "ADHD",
      "relation": "predicts",
      "object": "sleep duration on weekends",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "predicts",
      "object": "sleep periods on weekends",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "risk for",
      "object": "Brain injury",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "risk for",
      "object": "PUI",
      "weight": 1
    },
    {
      "subject": "ADHD",
      "relation": "treats",
      "object": "BPD",
      "weight": 1
    },
    {
      "subject": "ADHD co-morbidity",
      "relation": "associated with",
      "object": "IGT decision making",
      "weight": 1
    },
    {
      "subject": "ADHD current symptoms",
      "relation": "associated with",
      "object": "loops of one node (L1)",
      "weight": 1
    },
    {
      "subject": "ADHD patients",
      "relation": "regulates",
      "object": "Mean age",
      "weight": 1
    },
    {
      "subject": "ADHD symptom control",
      "relation": "treats",
      "object": "perceived risks",
      "weight": 1
    },
    {
      "subject": "ADHD symptomatology",
      "relation": "associated with",
      "object": "narrative discourses",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "associated with",
      "object": "narrative discourse problems",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "associated with",
      "object": "short-range recurrence",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "associated with",
      "object": "sleep problems",
      "weight": 2
    },
    {
      "subject": "ADHD symptoms",
      "relation": "causes",
      "object": "2008",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "causes",
      "object": "Hirvikoski et al.",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "causes",
      "object": "Randazzo et al.",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "causes",
      "object": "daily functioning",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "decreases",
      "object": "self-esteem",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "increases",
      "object": "1999",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "increases",
      "object": "Flynn et al.",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "predicts",
      "object": "children’s sleep length on weekdays",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "promotes",
      "object": "H1a",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "regulates",
      "object": "Age",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "regulates",
      "object": "IQ",
      "weight": 1
    },
    {
      "subject": "ADHD symptoms",
      "relation": "regulates",
      "object": "educational level",
      "weight": 1
    },
    {
      "subject": "ADHD traits",
      "relation": "risk for",
      "object": "Carli et al. 2013",
      "weight": 1
    },
    {
      "subject": "ADHD-related difficulties",
      "relation": "inhibits",
      "object": "WM",
      "weight": 1
    },
    {
      "subject": "ADI-R subscales",
      "relation": "expresses",
      "object": "Second Edition",
      "weight": 1
    },
    {
      "subject": "ADSA",
      "relation": "associated with",
      "object": "IGT",
      "weight": 1
    },
    {
      "subject": "ADSA impulsivity subscales",
      "relation": "predicts",
      "object": "emotive and interpersonal subscales",
      "weight": 1
    },
    {
      "subject": "ASD",
      "relation": "decreases",
      "object": "perspective taking",
      "weight": 1
    },
    {
      "subject": "ASRS-hyperactivity/impulsivity",
      "relation": "associated with",
      "object": "phonic, motor and obsessive-compulsive TS-like behaviors",
      "weight": 1
    },
    {
      "subject": "ASRS-inattention",
      "relation": "associated with",
      "object": "OCBs linked to TS",
      "weight": 1
    },
    {
      "subject": "Acute declines in cognitive performance",
      "relation": "increases",
      "object": "Blood biomarker levels",
      "weight": 1
    },
    {
      "subject": "Adults with ADHD",
      "relation": "decreases",
      "object": "Reduced Attainment",
      "weight": 1
    },
    {
      "subject": "Age-adjusted duration",
      "relation": "treats",
      "object": "Conduct disorder",
      "weight": 1
    },
    {
      "subject": "Age-adjusted duration",
      "relation": "treats",
      "object": "Oppositional defiant disorder",
      "weight": 1
    },
    {
      "subject": "Alberta Health and Wellness",
      "relation": "promotes",
      "object": "school children",
      "weight": 1
    },
    {
      "subject": "Animal studies",
      "relation": "causes",
      "object": "Structural changes",
      "weight": 1
    },
    {
      "subject": "Anxiety/depression",
      "relation": "associated with",
      "object": "weekend sleep time",
      "weight": 1
    },
    {
      "subject": "Arf6",
      "relation": "interacts with",
      "object": "PSD-95",
      "weight": 1
    },
    {
      "subject": "Arg326His variant",
      "relation": "associated with",
      "object": "[13]",
      "weight": 1
    },
    {
      "subject": "Arg326His variant",
      "relation": "associated with",
      "object": "more severe clinical outcome",
      "weight": 1
    },
    {
      "subject": "Athletes with ADHD",
      "relation": "risk for",
      "object": "Concussion",
      "weight": 1
    },
    {
      "subject": "Attention-deficit/ hyperactivity disorder",
      "relation": "decreases",
      "object": "Trauma induced brain injury",
      "weight": 1
    },
    {
      "subject": "B",
      "relation": "associated with",
      "object": "sleep onset delay",
      "weight": 1
    },
    {
      "subject": "B9",
      "relation": "associated with",
      "object": "ADHD",
      "weight": 1
    },
    {
      "subject": "B9",
      "relation": "decreases",
      "object": "ADHD group",
      "weight": 1
    },
    {
      "subject": "B9",
      "relation": "decreases",
      "object": "P-values",
      "weight": 1
    },
    {
      "subject": "BPD women",
      "relation": "regulates",
      "object": "Table 1",
      "weight": 1
    },
    {
      "subject": "BUP",
      "relation": "causes",
      "object": "enhanced evidence",
      "weight": 1
    },
    {
      "subject": "Because",
      "relation": "treats",
      "object": "age at first stimulant use",
      "weight": 1
    },
    {
      "subject": "Blood biomarker levels",
      "relation": "associated with",
      "object": "Ubiquitin-Cterminal-hydrolase-L1",
      "weight": 1
    },
    {
      "subject": "C-G and T-G haplotypes",
      "relation": "increases",
      "object": "95% CI",
      "weight": 1
    },
    {
      "subject": "C-G and T-G haplotypes",
      "relation": "increases",
      "object": "95%CI",
      "weight": 1
    },
    {
      "subject": "CC",
      "relation": "associated with",
      "object": "severity of ED",
      "weight": 1
    },
    {
      "subject": "CC",
      "relation": "associated with",
      "object": "severity of hyperactive-impulsive symptoms",
      "weight": 1
    },
    {
      "subject": "CD",
      "relation": "regulates",
      "object": "CGI-S",
      "weight": 1
    },
    {
      "subject": "COMT",
      "relation": "associated with",
      "object": "schizophrenia",
      "weight": 1
    },
    {
      "subject": "CON",
      "relation": "regulates",
      "object": "ADHD",
      "weight": 1
    },
    {
      "subject": "CON",
      "relation": "regulates",
      "object": "ADHD Group",
      "weight": 1
    },
    {
      "subject": "CPRS-R:L",
      "relation": "associated with",
      "object": "oppositional defiant disorder",
      "weight": 1
    },
    {
      "subject": "CPT",
      "relation": "causes",
      "object": "Reward",
      "weight": 1
    },
    {
      "subject": "Chen et al.",
      "relation": "expresses",
      "object": "human TPH2",
      "weight": 1
    },
    {
      "subject": "Child Psychiatrists",
      "relation": "associated with",
      "object": "DD Process",
      "weight": 1
    },
    {
      "subject": "Children and Adolescents with ADHD without MPH",
      "relation": "decreases",
      "object": "Pain Perception",
      "weight": 1
    },
    {
      "subject": "Concussion",
      "relation": "increases",
      "object": "Repeated prevalence",
      "weight": 1
    },
    {
      "subject": "D1-/D2-type receptor activity ratio",
      "relation": "regulates",
      "object": "gamma oscillation power",
      "weight": 1
    },
    {
      "subject": "DAT1",
      "relation": "associated with",
      "object": "maternal warmth",
      "weight": 1
    },
    {
      "subject": "DCE",
      "relation": "prevents",
      "object": "survey",
      "weight": 1
    },
    {
      "subject": "DDX3X syndrome",
      "relation": "causes",
      "object": "NDDs in girls",
      "weight": 1
    },
    {
      "subject": "DMN-FPCN interaction",
      "relation": "associated with",
      "object": "spontaneous SITUT",
      "weight": 1
    },
    {
      "subject": "DRD4 7-repeat polymorphism",
      "relation": "associated with",
      "object": "postsynaptic inhibition of dopamine",
      "weight": 1
    },
    {
      "subject": "Data",
      "relation": "increases",
      "object": "Delay Aversion",
      "weight": 1
    },
    {
      "subject": "Demographic factors",
      "relation": "regulates",
      "object": "Subconcussive head impacts",
      "weight": 1
    },
    {
      "subject": "Depression Case–Control (DeCC) study",
      "relation": "regulates",
      "object": "National adult ADHD out-patient clinic",
      "weight": 1
    },
    {
      "subject": "Developmental Coordination Disorder Questionnaire",
      "relation": "expresses",
      "object": "ADI-R subscales",
      "weight": 1
    },
    {
      "subject": "Dopaminergic neural pathways",
      "relation": "decreases",
      "object": "Brain volume",
      "weight": 1
    },
    {
      "subject": "Dopaminergic neural pathways",
      "relation": "decreases",
      "object": "Cortical thickness",
      "weight": 1
    },
    {
      "subject": "ED",
      "relation": "associated with",
      "object": "aggressive and violent criminality",
      "weight": 1
    },
    {
      "subject": "EF",
      "relation": "associated with",
      "object": "ADHD symptoms",
      "weight": 1
    },
    {
      "subject": "EF ability",
      "relation": "associated with",
      "object": "ADHD symptoms",
      "weight": 1
    },
    {
      "subject": "EF and ToM latent factors",
      "relation": "correlates with",
      "object": "ASD and ADHD factors",
      "weight": 1
    },
    {
      "subject": "EFA",
      "relation": "predicts",
      "object": "EF",
      "weight": 1
    },
    {
      "subject": "EFA",
      "relation": "predicts",
      "object": "ToM",
      "weight": 1
    },
    {
      "subject": "EFA6A",
      "relation": "decreases",
      "object": "spine formation",
      "weight": 1
    },
    {
      "subject": "Environmental correlation estimates",
      "relation": "decreases",
      "object": "non-significant",
      "weight": 1
    },
    {
      "subject": "Facebook addiction",
      "relation": "decreases",
      "object": "strained relationships",
      "weight": 1
    },
    {
      "subject": "Female adults",
      "relation": "predicts",
      "object": "ADHD",
      "weight": 1
    },
    {
      "subject": "Fig. 1",
      "relation": "correlates with",
      "object": "poor IGT performance",
      "weight": 1
    },
    {
      "subject": "Fragile X mental retardation protein",
      "relation": "causes",
      "object": "synapse loss",
      "weight": 1
    },
    {
      "subject": "Go/No-Go task",
      "relation": "inhibits",
      "object": "behavioral inhibition",
      "weight": 1
    },
    {
      "subject": "Group",
      "relation": "predicts",
      "object": "IGT decision making",
      "weight": 1
    },
    {
      "subject": "HR",
      "relation": "treats",
      "object": "Table 3",
      "weight": 1
    },
    {
      "subject": "Hardy-Weinberg equilibrium",
      "relation": "regulates",
      "object": "rs4565946",
      "weight": 1
    },
    {
      "subject": "Heym et al.",
      "relation": "regulates",
      "object": "Abramovitch et al.",
      "weight": 1
    },
    {
      "subject": "Highest 10th percentile",
      "relation": "associated with",
      "object": "Female gender",
      "weight": 1
    },
    {
      "subject": "Hoang et al",
      "relation": "decreases",
      "object": "2500g",
      "weight": 1
    },
    {
      "subject": "IQ",
      "relation": "decreases",
      "object": "WAIS-III–Wechsler Adult Intelligence Scale",
      "weight": 1
    },
    {
      "subject": "IQ",
      "relation": "decreases",
      "object": "verbal memory",
      "weight": 1
    },
    {
      "subject": "IQSEC2",
      "relation": "expresses",
      "object": "synaptic transmission",
      "weight": 1
    },
    {
      "subject": "IQSEC2",
      "relation": "regulates",
      "object": "AMPA receptor-mediated synaptic transmission",
      "weight": 1
    },
    {
      "subject": "Indeed",
      "relation": "causes",
      "object": "HM",
      "weight": 1
    },
    {
      "subject": "Iqsec2",
      "relation": "expresses",
      "object": "shRA",
      "weight": 1
    },
    {
      "subject": "L1",
      "relation": "associated with",
      "object": "hyperactivity-impulsivity symptoms",
      "weight": 1
    },
    {
      "subject": "Long-Term Stimulant Medication",
      "relation": "increases",
      "object": "Pain Threshold in ADHD",
      "weight": 1
    },
    {
      "subject": "Luria Hand Game",
      "relation": "inhibits",
      "object": "Trail Making Test",
      "weight": 1
    },
    {
      "subject": "MPH",
      "relation": "increases",
      "object": "Abnormally Reduced Pain Perception",
      "weight": 1
    },
    {
      "subject": "Methylphenidate treatment",
      "relation": "associated with",
      "object": "Behavioral effects",
      "weight": 1
    },
    {
      "subject": "NMA",
      "relation": "causes",
      "object": "statistical differences",
      "weight": 1
    },
    {
      "subject": "Non-syndromic X-linked mental retardation",
      "relation": "associated with",
      "object": "missense mutation",
      "weight": 1
    },
    {
      "subject": "Numerous studies",
      "relation": "increases",
      "object": "substance use disorders",
      "weight": 1
    },
    {
      "subject": "Occupational Attainment",
      "relation": "risk for",
      "object": "Substance Dependence and Abuse",
      "weight": 1
    },
    {
      "subject": "Opioid System",
      "relation": "associated with",
      "object": "Impulsive Behaviors",
      "weight": 1
    },
    {
      "subject": "Performance Improvements",
      "relation": "mediates",
      "object": "CPT",
      "weight": 1
    },
    {
      "subject": "Performance Improvements",
      "relation": "mediates",
      "object": "Reward",
      "weight": 1
    },
    {
      "subject": "Qiagen",
      "relation": "treats",
      "object": "DNase I",
      "weight": 1
    },
    {
      "subject": "RCTs",
      "relation": "associated with",
      "object": "drug therapy",
      "weight": 1
    },
    {
      "subject": "Reward",
      "relation": "causes",
      "object": "Task Performance",
      "weight": 1
    },
    {
      "subject": "Reward Circuit",
      "relation": "mediates",
      "object": "Strategy Use",
      "weight": 1
    },
    {
      "subject": "SEZ6L",
      "relation": "associated with",
      "object": "autism spectrum disorder",
      "weight": 1
    },
    {
      "subject": "SITUT-CPM",
      "relation": "associated with",
      "object": "goal-directed cognition",
      "weight": 1
    },
    {
      "subject": "SITUT-CPM",
      "relation": "predicts",
      "object": "daydreaming frequency scale scores (DDFS)",
      "weight": 1
    },
    {
      "subject": "SLC1A2 and CACNA1A",
      "relation": "causes",
      "object": "epileptic encephalopathies",
      "weight": 1
    },
    {
      "subject": "SNP rs4570625",
      "relation": "increases",
      "object": "G allele",
      "weight": 1
    },
    {
      "subject": "SNS use while driving",
      "relation": "associated with",
      "object": "brain regions",
      "weight": 1
    },
    {
      "subject": "SSQ",
      "relation": "causes",
      "object": "age",
      "weight": 1
    },
    {
      "subject": "Scientific Reports | 6:33439 | DOI: 10.1038/srep33439 4 www.nature.com/scientificreports/",
      "relation": "associated with",
      "object": "bipolar disorder",
      "weight": 1
    },
    {
      "subject": "Self-Control in Impulsive Disorders",
      "relation": "regulates",
      "object": "Brain Regions Implicated in Motivational Impulsiveness",
      "weight": 1
    },
    {
      "subject": "Serum vitamin levels",
      "relation": "regulates",
      "object": "Mann–Whitney U test",
      "weight": 1
    },
    {
      "subject": "Smokers",
      "relation": "decreases",
      "object": "B9",
      "weight": 1
    },
    {
      "subject": "Smokers",
      "relation": "decreases",
      "object": "vitamins B2",
      "weight": 1
    },
    {
      "subject": "Some studies",
      "relation": "increases",
      "object": "substance use disorders",
      "weight": 1
    },
    {
      "subject": "Stimulant treatment v. healthy control group",
      "relation": "regulates",
      "object": "Hazard ratios",
      "weight": 1
    },
    {
      "subject": "Subconcussive head impacts",
      "relation": "increases",
      "object": "Two decades",
      "weight": 1
    },
    {
      "subject": "TOL",
      "relation": "associated with",
      "object": "Cambridge Gamble Task",
      "weight": 1
    },
    {
      "subject": "TPH2 gene",
      "relation": "causes",
      "object": "central serotonergic system",
      "weight": 1
    },
    {
      "subject": "TPH2 polymorphisms",
      "relation": "regulates",
      "object": "Table 2",
      "weight": 1
    },
    {
      "subject": "TS-OCB",
      "relation": "associated with",
      "object": "TS-phonic",
      "weight": 1
    },
    {
      "subject": "Table 2",
      "relation": "regulates",
      "object": "poor IGT Performance",
      "weight": 1
    },
    {
      "subject": "Therefore",
      "relation": "treats",
      "object": "HM",
      "weight": 1
    },
    {
      "subject": "These Specifics",
      "relation": "increases",
      "object": "Avoidant",
      "weight": 1
    },
    {
      "subject": "These Specifics",
      "relation": "increases",
      "object": "Histrionic",
      "weight": 1
    },
    {
      "subject": "ToM",
      "relation": "associated with",
      "object": "ASD symptoms",
      "weight": 1
    },
    {
      "subject": "Total number of words (TNW)",
      "relation": "associated with",
      "object": "Hyperactivity-Impulsivity",
      "weight": 1
    },
    {
      "subject": "University Hospital",
      "relation": "decreases",
      "object": "Tuebingen",
      "weight": 1
    },
    {
      "subject": "VR classroom",
      "relation": "causes",
      "object": "school environment",
      "weight": 1
    },
    {
      "subject": "VR classroom",
      "relation": "decreases",
      "object": "Bioulac et al. (2012)",
      "weight": 1
    },
    {
      "subject": "VR technologies",
      "relation": "promotes",
      "object": "action-based answers",
      "weight": 1
    },
    {
      "subject": "Val158Met",
      "relation": "associated with",
      "object": "mood regulation",
      "weight": 1
    },
    {
      "subject": "Wang et al",
      "relation": "increases",
      "object": "dopamine transporters",
      "weight": 1
    },
    {
      "subject": "Working Memory scales",
      "relation": "associated with",
      "object": "ADHD symptoms",
      "weight": 1
    },
    {
      "subject": "YWN-inactive",
      "relation": "associated with",
      "object": "YWN-active",
      "weight": 1
    },
    {
      "subject": "YWN-inactive",
      "relation": "associated with",
      "object": "compulsive TS behaviors",
      "weight": 1
    },
    {
      "subject": "Yawning scales",
      "relation": "associated with",
      "object": "pure (and overall) TS-like behaviors",
      "weight": 1
    },
    {
      "subject": "accuracy coefficient scores",
      "relation": "decreases",
      "object": "reward condition",
      "weight": 1
    },
    {
      "subject": "adult rats",
      "relation": "treats",
      "object": "adolescence",
      "weight": 1
    },
    {
      "subject": "adverse responses",
      "relation": "associated with",
      "object": "mild symptoms",
      "weight": 1
    },
    {
      "subject": "age",
      "relation": "associated with",
      "object": "AQ",
      "weight": 1
    },
    {
      "subject": "age",
      "relation": "associated with",
      "object": "social skills subscale",
      "weight": 1
    },
    {
      "subject": "age at first stimulant use",
      "relation": "treats",
      "object": "current use of",
      "weight": 1
    },
    {
      "subject": "all attributes",
      "relation": "predicts",
      "object": "choice",
      "weight": 1
    },
    {
      "subject": "all-cause withdrawal",
      "relation": "decreases",
      "object": "CLON",
      "weight": 1
    },
    {
      "subject": "all-cause withdrawal",
      "relation": "decreases",
      "object": "LDX",
      "weight": 1
    },
    {
      "subject": "analysis of brain changes",
      "relation": "associated with",
      "object": "ADHD",
      "weight": 1
    },
    {
      "subject": "animal studies",
      "relation": "predicts",
      "object": "sensitisation hypothesis",
      "weight": 1
    },
    {
      "subject": "antisocial behaviour",
      "relation": "associated with",
      "object": "severity of ADHD",
      "weight": 1
    },
    {
      "subject": "antisocial behaviour",
      "relation": "mediates",
      "object": "anger problems",
      "weight": 1
    },
    {
      "subject": "antisocial behaviour",
      "relation": "mediates",
      "object": "emotional lability",
      "weight": 1
    },
    {
      "subject": "anxiety symptoms",
      "relation": "associated with",
      "object": "inhibitory problems",
      "weight": 1
    },
    {
      "subject": "anxiety/depression symptoms",
      "relation": "predicts",
      "object": "B",
      "weight": 1
    },
    {
      "subject": "anxiety/depression symptoms",
      "relation": "predicts",
      "object": "sleep duration on weekends",
      "weight": 1
    },
    {
      "subject": "attention-deficit hyperactivity disorder",
      "relation": "associated with",
      "object": "earlier initiation of smoking",
      "weight": 1
    },
    {
      "subject": "attribute describing duration",
      "relation": "expresses",
      "object": "number of hours per day",
      "weight": 1
    },
    {
      "subject": "author",
      "relation": "expresses",
      "object": "stimulant drugs",
      "weight": 1
    },
    {
      "subject": "birth weight",
      "relation": "regulates",
      "object": "gestational age",
      "weight": 1
    },
    {
      "subject": "brain injury",
      "relation": "associated with",
      "object": "low birth weight",
      "weight": 1
    },
    {
      "subject": "catastrophic thinking",
      "relation": "increases",
      "object": "pain",
      "weight": 1
    },
    {
      "subject": "child and adolescent psychiatry",
      "relation": "decreases",
      "object": "easing of measures",
      "weight": 1
    },
    {
      "subject": "child psychiatrists",
      "relation": "causes",
      "object": "perception of disorders",
      "weight": 1
    },
    {
      "subject": "childhood diagnosis of ADHD",
      "relation": "increases",
      "object": "substance use disorders",
      "weight": 1
    },
    {
      "subject": "children",
      "relation": "decreases",
      "object": "39",
      "weight": 1
    },
    {
      "subject": "children",
      "relation": "risk for",
      "object": "substance use disorders",
      "weight": 1
    },
    {
      "subject": "children and adolescents",
      "relation": "associated with",
      "object": "health-related quality of life",
      "weight": 1
    },
    {
      "subject": "children and adolescents",
      "relation": "decreases",
      "object": "attention/inattention",
      "weight": 1
    },
    {
      "subject": "children and adolescents",
      "relation": "decreases",
      "object": "irritability",
      "weight": 1
    },
    {
      "subject": "children with ADHD symptoms",
      "relation": "prevents",
      "object": "screen activities before bedtime",
      "weight": 1
    },
    {
      "subject": "child’s survey information",
      "relation": "associated with",
      "object": "administrative health care records",
      "weight": 1
    },
    {
      "subject": "cognitive abilities",
      "relation": "associated with",
      "object": "participants’ variant type",
      "weight": 1
    },
    {
      "subject": "common side effects",
      "relation": "treats",
      "object": "abuse",
      "weight": 1
    },
    {
      "subject": "common underlying factors",
      "relation": "causes",
      "object": "crime",
      "weight": 1
    },
    {
      "subject": "common underlying factors",
      "relation": "causes",
      "object": "substance use",
      "weight": 1
    },
    {
      "subject": "comorbid anxious and depressive disorders",
      "relation": "regulates",
      "object": "correlations",
      "weight": 1
    },
    {
      "subject": "comorbid anxious and depressive disorders",
      "relation": "regulates",
      "object": "parameters",
      "weight": 1
    },
    {
      "subject": "comorbidity",
      "relation": "causes",
      "object": "neurotic disorders",
      "weight": 1
    },
    {
      "subject": "conflicts within the family",
      "relation": "increases",
      "object": "behavioral problems of children with ADHD",
      "weight": 1
    },
    {
      "subject": "connectedness",
      "relation": "associated with",
      "object": "IQ",
      "weight": 1
    },
    {
      "subject": "cybersickness",
      "relation": "prevents",
      "object": "causes",
      "weight": 1
    },
    {
      "subject": "dendritic spines",
      "relation": "expresses",
      "object": "wild-type IQSEC2",
      "weight": 1
    },
    {
      "subject": "diagnosis",
      "relation": "decreases",
      "object": "time reproduction accuracy coefficient scores",
      "weight": 1
    },
    {
      "subject": "diagnostic criteria",
      "relation": "treats",
      "object": "age of patients",
      "weight": 1
    },
    {
      "subject": "different approaches to ADHD management",
      "relation": "causes",
      "object": "different ADHD treatment patterns",
      "weight": 1
    },
    {
      "subject": "dilemmas",
      "relation": "causes",
      "object": "child",
      "weight": 1
    },
    {
      "subject": "directionality",
      "relation": "expresses",
      "object": "Iqsec2/IQSEC2",
      "weight": 1
    },
    {
      "subject": "dopamine and serotonin",
      "relation": "regulates",
      "object": "behavioral response to rewards",
      "weight": 1
    },
    {
      "subject": "drug use disorder",
      "relation": "associated with",
      "object": "CC",
      "weight": 1
    },
    {
      "subject": "early intervention",
      "relation": "prevents",
      "object": "childhood diagnosis of ADHD",
      "weight": 1
    },
    {
      "subject": "early symptoms of ODD",
      "relation": "associated with",
      "object": "difficulties in inhibition and emotional regulation",
      "weight": 1
    },
    {
      "subject": "emotive",
      "relation": "associated with",
      "object": "IGT",
      "weight": 1
    },
    {
      "subject": "emotive",
      "relation": "predicts",
      "object": "poor IGT performance",
      "weight": 1
    },
    {
      "subject": "evidence-based prevention strategies",
      "relation": "decreases",
      "object": "ADHD",
      "weight": 1
    },
    {
      "subject": "executive function deficits",
      "relation": "causes",
      "object": "digressions",
      "weight": 1
    },
    {
      "subject": "expressive language",
      "relation": "expresses",
      "object": "Second Edition",
      "weight": 1
    },
    {
      "subject": "externalizing problems (ADHD, ODD)",
      "relation": "associated with",
      "object": "higher problem ratings",
      "weight": 1
    },
    {
      "subject": "eyes-closed EEG",
      "relation": "mediates",
      "object": "each movement",
      "weight": 1
    },
    {
      "subject": "false positive discoveries",
      "relation": "decreases",
      "object": "power to detect effects",
      "weight": 2
    },
    {
      "subject": "fetal development",
      "relation": "decreases",
      "object": "birth weight",
      "weight": 1
    },
    {
      "subject": "fewer autocorrections",
      "relation": "regulates",
      "object": "use of more words",
      "weight": 1
    },
    {
      "subject": "findings",
      "relation": "causes",
      "object": "results",
      "weight": 1
    },
    {
      "subject": "five possible candidate genes",
      "relation": "associated with",
      "object": "human-directed social behaviors",
      "weight": 1
    },
    {
      "subject": "full dataset",
      "relation": "associated with",
      "object": "small sample size",
      "weight": 1
    },
    {
      "subject": "gaming",
      "relation": "increases",
      "object": "adolescents",
      "weight": 1
    },
    {
      "subject": "gamma frequency oscillations",
      "relation": "associated with",
      "object": "psychiatric disorders",
      "weight": 1
    },
    {
      "subject": "gene x sex interaction",
      "relation": "causes",
      "object": "women",
      "weight": 1
    },
    {
      "subject": "general adjustment problems",
      "relation": "associated with",
      "object": "adults with ADHD",
      "weight": 1
    },
    {
      "subject": "genetic mutations",
      "relation": "associated with",
      "object": "severe non-syndromic sporadic intellectual disability",
      "weight": 1
    },
    {
      "subject": "grade five students",
      "relation": "associated with",
      "object": "internalizing disorders",
      "weight": 1
    },
    {
      "subject": "guanine nucleotide exchange factors (GEF)",
      "relation": "binds",
      "object": "ARFGEF",
      "weight": 1
    },
    {
      "subject": "having no other children living at home",
      "relation": "associated with",
      "object": "non-adherence",
      "weight": 1
    },
    {
      "subject": "head motion",
      "relation": "associated with",
      "object": "self and maternal reports",
      "weight": 1
    },
    {
      "subject": "healthy controls",
      "relation": "regulates",
      "object": "IQ",
      "weight": 1
    },
    {
      "subject": "healthy controls",
      "relation": "regulates",
      "object": "education",
      "weight": 1
    },
    {
      "subject": "healthy controls",
      "relation": "regulates",
      "object": "psychotropic use",
      "weight": 1
    },
    {
      "subject": "healthy participants",
      "relation": "predicts",
      "object": "ADHD",
      "weight": 1
    },
    {
      "subject": "heterozygotes",
      "relation": "mediates",
      "object": "Fig. 2b",
      "weight": 1
    },
    {
      "subject": "high SB",
      "relation": "associated with",
      "object": "poor mental health",
      "weight": 1
    },
    {
      "subject": "high exposure to games and TV",
      "relation": "decreases",
      "object": "sleep hours",
      "weight": 1
    },
    {
      "subject": "high score subgroup",
      "relation": "regulates",
      "object": "Table 4",
      "weight": 1
    },
    {
      "subject": "higher ADHD symptomatology",
      "relation": "associated with",
      "object": "more poorly connected report",
      "weight": 1
    },
    {
      "subject": "higher overall screen time",
      "relation": "causes",
      "object": "ADHD-related behaviors",
      "weight": 1
    },
    {
      "subject": "human emotions",
      "relation": "causes",
      "object": "rewards",
      "weight": 1
    },
    {
      "subject": "hyperactivity-impulsivity symptoms",
      "relation": "associated with",
      "object": "L1",
      "weight": 1
    },
    {
      "subject": "hyperventilation syndrome",
      "relation": "causes",
      "object": "Nijmegen scale",
      "weight": 1
    },
    {
      "subject": "hypothesis (iii)",
      "relation": "associated with",
      "object": "CI",
      "weight": 1
    },
    {
      "subject": "identified genes",
      "relation": "associated with",
      "object": "human social impairments",
      "weight": 1
    },
    {
      "subject": "impairments and disabilities",
      "relation": "associated with",
      "object": "brain damage",
      "weight": 1
    },
    {
      "subject": "impairments in ToM",
      "relation": "associated with",
      "object": "ASD symptoms",
      "weight": 1
    },
    {
      "subject": "impulsivity symptoms",
      "relation": "causes",
      "object": "behaviour",
      "weight": 1
    },
    {
      "subject": "increased reward sensitivity",
      "relation": "associated with",
      "object": "ADHD and impulsivity",
      "weight": 1
    },
    {
      "subject": "inhibitory control",
      "relation": "associated with",
      "object": "poor DM in BPD women",
      "weight": 1
    },
    {
      "subject": "interaction between genetic and environmental factors (GxE)",
      "relation": "regulates",
      "object": "behavioral reward sensitivity",
      "weight": 1
    },
    {
      "subject": "interactions with parents and peers",
      "relation": "associated with",
      "object": "behavioral and neural sensitivity to rewards",
      "weight": 1
    },
    {
      "subject": "less emphasis in the main story plot",
      "relation": "regulates",
      "object": "[8]",
      "weight": 1
    },
    {
      "subject": "literature search terms",
      "relation": "treats",
      "object": "quality of life",
      "weight": 1
    },
    {
      "subject": "loops of one node (L1)",
      "relation": "associated with",
      "object": "largest strongly connected component (LSC)",
      "weight": 1
    },
    {
      "subject": "low birth weight",
      "relation": "associated with",
      "object": "environmental risks",
      "weight": 1
    },
    {
      "subject": "main diagnosis",
      "relation": "regulates",
      "object": "ASD",
      "weight": 1
    },
    {
      "subject": "main diagnosis",
      "relation": "regulates",
      "object": "MDD",
      "weight": 1
    },
    {
      "subject": "main diagnosis",
      "relation": "regulates",
      "object": "adult ADHD",
      "weight": 1
    },
    {
      "subject": "marihuana users",
      "relation": "risk for",
      "object": "subsequent tobacco use",
      "weight": 1
    },
    {
      "subject": "maternal 5-HTT",
      "relation": "associated with",
      "object": "deviant peer afﬁliation",
      "weight": 1
    },
    {
      "subject": "maternal criticism",
      "relation": "associated with",
      "object": "VS BOLD response",
      "weight": 1
    },
    {
      "subject": "maternal deprivation",
      "relation": "increases",
      "object": "dopamine levels",
      "weight": 1
    },
    {
      "subject": "maternal warmth",
      "relation": "associated with",
      "object": "adolescent reward speeding",
      "weight": 1
    },
    {
      "subject": "media consumption",
      "relation": "increases",
      "object": "lockdown",
      "weight": 1
    },
    {
      "subject": "medication non-adherence",
      "relation": "treats",
      "object": "ADHD",
      "weight": 1
    },
    {
      "subject": "methylphenidate",
      "relation": "treats",
      "object": "behavioral changes",
      "weight": 1
    },
    {
      "subject": "mind wandering",
      "relation": "regulates",
      "object": "DMN",
      "weight": 2
    },
    {
      "subject": "more bedtime eating behaviors",
      "relation": "associated with",
      "object": "night waking problems",
      "weight": 1
    },
    {
      "subject": "mutual decision-making with their parents",
      "relation": "causes",
      "object": "Iowa Gambling Task",
      "weight": 1
    },
    {
      "subject": "naturalistic and non-randomised",
      "relation": "regulates",
      "object": "possible confounding factors",
      "weight": 1
    },
    {
      "subject": "nausea",
      "relation": "treats",
      "object": "GXR",
      "weight": 1
    },
    {
      "subject": "nausea",
      "relation": "treats",
      "object": "MPH",
      "weight": 1
    },
    {
      "subject": "network-based approach",
      "relation": "promotes",
      "object": "external datasets",
      "weight": 1
    },
    {
      "subject": "nicotine dependence",
      "relation": "causes",
      "object": "motivations for smoking",
      "weight": 1
    },
    {
      "subject": "no difference",
      "relation": "risk for",
      "object": "nicotine dependence",
      "weight": 1
    },
    {
      "subject": "no difference",
      "relation": "risk for",
      "object": "substance use disorder",
      "weight": 1
    },
    {
      "subject": "no-stimulant treatment group",
      "relation": "increases",
      "object": "nicotine dependence",
      "weight": 1
    },
    {
      "subject": "non-stimulant therapies",
      "relation": "decreases",
      "object": "safety concerns",
      "weight": 1
    },
    {
      "subject": "norepinephrine",
      "relation": "binds",
      "object": "serotonin transporter",
      "weight": 1
    },
    {
      "subject": "normal development of these skills",
      "relation": "causes",
      "object": "ability to perform well (on tasks)",
      "weight": 1
    },
    {
      "subject": "normal population",
      "relation": "associated with",
      "object": "hyperactive/impulsive ADHD-like behaviors",
      "weight": 1
    },
    {
      "subject": "normalisation",
      "relation": "risk for",
      "object": "substance use disorders",
      "weight": 1
    },
    {
      "subject": "not mentioned",
      "relation": "decreases",
      "object": "Lee et al. (2001)",
      "weight": 1
    },
    {
      "subject": "oppositional defiant disorder in youth",
      "relation": "associated with",
      "object": "antisocial behaviour",
      "weight": 1
    },
    {
      "subject": "our study",
      "relation": "associated with",
      "object": "behavior traits",
      "weight": 1
    },
    {
      "subject": "overall",
      "relation": "associated with",
      "object": "ASRS scales",
      "weight": 1
    },
    {
      "subject": "overall ASRS",
      "relation": "associated with",
      "object": "TS-OCB",
      "weight": 1
    },
    {
      "subject": "p",
      "relation": "decreases",
      "object": "other-report",
      "weight": 1
    },
    {
      "subject": "pairwise Pearson correlation coefficients",
      "relation": "increases",
      "object": "fixed power (b = 12)",
      "weight": 1
    },
    {
      "subject": "parent",
      "relation": "causes",
      "object": "DD",
      "weight": 1
    },
    {
      "subject": "parental support",
      "relation": "associated with",
      "object": "substance use",
      "weight": 1
    },
    {
      "subject": "parents in the US",
      "relation": "causes",
      "object": "tendency to believe",
      "weight": 1
    },
    {
      "subject": "participant and informant",
      "relation": "causes",
      "object": "analyses",
      "weight": 1
    },
    {
      "subject": "participants",
      "relation": "treats",
      "object": "MPH",
      "weight": 1
    },
    {
      "subject": "participants with a diagnosis of ADHD",
      "relation": "risk for",
      "object": "substance use disorders",
      "weight": 1
    },
    {
      "subject": "patients’ treating physicians",
      "relation": "treats",
      "object": "stimulants",
      "weight": 1
    },
    {
      "subject": "phalloidin-stained",
      "relation": "expresses",
      "object": "EGFP",
      "weight": 1
    },
    {
      "subject": "pharmacotherapy",
      "relation": "causes",
      "object": "adherence",
      "weight": 1
    },
    {
      "subject": "phenotypic heterogeneity",
      "relation": "associated with",
      "object": "these disorders",
      "weight": 1
    },
    {
      "subject": "physical or psychosocial functioning",
      "relation": "associated with",
      "object": "mental health problems",
      "weight": 1
    },
    {
      "subject": "polymorphism",
      "relation": "associated with",
      "object": "“persistence” personality trait",
      "weight": 1
    },
    {
      "subject": "poor diet quality",
      "relation": "associated with",
      "object": "decreased mental health",
      "weight": 1
    },
    {
      "subject": "positive attributes",
      "relation": "treats",
      "object": "negative aspects",
      "weight": 1
    },
    {
      "subject": "positive social inﬂuences",
      "relation": "promotes",
      "object": "optimal reward learning",
      "weight": 1
    },
    {
      "subject": "predicted two additional outcomes",
      "relation": "associated with",
      "object": "low income",
      "weight": 1
    },
    {
      "subject": "prevalence of ADHD",
      "relation": "decreases",
      "object": "world population",
      "weight": 1
    },
    {
      "subject": "processes",
      "relation": "mediates",
      "object": "ADHD symptoms",
      "weight": 1
    },
    {
      "subject": "prodrug technology",
      "relation": "decreases",
      "object": "interand intra-patient variability",
      "weight": 1
    },
    {
      "subject": "promoter rs4570625",
      "relation": "causes",
      "object": "CdxA transcription factor",
      "weight": 1
    },
    {
      "subject": "proxies",
      "relation": "decreases",
      "object": "participants themselves",
      "weight": 1
    },
    {
      "subject": "pupil diameter",
      "relation": "predicts",
      "object": "task-unrelated thought",
      "weight": 1
    },
    {
      "subject": "putative candidate genes",
      "relation": "associated with",
      "object": "interspecies communication in dogs",
      "weight": 1
    },
    {
      "subject": "rarely reported",
      "relation": "increases",
      "object": "lockdown",
      "weight": 1
    },
    {
      "subject": "rate of maternal depression",
      "relation": "decreases",
      "object": "North and South of Vietnam",
      "weight": 1
    },
    {
      "subject": "representative module expression profile",
      "relation": "expresses",
      "object": "first principal component",
      "weight": 1
    },
    {
      "subject": "reward",
      "relation": "causes",
      "object": "task performance",
      "weight": 1
    },
    {
      "subject": "reward",
      "relation": "increases",
      "object": "subjects with ADHD",
      "weight": 1
    },
    {
      "subject": "reward processing decision probe",
      "relation": "causes",
      "object": "DM",
      "weight": 1
    },
    {
      "subject": "school-age children",
      "relation": "causes",
      "object": "behavioral competencies",
      "weight": 1
    },
    {
      "subject": "secondary group",
      "relation": "associated with",
      "object": "nausea",
      "weight": 1
    },
    {
      "subject": "selection",
      "relation": "causes",
      "object": "estimates of relationships between variables of interest",
      "weight": 1
    },
    {
      "subject": "self-esteem",
      "relation": "increases",
      "object": "stress",
      "weight": 1
    },
    {
      "subject": "self-esteem",
      "relation": "regulates",
      "object": "SNS",
      "weight": 1
    },
    {
      "subject": "self-reported AQ scores",
      "relation": "decreases",
      "object": "Table 2",
      "weight": 1
    },
    {
      "subject": "serum vitamin D levels",
      "relation": "decreases",
      "object": "children and adolescents",
      "weight": 1
    },
    {
      "subject": "seven",
      "relation": "prevents",
      "object": "preference item combinations",
      "weight": 1
    },
    {
      "subject": "severity of ED",
      "relation": "associated with",
      "object": "CC",
      "weight": 1
    },
    {
      "subject": "sex differences",
      "relation": "associated with",
      "object": "ADHD",
      "weight": 1
    },
    {
      "subject": "sex differences",
      "relation": "associated with",
      "object": "SNS",
      "weight": 1
    },
    {
      "subject": "shRC",
      "relation": "causes",
      "object": "Iqsec2",
      "weight": 1
    },
    {
      "subject": "shRNA",
      "relation": "expresses",
      "object": "EGFP",
      "weight": 1
    },
    {
      "subject": "shortened delay reward gradient",
      "relation": "increases",
      "object": "delayed reward discounting",
      "weight": 1
    },
    {
      "subject": "sleep problems",
      "relation": "associated with",
      "object": "diet behavior",
      "weight": 2
    },
    {
      "subject": "sleep problems",
      "relation": "associated with",
      "object": "r",
      "weight": 2
    },
    {
      "subject": "social media",
      "relation": "increases",
      "object": "adolescents",
      "weight": 1
    },
    {
      "subject": "social welfare receipt",
      "relation": "predicts",
      "object": "low income",
      "weight": 1
    },
    {
      "subject": "soft-thresholding",
      "relation": "causes",
      "object": "weighted adjacency matrix",
      "weight": 1
    },
    {
      "subject": "specific genes",
      "relation": "associated with",
      "object": "social skills",
      "weight": 1
    },
    {
      "subject": "specifically",
      "relation": "predicts",
      "object": "higher ADHD symptomatology",
      "weight": 1
    },
    {
      "subject": "standard MBCT",
      "relation": "treats",
      "object": "anxiety",
      "weight": 1
    },
    {
      "subject": "standard MBCT",
      "relation": "treats",
      "object": "depression",
      "weight": 1
    },
    {
      "subject": "stimulant therapy",
      "relation": "causes",
      "object": "substance use disorders",
      "weight": 1
    },
    {
      "subject": "stimulant treatment",
      "relation": "prevents",
      "object": "nicotine dependence",
      "weight": 1
    },
    {
      "subject": "stimulant treatment",
      "relation": "prevents",
      "object": "substance use disorders",
      "weight": 1
    },
    {
      "subject": "stimulant treatment group",
      "relation": "risk for",
      "object": "Fig. 1(b)",
      "weight": 1
    },
    {
      "subject": "stimulant treatment group",
      "relation": "risk for",
      "object": "nicotine dependence",
      "weight": 1
    },
    {
      "subject": "stimulant treatment group",
      "relation": "risk for",
      "object": "substance use disorder",
      "weight": 1
    },
    {
      "subject": "stimulant-treated group",
      "relation": "decreases",
      "object": "power of our analyses",
      "weight": 1
    },
    {
      "subject": "stop signal reaction time (SSRT)",
      "relation": "regulates",
      "object": "[32]",
      "weight": 1
    },
    {
      "subject": "stress",
      "relation": "increases",
      "object": "SNS",
      "weight": 1
    },
    {
      "subject": "subconcussive head impacts",
      "relation": "increases",
      "object": "serum GFAP",
      "weight": 1
    },
    {
      "subject": "subconcussive-induced neural injury",
      "relation": "increases",
      "object": "serum NF-L",
      "weight": 1
    },
    {
      "subject": "substance use and addiction",
      "relation": "causes",
      "object": "crime",
      "weight": 1
    },
    {
      "subject": "surrogate variable (SV)1",
      "relation": "associated with",
      "object": "SV2",
      "weight": 1
    },
    {
      "subject": "symptom clusters",
      "relation": "associated with",
      "object": "EF difficulties",
      "weight": 1
    },
    {
      "subject": "symptom control",
      "relation": "regulates",
      "object": "side effects",
      "weight": 1
    },
    {
      "subject": "symptomatic information",
      "relation": "associated with",
      "object": "scale ‘hyperactivity’",
      "weight": 1
    },
    {
      "subject": "symptoms of ADHD",
      "relation": "associated with",
      "object": "deviances in EF",
      "weight": 1
    },
    {
      "subject": "the amount of variance in ADHD symptoms",
      "relation": "predicts",
      "object": "each of the five BRIEF-P subscales",
      "weight": 1
    },
    {
      "subject": "these behaviors",
      "relation": "associated with",
      "object": "sleep problems",
      "weight": 1
    },
    {
      "subject": "these disorders",
      "relation": "associated with",
      "object": "development",
      "weight": 1
    },
    {
      "subject": "these findings",
      "relation": "treats",
      "object": "preliminary",
      "weight": 1
    },
    {
      "subject": "these findings",
      "relation": "treats",
      "object": "should be replicated",
      "weight": 1
    },
    {
      "subject": "these rates",
      "relation": "decreases",
      "object": "ours",
      "weight": 1
    },
    {
      "subject": "three",
      "relation": "decreases",
      "object": "12%",
      "weight": 1
    },
    {
      "subject": "total number of words",
      "relation": "associated with",
      "object": "Hyperactivity-Impulsivity",
      "weight": 1
    },
    {
      "subject": "trait mind wandering",
      "relation": "associated with",
      "object": "within-DMN functional connectivity",
      "weight": 1
    },
    {
      "subject": "transcriptional activity",
      "relation": "associated with",
      "object": "HTTLPR short allele",
      "weight": 1
    },
    {
      "subject": "transcriptional activity",
      "relation": "causes",
      "object": "dopamine",
      "weight": 1
    },
    {
      "subject": "treatment",
      "relation": "prevents",
      "object": "risk of abuse potential",
      "weight": 1
    },
    {
      "subject": "treatment combinations",
      "relation": "treats",
      "object": "costs",
      "weight": 1
    },
    {
      "subject": "twinkling",
      "relation": "causes",
      "object": "somnolence",
      "weight": 1
    },
    {
      "subject": "two novel IQSEC2 mutations",
      "relation": "associated with",
      "object": "X-linked intellectual disability with seizures",
      "weight": 1
    },
    {
      "subject": "use of medication",
      "relation": "treats",
      "object": "long-term treatment",
      "weight": 1
    },
    {
      "subject": "use of more words",
      "relation": "regulates",
      "object": "fewer utterances related to the main plot",
      "weight": 1
    },
    {
      "subject": "use of more words",
      "relation": "regulates",
      "object": "to correct an error",
      "weight": 1
    },
    {
      "subject": "using VR technologies as computer graphics",
      "relation": "decreases",
      "object": "malfunction of patients",
      "weight": 1
    },
    {
      "subject": "validation",
      "relation": "causes",
      "object": "excessive use",
      "weight": 1
    },
    {
      "subject": "validation",
      "relation": "causes",
      "object": "potential addiction",
      "weight": 1
    },
    {
      "subject": "variables",
      "relation": "mediates",
      "object": "ADHD",
      "weight": 1
    },
    {
      "subject": "vitamin D",
      "relation": "regulates",
      "object": "cell and tissue growth and differentiation",
      "weight": 1
    },
    {
      "subject": "vitamin levels",
      "relation": "associated with",
      "object": "ADHD diagnosis and psychiatric symptoms",
      "weight": 1
    },
    {
      "subject": "watching TV",
      "relation": "associated with",
      "object": "health care services",
      "weight": 1
    },
    {
      "subject": "weekdays",
      "relation": "decreases",
      "object": "children with ADHD",
      "weight": 1
    },
    {
      "subject": "white matter abnormalities",
      "relation": "causes",
      "object": "brain injury",
      "weight": 1
    },
    {
      "subject": "wild-type IQSEC2",
      "relation": "decreases",
      "object": "neurite processes",
      "weight": 1
    }
  ]
}